<SEC-DOCUMENT>0001144204-16-126914.txt : 20161005
<SEC-HEADER>0001144204-16-126914.hdr.sgml : 20161005
<ACCEPTANCE-DATETIME>20161005080143
ACCESSION NUMBER:		0001144204-16-126914
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20161115
FILED AS OF DATE:		20161005
DATE AS OF CHANGE:		20161005
EFFECTIVENESS DATE:		20161005

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AYTU BIOSCIENCE, INC
		CENTRAL INDEX KEY:			0001385818
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				470883144
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-53121
		FILM NUMBER:		161921346

	BUSINESS ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 200
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		(720) 437-6580

	MAIL ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 200
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC.
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rosewind CORP
		DATE OF NAME CHANGE:	20070110
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>v449779_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>SCHEDULE 14A
INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Proxy Statement Pursuant to Section&nbsp;14(a)
of the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">Filed by the Registrant&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings">x</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;Filed
by a Party other than the Registrant&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Preliminary Proxy Statement</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Confidential, for Use of
the Commission Only (as permitted by Rule 14a-6(e)(2))</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#120;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Definitive Proxy Statement</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Definitive Additional Materials</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Soliciting Material Pursuant
to &sect; 240.14a-12</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 12pt"><B>Aytu BioScience, Inc.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Name of Registrant as Specified In Its Charter)</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Name of Person(s) Filing Proxy Statement if other Than the Registrant)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Payment of Filing Fee (Check the appropriate box):</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">x</FONT></TD><TD><FONT STYLE="font-size: 10pt">No fee required.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1)</TD><TD>Title of each class of securities to which transaction applies:</TD></TR>                                                                                                                                             <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2)</TD><TD>Aggregate number of securities to which transaction applies:</TD></TR>                                                                                                                                          <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3)</TD><TD>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on
which the filing fee is calculated and state how it was determined):</TD></TR>                                                                              <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4)</TD><TD>Proposed maximum aggregate value of transaction:</TD></TR>                                                                                                                              <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5)</TD><TD>Total fee paid:</TD></TR>                                                                                             <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Fee paid previously with
preliminary materials.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify
the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or
the Form or Schedule and the date of its filing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1)</TD><TD>Amount Previously Paid:</TD></TR>                                                                                                     <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2)</TD><TD>Form, Schedule or Registration Statement No.:</TD></TR>                                                                                                                           <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3)</TD><TD>Filing Party:</TD></TR>                                                                                           <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4)</TD><TD>Date Filed:</TD></TR>                                                                                         <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>AYTU BIOSCIENCE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>373 Inverness Parkway, Suite 206</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Englewood, Colorado 80112</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>TO BE HELD NOVEMBER 15, 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">TO THE STOCKHOLDERS OF</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">AYTU BIOSCIENCE, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The 2017 annual meeting of stockholders of
Aytu BioScience, Inc. will be held at the offices of Wyrick Robbins Yates &amp; Ponton LLP, 4101 Lake Boone Trail, Suite 300, Raleigh,
North Carolina 27607, on November 15, 2016, at 10:00 a.m. Eastern time, for the following purposes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>To elect five directors to serve until the 2017 Annual Meeting of Stockholders and until their successors are duly elected
and qualified;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>To approve an amendment to our Certificate of Incorporation to effect a reverse stock split at a ratio of any whole number
between 1-for-2 and 1-for-4, as determined by our board of directors, at any time before November 15, 2017, if and as determined
by our board of directors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>To approve amendments to our 2015 Stock Option and Incentive Plan to (i) increase <FONT STYLE="background-color: white">the
number of authorized shares of common stock reserved for issuance thereunder from 833,334 shares to 2,000,000 shares, (ii) increase
the number of shares that may be issued as incentive stock options from 833,334 shares to 2,000,000 shares, </FONT>and (iii) increase
the maximum number of shares of common stock (A) underlying stock options or stock appreciation rights that may be granted to any
one individual during any calendar year period, and (B) granted to any one individual that is intended to qualify as &ldquo;performance-based
compensation&rdquo; under Section&nbsp;162(m) of the Internal Revenue Code of 1986, as amended, for any performance cycle, in each
case from 166,667 shares to 1,000,000 shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>To ratify the appointment of EKS&amp;H LLLP as our independent registered public accounting firm for the fiscal year ending
June 30, 2017; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD>To act upon such other matters as may properly come before the meeting or any adjournment thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">These matters are more fully described in the
proxy statement accompanying this notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The Board has fixed the close of business on
September 22, 2016 as the record date for the determination of stockholders entitled to notice of and to vote at the meeting or
any adjournment thereof. A list of stockholders eligible to vote at the meeting will be available for review during our regular
business hours at our principal offices in Englewood, Colorado for the 10 days prior to the meeting for review for any purposes
related to the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">You are cordially invited to attend the meeting
in person. However, to assure your representation at the meeting, you are urged to vote by proxy by following the instructions
contained in the proxy statement. You may revoke your proxy in the manner described in the proxy statement at any time before it
has been voted at the meeting. Any stockholder attending the meeting may vote in person even if he or she has returned a proxy.<B>
Your vote is important</B>.<B> Whether or not you plan to attend the annual meeting, we hope that you will vote as soon as possible.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">We are pleased to take advantage of the Securities
and Exchange Commission, or SEC, rules that allow us to furnish proxy materials, including this notice, the proxy statement (including
an electronic proxy card for the meeting) and our 2016 Annual Report to Stockholders via the Internet. Taking advantage of these
rules allows us to lower the cost of delivering annual meeting materials to our stockholders and reduce the environmental impact
of printing and mailing these materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Englewood, Colorado</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dated: October 5, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">By Order of the Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Joshua R. Disbrow</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">President, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>QUESTIONS AND ANSWERS ABOUT THE 2016 ANNUAL
MEETING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>Q:</B></TD><TD><B>Who may vote at the meeting? </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>A:</B></TD><TD>The Board of Directors has set September 22, 2016 as the record date for the meeting. If you owned shares of our common stock
at the close of business on September 22, 2016, you may attend and vote at the meeting. Each stockholder is entitled to one vote
for each share of common stock held on all matters to be voted on. As of September 22, 2016, there were 5,080,591 shares of our
common stock outstanding and entitled to vote at the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -36.05pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 36pt"><B>Q:</B></TD><TD><B>What is the difference between holding shares as a stockholder of record and as a beneficial owner? </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>A:</B></TD><TD>If your shares are registered directly in your name with our transfer agent, VStock Transfer, LLC, you are considered, with
respect to those shares, a &ldquo;stockholder of record.&rdquo; If you are a stockholder of record, we have sent these proxy materials
to you directly.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"></TD><TD>If your shares are held in a stock brokerage account or by a bank or other holder of record, you are considered the &ldquo;beneficial
owner&rdquo; of shares held in street name. In that case, these proxy materials have been forwarded to you by your broker, bank,
or other holder of record who is considered, with respect to those shares, the stockholder of record. As the beneficial owner,
you have the right to direct your broker, bank, or other holder of record on how to vote your shares by using the voting instruction
card included in the mailing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -36.05pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 36pt"><B>Q:</B></TD><TD><B>What is the quorum requirement for the meeting? </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>A:</B></TD><TD>A majority of our outstanding shares of capital stock entitled to vote as of the record date must be present at the meeting
in order for us to hold the meeting and conduct business. This is called a quorum. Your shares will be counted as present at the
meeting if you:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>are present and entitled to vote in person at the meeting; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>properly submitted a proxy card or voter instruction card in advance of or at the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">If you are present in person or by proxy at the meeting,
but abstain from voting on any or all proposals, your shares are still counted as present and entitled to vote. Each proposal listed
in this proxy statement identifies the votes needed to approve or ratify the proposed action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>Q:</B></TD><TD><B>What proposals will be voted on at the meeting? </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>A:</B></TD><TD>The four proposals to be voted on at the meeting are as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>To elect the five directors named in the proxy statement to serve until our next annual meeting or until their successors have
been elected and qualified;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>To approve a reverse stock split at a ratio of any whole number between 1-for-2 and 1-for-4, as determined by our board of
directors, at any time before November 15, 2017, if and as determined by our board of directors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>To approve amendments to our 2015 Stock Option and Incentive Plan to (i) increase <FONT STYLE="background-color: white">the
number of authorized shares of common stock reserved for issuance thereunder from 833,334 shares to 2,000,000 shares, (ii) increase
the number of shares that may be issued as incentive stock options from 833,334 shares to 2,000,000 shares,</FONT> and (iii) increase
the maximum number of shares of common stock (A) underlying stock options or stock appreciation rights that may be granted to any
one individual during any calendar year period, and (B) granted to any one individual that is intended to qualify as &ldquo;performance-based
compensation&rdquo; under Section&nbsp;162(m) of the Internal Revenue Code of 1986, as amended, for any performance cycle, in each
case from 166,667 shares to 1,000,000 shares; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>To ratify the appointment of EKS&amp;H LLLP as our independent registered public accounting firm for the fiscal year ending
June 30, 2017.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">We will also consider any other business that properly
comes before the meeting. As of the record date, we are not aware of any other matters to be submitted for consideration at the
meeting. If any other matters are properly brought before the meeting, the persons named in the enclosed proxy card or voter instruction
card will vote the shares they represent using their best judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -36.05pt"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -36.05pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 36pt"><B>Q:</B></TD><TD><B>How may I vote my shares in person at the meeting? </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>A:</B></TD><TD>If your shares are registered directly in your name with our transfer agent, VStock Transfer, LLC, you are considered, with
respect to those shares, the stockholder of record. As the stockholder of record, you have the right to vote in person at the meeting.
You will need to present a form of personal photo identification in order to be admitted to the meeting. If your shares are held
in a brokerage account or by another nominee or trustee, you are considered the beneficial owner of shares held in street name.
As the beneficial owner, you are also invited to attend the meeting. Because a beneficial owner is not the stockholder of record,
you may not vote these shares in person at the meeting unless you obtain a &ldquo;legal proxy&rdquo; from your broker, nominee,
or trustee that holds your shares, giving you the right to vote the shares at the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>Q:</B></TD><TD><B>How can I vote my shares without attending the meeting? </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>A:</B></TD><TD>Whether you hold shares directly as a registered stockholder of record or beneficially in street name, you may vote without
attending the meeting. <FONT STYLE="font-family: Times New Roman, Times, Serif">If your common stock is held by a broker, bank
or other nominee, they should send you instructions that you must follow in order to have your shares voted. If you hold shares
in your own name, you may vote by proxy in any one of the following ways:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>Via the Internet by accessing the proxy<FONT STYLE="font-family: Times New Roman, Times, Serif"> materials on the secured website
<U>https://www.proxyvote.com</U> and following the voting instructions on that website;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Via telephone by calling toll free 1-800-690-6903 in the United States
and following the recorded instructions; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By requesting that printed copies of the proxy materials be mailed
to you pursuant to the instructions provided in the Notice of Internet Availability of Proxy Materials and completing, dating,
signing and returning the proxy card that you receive in response to your request. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">The Internet and telephone voting procedures
are designed to authenticate stockholders&rsquo; identities by use of a control number to allow stockholders to vote their
shares and to confirm that stockholders&rsquo; instructions have been properly recorded. Voting via the Internet or telephone
must be completed by 11:59 p.m. Eastern Time on November 14, 2016. If stockholders have any questions or need assistance
voting their proxy, please call Gregory A. Gould at our headquarters at 1-720-437-6580. Of course, you can always come to the
meeting and vote your shares in person. If you submit or return a proxy card without giving specific voting instructions,
your shares will be voted as recommended by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>Q:</B></TD><TD><B>How can I change my vote after submitting it? </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>A:</B></TD><TD>If you are a stockholder of record, you can revoke your proxy before your shares are voted at the meeting by:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>Filing a written notice of revocation bearing a later date than the proxy with our Corporate Secretary either before the meeting
or at the meeting at 373 Inverness Parkway, Suite 206, Englewood, Colorado 80112;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>Duly executing a later-dated proxy relating to the same shares and delivering it to our Corporate Secretary either before or
at the meeting and before the taking of the vote, at 373 Inverness Parkway, Suite 206, Englewood, Colorado 80112; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>Attending the meeting and voting in person (although attendance at the meeting will not in and of itself constitute a revocation
of a proxy).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">If you are a beneficial owner of shares, you may submit
new voting instructions by contacting your bank, broker, or other holder of record. You may also vote in person at the meeting
if you obtain a legal proxy from them as described in the answer to a previous question.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>Q:</B></TD><TD><B>Where can I find the voting results of the meeting? </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>A:</B></TD><TD>We will announce the voting results at the annual meeting. We will publish the results in a Form 8-K filed with the SEC within
four business days of the annual meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AYTU BIOSCIENCE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>373 Inverness Parkway, Suite 206</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Englewood, Colorado 80112</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PROXY STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ANNUAL MEETING OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>November 15, 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">This proxy statement has been prepared by the
management of Aytu BioScience, Inc. &ldquo;We,&rdquo; &ldquo;our&rdquo; and the &ldquo;Company&rdquo; each refers to Aytu BioScience,
Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In accordance with the rules of the SEC, instead
of mailing a printed copy of our proxy materials to each stockholder of record, we are furnishing proxy materials, including the
notice, this proxy statement, our 2016 Annual Report to Stockholders, including financial statements, and a proxy card for the
meeting, by providing access to them on the Internet to save printing costs and benefit the environment. These materials were first
available on the Internet on or about October 5, 2016. We mailed a Notice of Internet Availability of Proxy Materials on or about
October 5, 2016 to our stockholders of record and beneficial owners as of September 22, 2016, the record date for the meeting.
This proxy statement and the Notice of Internet Availability of Proxy Materials contain instructions for accessing and reviewing
our proxy materials on the Internet and for voting by proxy over the Internet. You will need to obtain your own Internet access
if you choose to access the proxy materials and/or vote over the Internet. If you prefer to receive printed copies of our proxy
materials, the Notice of Internet Availability of Proxy Materials contains instructions on how to request the materials by mail.
You will not receive printed copies of the proxy materials unless you request them. If you elect to receive the materials by mail,
you may also vote by proxy on the proxy card or voter instruction card that you will receive in response to your request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 20.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>GENERAL INFORMATION ABOUT SOLICITATION VOTING AND ATTENDING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Who Can Vote</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">You are entitled to attend the meeting
and vote your common stock if you held shares as of the close of business on September 22, 2016. At the close of business on
September 22, 2016, a total of 5,080,591   shares of common stock were outstanding and entitled to vote. Each share of common
stock has one vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Counting Votes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Consistent with state law and our bylaws, the
presence, in person or by proxy, of at least a majority of the shares entitled to vote at the meeting will constitute a quorum
for purposes of voting on a particular matter at the meeting. Once a share is represented for any purpose at the meeting, it is
deemed present for quorum purposes for the remainder of the meeting and any adjournment thereof unless a new record date is set
for the adjournment. Shares held of record by stockholders or their nominees who do not vote by proxy or attend the meeting in
person will not be considered present or represented and will not be counted in determining the presence of a quorum. Signed proxies
that withhold authority or reflect abstentions and &ldquo;broker non-votes&rdquo; will be counted for purposes of determining whether
a quorum is present. &ldquo;Broker non-votes&rdquo; are proxies received from brokerage firms or other nominees holding shares
on behalf of their clients who have not been given specific voting instructions from their clients with respect to matters being
voted on. Broker non-votes will be counted for purposes of establishing a quorum to conduct business at the meeting, but not for
determining the number of shares voted FOR, AGAINST, ABSTAINING or WITHHELD FROM with respect to any matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Assuming the presence of a quorum at the meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>The election of directors will be determined by a plurality of the votes cast at the meeting. This means that the five nominees
receiving the highest number of &ldquo;FOR&rdquo; votes will be elected as directors. Withheld votes and broker non-votes, if any,
are not treated as votes cast, and therefore will have no effect on the proposal to elect directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>The affirmative vote of the holders of a majority of the total outstanding shares of our common stock as of the record date
is necessary to approve the reverse stock split. Withheld votes and broker non-votes, if any, are not treated as votes cast, and
therefore will effectively be a vote against this proposal.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>The amendments to our 2015 Stock Option and Incentive Plan require the affirmative vote of a majority of the votes cast at
the meeting. Withheld votes and broker non-votes, if any, are not treated as votes cast, and therefore will have no effect on this
proposal.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>The ratification of the appointment of our independent registered public accounting firm requires the affirmative vote of a
majority of the votes cast at the meeting. Withheld votes and broker non-votes, if any, are not treated as votes cast, and therefore
will have no effect on this proposal.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">We strongly encourage you to provide instructions
to your bank, brokerage firm, or other nominee by voting your proxy. This action ensures that your shares will be voted in accordance
with your wishes at the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Cost of this Proxy Solicitation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">We will pay the cost of this proxy solicitation.
In addition to soliciting proxies by mail, our directors and employees might solicit proxies personally and by telephone. None
of these individuals will receive any additional compensation for this. As pf the date of this proxy statement, we have not retained
a proxy solicitor to assist in the forwarding and solicitation of proxies, although we may do so if we determine that it would
be advisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Attending the Annual Meeting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">If you are a holder of record and plan to attend
the annual meeting, please bring a photo identification to confirm your identity. If you are a beneficial owner of common stock
held by a bank or broker, i.e., in &ldquo;street name,&rdquo; you will need proof of ownership to be admitted to the meeting. A
recent brokerage statement or letter from a bank or broker are examples of proof of ownership. If you want to vote in person your
common stock held in street name, you must get a proxy in your name from the registered holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PROPOSAL NO. 1 &mdash; ELECTION OF DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our bylaws currently provide that the number
of directors constituting the Board shall be determined solely and exclusively by resolution duly adopted from time to time by
the Board. There are five directors presently serving on our Board, and the number of directors to be elected at this annual meeting
is five. Because our Board only recently achieved a majority of independent directors in July 2016, at which time an independent
Nominating and Governance Committee was appointed, the full Board has proposed the five nominees listed below for election to the
Board for a one-year term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our common stock is not listed on any exchange
and is only quoted on the OTCQX. Consequently no exchange rules regarding director independence are applicable to us. However,
our Board has applied the NYSE MKT test for director independence to all of our directors.&nbsp;Two of our five directors
are not independent under the NYSE MKT definition due to (i) being an executive officer of our Company, in the case of Mr. Disbrow,
and (ii) the payments we make to Ampio Pharmaceuticals, Inc. under our services agreement with Ampio, in the case of Mr. Macaluso.
Mr. Macaluso is the President and CEO and a director of Ampio. In addition to the specific bars to independence set forth in the
NYSE MKT rule, we also consider whether a director or his affiliates have provided any services to, worked for or received any
compensation from us or any of our subsidiaries in the past three years in particular. In addition, none of the nominees are related
by blood, marriage or adoption to any other nominee or any of our executive officers except that Joshua Disbrow and Jarrett Disbrow,
our Chief Operating Officer, are brothers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Directors with Terms Expiring in 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 29%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Name </B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 15%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Director&nbsp;Since</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Position(s) with Aytu</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8.8pt; text-indent: -8.8pt">Joshua R. Disbrow </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">41</TD>
    <TD>&nbsp;</TD>
    <TD>January 2016</TD>
    <TD>&nbsp;</TD>
    <TD>President, Chief Executive Officer, Director</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8.8pt; text-indent: -8.8pt">Gary V. Cantrell</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">61</TD>
    <TD>&nbsp;</TD>
    <TD>July 2016</TD>
    <TD>&nbsp;</TD>
    <TD>Director</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8.8pt; text-indent: -8.8pt">Carl C. Dockery</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">53</TD>
    <TD>&nbsp;</TD>
    <TD>April 2016</TD>
    <TD>&nbsp;</TD>
    <TD>Director</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8.8pt; text-indent: -8.8pt">John A. Donofrio, Jr.</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">49</TD>
    <TD>&nbsp;</TD>
    <TD>July 2016</TD>
    <TD>&nbsp;</TD>
    <TD>Director</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8.8pt; text-indent: -8.8pt">Michael Macaluso</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">64</TD>
    <TD>&nbsp;</TD>
    <TD>April 2015</TD>
    <TD>&nbsp;</TD>
    <TD>Director </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Joshua R. Disbrow &ndash; Chairman and Chief Executive Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Joshua R. Disbrow has been employed by us since
April 16, 2015. Prior to the closing of the merger with Luoxis and Vyrix, Mr. Disbrow was the Chief Executive Officer of Luoxis
since January 2013. Mr. Disbrow was also the Chief Operating Officer of Ampio since December 2012. Prior to joining Ampio, he served
as the Vice President of Commercial Operations at Arbor Pharmaceuticals, a specialty pharmaceutical company, from May 2007 through
October 2012. He joined Arbor as that company&rsquo;s second full-time employee. Mr. Disbrow led the company&rsquo;s commercial
efforts from inception to the company&rsquo;s acquisition in 2010 and growth to over $127 million in net sales in 2011. By the
time Mr. Disbrow departed Arbor in late 2012, he had led the growth of the commercial organization to comprise over 150 people
in sales, marketing sales training, managed care, national accounts, and other commercial functions. Mr. Disbrow has spent over
17 years in the pharmaceutical, diagnostic and medical device industries and has held positions of increasing responsibility in
sales, marketing, sales management, commercial operations and commercial strategy. Prior to joining Arbor, Mr. Disbrow served as
Regional Sales Manager with Cyberonics, Inc., a medical device company focused on neuromodulation therapies from June 2005 through
April 2007. Prior to joining Cyberonics he was the Director of Marketing at LipoScience, an in vitro diagnostics company. Mr. Disbrow
holds an MBA from Wake Forest University and BS in Management from North Carolina State University. Mr. Disbrow&rsquo;s experience
in executive management and marketing within the pharmaceutical industry, monetizing company opportunities, and corporate finance
led to the conclusion that he should serve as a director of our Company in light of our business and structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Gary V. Cantrell &ndash; Director</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Gary Cantrell joined our Board in July
2016. He has 30 years of experience in the life sciences industry ranging from clinical experience as a respiratory therapist
to his current exclusive consulting role with Mayne Pharma (ASX: MYX) as Business Development Executive focused on acquiring
branded prescription assets for Mayne&rsquo;s U.S. Specialty Brands Division. Mr. Cantrell served as CEO of Yasoo Health
Inc., a global specialty nutritional company from 2007 through June 2015, highlighted by the sale of its majority asset
AquADEKs to Actavis in March 2016. Previously, he was President of The Catevo Group, a U.S.-based healthcare consulting firm.
Prior to that, he was Executive Vice President, Sales and Marketing for TEAMM Pharmaceuticals, an Accentia Biopharmaceuticals
company, where he led all commercial activities for a public specialty pharmaceutical business. His previous 22 years were at
GlaxoSmithKline plc where he held progressively senior management positions in sales, marketing and business development. Mr.
Cantrell is a graduate of Wichita State University and serves as an advisor to several emerging life science companies. He
served as a director for Yasoo Health Inc., Yasoo Health Limited and Flexible Stenting Solutions, Inc., a leading developer
of next generation peripheral arterial, venous, neurovascular and biliary stents, which was sold to Cordis, while a Division
of Johnson &amp; Johnson in March 2013. Mr. Cantrell served as a director of Vyrix Pharmaceuticals from February 2014 to
April 2015. Mr. Cantrell&rsquo;s experience in consulting and executive management within the pharmaceutical industry led to
the conclusion that he should serve as a director of our company in light of our business and structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Carl C. Dockery &ndash; Director</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Carl Dockery joined our Board in April 2016.
Mr. Dockery is a financial executive with 30 years of experience as an executive in the insurance and reinsurance industry and
more recently in 2006 as the founder and president of a registered investment advisory firm, Alpha Advisors, LLC. Mr. Dockery&rsquo;s
career as an insurance executive began in 1988 as an officer and director of two related and closely held insurance companies,
including serving as secretary of Crossroads Insurance Co. Ltd. of Bermuda and as vice president of Gulf Insurance Co. Ltd. of
Grand Cayman. Familiar with the London reinsurance market, in the 1990s, Mr. Dockery worked at Lloyd&rsquo;s and the London Underwriting
Centre brokering various types of reinsurance placements. Mr. Dockery serves as a director of CytoDyn Inc. (OTCQB: &ldquo;CYDY&rdquo;),
a biotechnology company. Mr. Dockery graduated from Southeastern University with a Bachelor of Arts in Humanities. Mr. Dockery&rsquo;s
financial expertise and experience, as well as his experience as a director of a publicly traded biopharmaceutical company, led
to the conclusion that he should serve as a director of our company in light of our business and structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>John A. Donofrio, Jr. &ndash; Director</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="background-color: white">John
Donofrio </FONT>joined our Board in July 2016. He <FONT STYLE="background-color: white">is a Senior Finance Executive with </FONT>24
years of experience in the pharmaceutical industry across a broad range of areas, including consolidated financial reporting, international
accounting and internal controls, financial systems development and implementation, cost accounting, inventory management, supply
chain, transfer pricing, budget and forecast planning, integration of mergers and acquisitions and business development.<FONT STYLE="background-color: white">
He has served as the </FONT>Chief Financial Officer and Head of North American Business Development for Merz North America, or
Merz, since August 2013. Merz is a specialty healthcare company that develops and commercializes innovative treatment solutions
in aesthetics, dermatology and neurosciences in the U.S. and Canada.&nbsp;At Merz, Mr. Donofrio is accountable for financial performance,
cost management, business development and strategic business planning and analysis for the finance organization in North America.
Prior to joining Merz, Mr. Donofrio served as Vice President, Stiefel Global Finance, U.S. Specialty Business and Puerto Rico for
Stiefel, a GlaxoSmithKline plc company from July 2009 to July 2013. In that role, Mr. Donofrio was responsible for the financial
strategy, management reporting, and overall control framework for the Global Dermatology Business Unit. He was also the Senior
Finance Partner accountable for the U.S. Specialty Business Units of GlaxoSmithKline plc. Mr. Donofrio served as a director of
Vyrix Pharmaceuticals from February 2014 to April 2015. Mr. Donofrio holds a degree in Accounting from North Carolina State University.
Mr. Donofrio&rsquo;s financial expertise and experience in the pharmaceutical industry, led to the conclusion that he should serve
as a director of our company in light of our business and structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Michael Macaluso &ndash; Director</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Michael Macaluso has been a member of our Board
of Directors since April 2015. Mr. Macaluso is also the Chairman and Chief Executive Officer of Ampio. Mr. Macaluso has been a
member of Ampio Pharmaceuticals&rsquo; Board of Directors since March 2010 and Ampio&rsquo;s Chief Executive Officer since January
2012. Mr. Macaluso served in the roles of president and Chief Executive Officer of Isolagen, Inc. (AMEX: ILE) from June 2001 until
September 2004. Mr. Macaluso also served on the board of directors of Isolagen from June 2001 until April 2005. From October 1998
until June 2001, Mr. Macaluso was the owner of Page International Communications, a manufacturing business. Mr. Macaluso was a
founder and principal of International Printing and Publishing, a position Mr. Macaluso held from 1989 until 1997, when he sold
that business to a private equity firm. Mr. Macaluso&rsquo;s experience in executive management and marketing within the pharmaceutical
industry, monetizing company opportunities, and corporate finance led to the conclusion that he should serve as a director of our
company in light of our business and structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Directors are elected by a plurality of the
votes cast at the annual meeting. This means that the five nominees receiving the highest number of votes will be elected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Recommendation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The Board unanimously recommends that stockholders
vote <B>FOR</B> the election of the five nominees for election to the Board for a one-year term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PROPOSAL NO. 2 &mdash;APPROVAL OF AN AMENDMENT
TO OUR CERTIFICATE OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>INCORPORATION TO EFFECT A REVERSE STOCK SPLIT AT THE DISCRETION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OF OUR BOARD OF DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>General </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our Board believes it is in our best interests
and the best interests of our stockholders to authorize a reverse stock split of the Company&rsquo;s outstanding common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The Board is asking our stockholders to approve
a reverse split of our common stock and grant to the Board the authority to set the ratio for the reverse split in the range of
1-for-2 and 1-for-4 (the &ldquo;Reverse Stock Split&rdquo;), or not to complete the Reverse Stock Split, as determined in the discretion
of the Board at any time before November 15, 2017. If the proposal is approved by our stockholders, our Board will have authority
to effect the Reserve Stock Split if and at such time as it determines to be appropriate. The principal effect of the Reverse Stock
Split would be to decrease the outstanding number of shares of common stock, while maintaining the authorized number of shares
at their current levels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The Board is asking that our stockholders approve
a range of exchange ratios for the Reverse Stock Split because it is not possible at this time to predict market conditions at
the time the split would be implemented. If approved by our stockholders, the Board will be authorized to implement a reverse stock
split at a ratio of any whole number between 1-for-2 and 1-for-4, or to abandon the split, as determined at the discretion of the
Board. The Board will set the ratio for the Reverse Stock Split or abandon the Reverse Stock Split as it determines is advisable
considering relevant market conditions at the time the reverse split is to be implemented or abandoned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">To implement the Reverse Stock Split, we would,
at a meeting of the Board or by written consent in lieu of a meeting, resolve to effect the Reverse Stock Split, and the number
of issued and outstanding shares of common stock would thereby be reduced by a ratio of one share for every two, three or four
shares outstanding, depending on the ratio chosen by the Board. If our Board determines that effecting the reverse stock split
is in our best interest, the Reverse Stock Split will become effective upon filing of an amendment to our Certificate of Incorporation
with the Secretary of State of the State of Delaware. The amendment filed thereby will set forth the number of shares to be combined
into one share of our common stock within the limits set forth in this proposal. Except for adjustments that may result from the
treatment of fractional shares as described below, each stockholder will hold the same percentage of our outstanding common stock
immediately following the Reverse Stock Split as such stockholder holds immediately prior to the reverse split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The text of the form of amendment to the Certificate
of Incorporation, which would be filed with the Secretary of State of the State of Delaware to effect the Reverse Stock Split,
is set forth in <U>Appendix A</U> to this proxy statement. The text of the form of amendment accompanying this proxy statement
is, however, subject to amendment to reflect the exact ratio for the Reverse Stock Split and any changes that may be required by
the office of the Secretary of State of the State of Delaware or that the Board of Directors may determine to be necessary or advisable
ultimately to comply with applicable law and to effect the Reverse Stock Split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Under Delaware law, our stockholders would
not be entitled to dissenters&rsquo; rights or rights of appraisal in connection with the implementation of the Reverse Stock Split,
and we will not independently provide our stockholders with any such rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Purpose </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The Board is proposing the Reverse Stock Split
in an effort to decrease the number of shares of common stock outstanding and increase the market price of its shares. The Board
is also seeking to reduce certain administrative burdens and costs relating to the large number of shares that are currently issued
and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The Board believes that the Reverse Stock Split
will enhance our ability to obtain an initial listing on a national securities exchange. The NYSE MKT and The NASDAQ Capital Market
each requires, among other items, an initial bid price of least $3.00&nbsp;per share, in the case of the NYSE MKT, or at least
$4.00 per share, in the case of The NASDAQ Capital Market, and, following initial listing, maintenance of a continued price of
at least $1.00&nbsp;per share in the case of The NASDAQ Capital Market and an undesignated &ldquo;low selling price&rdquo; in the
case of the NYSE MKT. Reducing the number of outstanding shares of our common stock should, absent other factors, increase the
per share market price of our common stock, although we cannot provide any assurance that the minimum bid price would be achieved
following any Reverse Stock Split or that any listing on an exchange would be obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Among the other factors considered by the Board
in reaching its decision to recommend the Reverse Stock Split, the Board considered the potential effects of having a stock that
trades at a low price; our closing stock price on September 30, 2016, was $3.26 per share as quoted on the OTCQX. For example,
certain brokerage firms have internal practices and policies that discourage individual brokers from dealing in stocks trading
below a particular dollar level. Further, since the brokerage commissions on stock with a low trading price generally represent
a higher percentage of the stock price than commissions on higher priced stock, investors in stocks with a low trading price pay
transaction costs (commissions, markups, or markdowns) at a higher percentage of their total share value, which may limit the willingness
of individual investors and institutions to purchase our common stock. The Board also believes that certain institutional investors,
such as mutual funds or pension plans, have policies or procedures that discourage or prohibit acquisitions of shares priced at
less than $5.00 per share, making our shares less attractive. Each of these factors could weaken the market for our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">As stated above, reducing the number of outstanding
shares of our common stock through the Reverse Stock Split is intended, absent other factors, to increase the per share market
price of our common stock. However, other factors, such as financial results and market conditions, may adversely affect the market
price of our common stock. As a result, there can be no assurance that the Reverse Stock Split, if completed, will result in the
intended benefits described above, that the market price of our common stock will increase proportionately following the Reverse
Stock Split, or that the market price of our common stock will not decrease in the future. Accordingly, the total market capitalization
of our common stock after the Reverse Stock Split may be lower than the total market capitalization before the Reverse Stock Split.
Additionally, if implemented, the Reverse Stock Split may result in some stockholders owning &ldquo;odd-lots&rdquo; of less than
100 shares of common stock, particularly as the ratio for the Reverse Stock Split increases. Brokerage commissions and other costs
of transactions in odd-lots may be higher, particularly on a per-share basis, than the cost of transactions in even multiples of
100&nbsp;shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The Board will not decrease the authorized
common stock in connection with the Reverse Stock Split, which will result in a significant increase in the availability of authorized
shares of common stock. Any additional common stock so authorized will be available for issuance by the Board for stock splits
or stock dividends, acquisitions, raising additional capital, conversion of our debt into equity, stock options or other corporate
purposes, and any such issuances may be dilutive to current stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Other than as disclosed in this proxy statement,
we have no other specific plans, arrangements or understandings regarding the issuance of shares of our common stock that may become
available for issuance as a result of implementation of the Reverse Stock Split if this proposal is approved by our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Effects of the Reverse Stock Split </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">To implement the Reverse Stock Split, we would,
at a meeting of the Board or by written consent in lieu of a meeting, resolve to effect the Reverse Stock Split. Upon such resolution
and without further action on the part of our stockholders, the shares of our common stock held by stockholders of record as of
the effective time of the amendment to our Certificate of Incorporation would be converted into the number of shares of common
stock (the &ldquo;New Common Stock&rdquo;) calculated based on the reverse split ratio determined and approved by the Board pursuant
to such resolution. We will issue one whole share in lieu of any fractional shares left after the Reverse Stock Split has been
effected even to stockholders who held less than two shares, three share or four shares in the case of a 1-for-2, 1-for-3 or 1-for-4
reverse stock split, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-size: 10pt">&nbsp;&#9;</FONT>For
example, if a stockholder presently holds 100&nbsp;shares of common stock, he or she would hold 50&nbsp;shares following a 1-for-2
split, 34&nbsp;shares following a 1-for-3 split, or 25 shares following a 1-for-4 split. No fractional shares or scrip would be
issued. Each stockholder who would otherwise be entitled to a fraction of a share would receive one whole share for such fractional
share; the issuance of one whole share for a fractional share is reflected in the share amounts given in the preceding sentence
as a result of the Reverse Stock Split, in the case of a 1-for-3 reverse stock split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">All outstanding stock options, warrants and
convertible securities will be adjusted to reduce the number of shares to be issued upon exercise or conversion of such options,
warrants or convertible securities, and increase the exercise or conversion price thereof, proportionately.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">As of the record date, there were 492
holders of record of our common stock (although there are significantly more beneficial holders). Based on our
stockholders of record as of September 22, 2016, we do not expect that cashing out fractional stockholders, if any, would
reduce the number of our stockholders of record to under 300 holders. In addition, our Board of Directors does not intend for
this transaction to be the first step in a series of plans or proposals of a &ldquo;going private transaction&rdquo; within
the meaning of Rule 13e-3 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Board Discretion to Implement the Reverse Stock Split </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">If this proposal is approved by the stockholders,
the Reverse Stock Split will be effected, if at all, only upon a determination by the Board that a reverse stock split (at a ratio
determined by the Board as described above) is in the best interests of our Company and our stockholders. The Board&rsquo;s determination
as to whether the Reverse Stock Split will be effected and, if so, at what ratio, will be based upon certain factors, including
existing and expected marketability and liquidity of our common stock, prevailing market conditions, and the likely effect on the
market price of our common stock. If the Board determines to effect the Reverse Stock Split, the Board will consider various factors
in selecting the ratio, including the overall market conditions at the time, the effect of a particular ratio on the market for
our common stock, and the recent trading history of the common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exchange of Stock Certificates; Fractional Shares </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">As soon as practicable after the effective
time of the Reverse Stock Split, we, or our transfer agent, will send a letter to each stockholder of record for use in transmitting
certificates representing shares of common stock (&ldquo;Old Certificates&rdquo;) to our transfer agent, VStock Transfer, LLC (the
&ldquo;Exchange Agent&rdquo;). The letter of transmittal will contain instructions for the surrender of Old Certificates to the
Exchange Agent in exchange for certificates representing the appropriate number of whole shares of New Common Stock. No new certificates
will be issued to a stockholder until such Old Certificates are surrendered, together with a properly completed and executed letter
of transmittal, to the Exchange Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Stockholders will then receive a new certificate
or certificates representing the number of whole shares of New Common Stock into which their shares of common stock have been converted
as a result of the Reverse Stock Split. Until surrendered, outstanding stock certificates held by stockholders will be deemed for
all purposes to represent the number of whole shares of New Common Stock to which such stockholders are entitled as a result of
the Reverse Stock Split. Stockholders should not send their Old Certificates to the Exchange Agent until they have received the
letter of transmittal. We will bear all expenses of the exchange of certificates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">We intend to treat shares held by stockholders
in &ldquo;street name,&rdquo; through a bank, broker or other nominee, in the same manner as stockholders whose shares are registered
in their names. Banks, brokers or other nominees will be instructed to effect the Reverse Stock Split for their beneficial or &ldquo;street
name&rdquo; holders. However, these banks, brokers or other nominees may have different procedures for processing the Reverse Stock
Split and making payment for fractional shares. Stockholders holding shares of our common stock with a bank, broker or other nominee
should contact their bank, broker or other nominee with any questions in this regard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Material U.S. Federal Income Tax Consequences </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The following is a summary of material U.S.
federal income tax consequences of the Reverse Stock Split to a U.S. stockholder (as defined below), and does not purport to be
a complete discussion of all of the possible U.S. federal income tax consequences of the Reverse Stock Split. The summary assumes
that the pre-Reverse Stock Split shares were, and the post-Reverse Stock Split shares will be, held as &ldquo;capital assets&rdquo;
as defined in the Internal Revenue Code of 1986, as amended, or the Code, which generally means property held for investment. It
does not address stockholders subject to special rules, such as non-U.S. stockholders, financial institutions, tax-exempt organizations,
insurance companies, dealers in securities, traders in securities that elect the mark-to-market method of accounting, mutual funds,
S corporations, partnerships or other pass-through entities, U.S. persons with a functional currency other than the U.S. dollar,
stockholders who hold the pre-Reverse Stock Split shares as part of a straddle, hedge, integration, constructive sale or conversion
transaction, stockholders who hold the pre-Reverse Stock Split shares as qualified small business stock within the meaning of Section
1202 of the Code, stockholders who are subject to the alternative minimum tax provisions of the Code, and stockholders who acquired
their pre-Reverse Stock Split shares pursuant to the exercise of employee stock options or otherwise as compensation. This summary
is based upon the provisions of the U.S. federal income tax law as of the date hereof, which are subject to change, possibly with
retroactive effect. It does not address tax considerations under state, local, non-U.S, and non-income tax laws. Furthermore, we
have not obtained a ruling from the Internal Revenue Service or an opinion of legal or tax counsel with respect to the consequences
of the Reverse Stock Split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">As used herein, the term &ldquo;U.S. stockholder&rdquo;
means a beneficial owner of common stock that is a United States citizen or resident, United States corporation or other United
States entity taxable as a corporation, an estate the income of which is subject to United States federal income taxation regardless
of its source, or a trust if a court within the United States is able to exercise primary jurisdiction over the administration
of the trust and one or more United States persons have the authority to control all substantial decisions of the trust.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;We believe that the Reverse Stock Split
will qualify as a recapitalization under Section 368(a)(1)(E) of the Code, in which case a stockholder generally will not recognize
gain or loss on the Reverse Stock Split (except possibly for stockholders receiving a whole share of common stock in lieu of a
fractional share, as noted below). The aggregate tax basis of the post-Reverse Stock Split shares received will be equal to the
aggregate tax basis of the pre-Reverse Stock Split shares exchanged therefor, and the holding period of the post-Reverse Stock
Split shares received will include the holding period of the pre-Reverse Stock Split shares exchanged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The treatment of the fractional shares being
rounded up to the next whole share is uncertain and a stockholder who receives a whole share of common stock in lieu of a fractional
share may possibly recognize gain in an amount not to exceed the excess of the fair market value of such whole share over the fair
market value of the fractional shares to which the stockholder was otherwise entitled. Stockholders should consult their own tax
advisors regarding the U.S. federal income tax and other tax consequences of fractional shares being rounded to the next whole
share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">United States Treasury Regulations will require
stockholders to retain permanent records relating to the Reverse Stock Split, including information about the amount, basis, and
fair market value of all transferred property. In addition, for each stockholder that owns, immediately before the Reverse Stock
Split, at least 5% of the outstanding stock of our Company (whether by voting power or value) or that has tax basis of at least
$1,000,000 in our Company&rsquo;s stock, United States Treasury Regulations Section 1.368-3 will require a statement to be included
in the stockholder&rsquo;s U.S. federal income tax return for the year of the Reverse Stock Split setting forth (i)&nbsp;the name
and employer identification number of our Company, (ii)&nbsp;the date of the Reverse Stock Split, and (iii)&nbsp;the fair market
value and the adjusted tax basis of the stockholder&rsquo;s shares of our Company&rsquo;s common stock immediately before the Reverse
Stock Split. The information for these first two items will be found in the Internal Revenue Service Form 8937 that we will prepare.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">TAX MATTERS ARE COMPLICATED, AND THE TAX CONSEQUENCES OF THE REVERSE
STOCK SPLIT DEPEND UPON THE PARTICULAR CIRCUMSTANCES OF EACH STOCKHOLDER.&nbsp;ACCORDINGLY, EACH STOCKHOLDER IS ADVISED TO CONSULT
HIS, HER OR ITS TAX ADVISOR WITH RESPECT TO ALL OF THE POTENTIAL TAX CONSEQUENCES TO HIM, HER OR IT OF THE REVERSE STOCK SPLIT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Vote Required </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Approval of the amendment to our Certificate
of Incorporation to effect the Reverse Stock Split at the discretion of our Board requires the receipt of the affirmative vote
of a majority of the shares of our common stock issued and outstanding as of the record date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Recommendation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The Board of Directors recommends that you
vote <B>FOR</B> approval of the amendment to our Company&rsquo;s Certificate of Incorporation to effect the Reverse Stock Split
at a ratio of any whole number between 1-for-2 and 1-for-4, as determined by the Board, at any time before November 15, 2017, if
and as determined by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PROPOSAL NO. 3 &ndash; APPROVAL OF THE AMENDMENTS
TO THE 2015 STOCK OPTION AND INCENTIVE PLAN </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">On April 16, 2015, our Board of Directors approved
the 2015 Stock Option and Incentive Plan, or the 2015 Plan. On June 1, 2015, our stockholders approved the 2015 Plan. We believe
that the 2015 Plan is critical to our effort to build stockholder value. Our equity incentive program is broad-based and equity
incentive awards are also an important component of our executive and non-executive employees&rsquo; compensation. Our Board believes
we must offer a competitive equity compensation program in order to attract, retain and motivate the talented and qualified employees
necessary for our continued growth and success. Our compensation philosophy reflects broad-based eligibility for equity incentive
awards, and we grant awards to substantially all of our employees. By doing so, we link employee interests with stockholder interests
throughout the organization and motivate our employees to act as owners of the business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">As of August 31, 2016, an aggregate of 833,334
shares were authorized for issuance under the 2015 Plan, after giving effect to the 1-for-12 reverse stock split effected on June
30, 2016. Through August 31, 2016, options issued under the 2015 Plan and still outstanding totaled 762,217 shares. As a result,
as of August 31, 2016, there were only 71,117 shares currently available for issuance under the 2015 Plan. If the amendments to
the 2015 Plan are approved at the annual meeting, immediately thereafter there will be a total of 2,000,000 shares of common stock
reserved for issuance under the 2015 Plan with a total of 1,237,783 shares available for issuance in the form of new grants (assuming
the amendment had been effective at August 31, 2016).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In August 2016, the Board approved (i) increasing
the number of shares of common stock referenced under the 2015 Plan from 833,334 to 2,000,000, <FONT STYLE="background-color: white">(ii)
increasing the number of shares that may be issued as incentive stock options from 833,334 shares to 2,000,000 shares,</FONT> and
(iii) increasing (A) the number of shares of common stock underlying stock options and stock appreciation rights that may be granted
under the 2015 Plan to any employee from 166,667 shares to 1,000,000 shares per year, and (B) the number of shares and share-based
awards that may granted to any one individual that is intended to qualify as &ldquo;performance-based compensation&rdquo; under
Section&nbsp;162(m) of the Code from 166,667 shares to 1,000,000 shares per performance cycle. As we continue to grow our company
and continue the commercialization of our approved products, we believe that it will be critical to attracting and retaining individuals
to be able to offer larger equity awards under the 2015 Plan as an important incentive. Our Board believes that the remaining 71,117 shares of common stock available for issuance under the 2015 Plan as of August 31, 2016 and the current limitation that restricts
grants to employees of stock options and stock appreciation rights covering more than 166,667 shares of common stock during any
calendar year under the 2015 Plan is insufficient to accomplish the purposes of the 2015 Plan as described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;Following is a summary of the principal
features of the 2015 Plan, as proposed to be amended. The summary is qualified by the full text of the 2015 Plan, as amended, attached
to this proxy statement as <U>Appendix B</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Key Provisions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Following are the key provisions of the 2015
Plan, as proposed to be amended:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid"><B>Provisions of 2015 Plan</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 64%; border-bottom: Black 1pt solid"><B>Description</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Eligible Participants</TD>
    <TD>&nbsp;</TD>
    <TD>Employees, directors, consultants, advisors and other independent contractors of our company and any successor entity that adopts the 2015 Plan.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Share Reserve</TD>
    <TD STYLE="padding-left: 11.5pt; text-indent: -9pt">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-indent: -9pt"><FONT STYLE="font: 10pt Symbol">&middot;</FONT>&nbsp;&nbsp;Total
        of 2,000,000 shares of our common stock.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-indent: -9pt"><FONT STYLE="font: 10pt Symbol">&middot;</FONT>&nbsp;&nbsp;Shares
        of common stock that are issued under the 2015 Plan or that are subject to outstanding awards will be applied to reduce the number
        of shares reserved for issuance under the 2015 Plan.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-indent: -9pt"><FONT STYLE="font: 10pt Symbol">&middot;</FONT>&nbsp;&nbsp;Except
as otherwise required by Section 162(m) of the Internal Revenue Code, or the Code, in the event that a stock option granted under
the 2015 Plan expires or is terminated or cancelled unexercised or unvested as to any shares of common stock, or in the event
that shares of common stock are issued as restricted stock or as part of another award under the 2015 Plan and thereafter forfeited
or reacquired by us, such shares will return to the share reserve and will again be issuable under the 2015 Plan.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid"><B>Provisions of 2015 Plan</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 64%; border-bottom: Black 1pt solid"><B>Description</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Award Types</TD>
    <TD STYLE="padding-left: 11.5pt; text-indent: -9pt">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-indent: -9pt"><FONT STYLE="font: 10pt Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;Incentive
        stock options</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-indent: -9pt"><FONT STYLE="font: 10pt Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;Non-qualified
        stock options</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-indent: -9pt"><FONT STYLE="font: 10pt Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;Restricted
        stock</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-indent: -9pt"><FONT STYLE="font: 10pt Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;Restricted
        stock units</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-indent: -9pt"><FONT STYLE="font: 10pt Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;Unrestricted
        stock</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-indent: -9pt"><FONT STYLE="font: 10pt Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;Performance
        shares</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-indent: -9pt"><FONT STYLE="font: 10pt Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;Stock
        appreciation rights</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-indent: -9pt"><FONT STYLE="font: 10pt Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;Dividend
        equivalent rights</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-indent: -9pt"><FONT STYLE="font: 10pt Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;Cash-based
        awards</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Vesting</TD>
    <TD>&nbsp;</TD>
    <TD>Determined by the Compensation Committee of the Board of Directors</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Award Limits</TD>
    <TD>&nbsp;</TD>
    <TD>Stock options and stock appreciation rights covering no more than 1,000,000 shares may be issued to a single participant pursuant to awards under the 2015 Plan in a calendar year.&nbsp;&nbsp;Awards granted to any one individual that is intended to qualify as &ldquo;performance-based compensation&rdquo; under Section&nbsp;162(m) of the Code for any performance cycle may be no more than 1,000,000 shares.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>2015 Plan Termination Date</TD>
    <TD>&nbsp;</TD>
    <TD>April 16, 2025</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Summary of the 2015 Plan </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The following description of certain features
of the 2015 Plan is intended to be a summary only. The summary is qualified in its entirety by the full text of the 2015 Plan that
is attached hereto as <U>Appendix B</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Plan Administration</I>. The 2015 Plan is
administered by the Board or a committee designated by the Board (the &ldquo;<B><I>Committee</I></B>&rdquo; and, either the Board
or the Committee, as applicable, the &ldquo;<B><I>Administrator</I></B>&rdquo;). The Administrator has full power to select, from
among the individuals eligible for awards, the individuals to whom awards will be granted, to make any combination of awards to
participants, and to determine the specific terms and conditions of each award, subject to the provisions of the 2015 Plan. The
Administrator may delegate to our Chief Executive Officer the authority to grant stock options and other awards to employees who
are not subject to the reporting and other provisions of Section&nbsp;16 of the Exchange Act and not subject to Section&nbsp;162(m)
of the Code, subject to certain limitations and guidelines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Eligibility</I>. Persons eligible to
participate in the 2015 Plan are those full or part-time officers, employees, non-employee directors, directors and other key
persons of the Company (including current and prior consultants, former employees and employees and directors of the former
parent company) as selected from time to time by the Administrator in
its discretion. Approximately 64&nbsp;individuals are currently eligible to participate in the 2015 Plan, which
includes three&nbsp;officers, 57 employees who are not officers, and four non-employee directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Plan Limits</I>. The maximum award of stock
options or stock appreciation rights granted to any one individual will not exceed 1,000,000 shares of common stock (subject to adjustment
for stock splits and similar events) for any calendar year period. If any award of restricted stock, restricted stock units or
performance shares granted to an individual is intended to qualify as &ldquo;performance-based compensation&rdquo; under Section&nbsp;162(m)
of the Code, then the maximum award shall not exceed 1,000,000 shares of common stock (subject to adjustment for stock splits and
similar events) to any one such individual in any performance cycle. If any cash-based award is intended to qualify as &ldquo;performance-based
compensation&rdquo; under Section&nbsp;162(m) of the Code, then the maximum award to be paid in cash in any performance cycle may
not exceed $5,000,000. In addition, no more than 2,000,000 shares will be issued in the form of incentive stock options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Effect of Awards</I>. For purposes of determining
the number of shares of common stock available for issuance under the 2015 Plan, the grant of any award will be counted as one
share for each share of common stock actually subject to the award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Stock Options</I>. The 2015 Plan permits
the granting of (1)&nbsp;options to purchase common stock intended to qualify as incentive stock options under Section&nbsp;422
of the Code and (2)&nbsp;options that do not so qualify. Options granted under the 2015 Plan will be non-qualified stock options
if they fail to qualify as incentive stock options or exceed the annual limit on incentive stock options. Incentive stock options
may only be granted to employees of the Company and its subsidiaries. Non-qualified stock options may be granted to any persons
eligible to receive incentive stock options and to non-employee directors and key persons. The option exercise price of each option
will be determined by the Administrator but may not be less than 100 percent of the fair market value of the common stock on the
date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The term of each option will be fixed by the
Administrator and may not exceed ten years from the date of grant. The Compensation Committee will determine at what time or times
each option may be exercised. Options may be made exercisable in installments and the exercisability of options may be accelerated
by the Administrator. In general, unless otherwise permitted by the Administrator, no option granted under the 2015 Plan is transferable
by the optionee other than by will or by the laws of descent and distribution, and options may be exercised during the optionee&rsquo;s
lifetime only by the optionee, or by the optionee&rsquo;s legal representative or guardian in the case of the optionee&rsquo;s
incapacity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Upon exercise of options, the option exercise
price must be paid in full either in cash, by certified or bank check or other instrument acceptable to the Administrator or by
delivery (or attestation to the ownership) of shares of common stock that are beneficially owned by the optionee for at least six
months or were purchased in the open market. Subject to applicable law, the exercise price may also be delivered to the Company
by a broker pursuant to irrevocable instructions to the broker from the optionee. In addition, the Administrator may permit non-qualified
stock options to be exercised using a net exercise feature which reduces the number of shares issued to the optionee by the number
of shares with a fair market value equal to the exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">To qualify as incentive stock options, options
must meet additional federal tax requirements, including a $100,000 limit on the value of shares subject to incentive stock options
that first become exercisable by a participant in any one calendar year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Stock Appreciation Rights</I>. The Administrator
may award stock appreciation rights subject to such conditions and restrictions as the Administrator may determine. Stock appreciation
rights entitle the recipient to shares of common stock equal to the value of the appreciation in the stock price over the exercise
price. The exercise price is the fair market value of the common stock on the date of grant. The maximum term of a stock appreciation
right is ten years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Restricted Stock</I>. The Administrator
may award shares of common stock to participants subject to such conditions and restrictions as the Administrator may determine.
These conditions and restrictions may include the achievement of certain performance goals (as summarized above) and/or continued
employment with us through a specified restricted period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Restricted Stock Units</I>. The Administrator
may award restricted stock units to any participants. Restricted stock units are ultimately payable in the form of shares of common
stock and may be subject to such conditions and restrictions as the Administrator may determine. These conditions and restrictions
may include the achievement of certain performance goals (as summarized above) and/or continued employment with the Company through
a specified vesting period. In the Administrator&rsquo;s sole discretion, it may permit a participant to make an advance election
to receive a portion of his or her future cash compensation otherwise due in the form of a deferred stock unit award, subject to
the participant&rsquo;s compliance with the procedures established by the Administrator and requirements of Section&nbsp;409A of
the Code. During the deferral period, the deferred stock awards may be credited with dividend equivalent rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Unrestricted Stock Awards</I>. The Administrator
may also grant shares of common stock, which are free from any restrictions under the 2015 Plan. Unrestricted stock may be granted
to any participant in recognition of past services or other valid consideration and may be issued in lieu of cash compensation
due to such participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Performance Share Awards</I>. The Administrator
may grant performance share awards to any participant which entitle the recipient to receive shares of common stock upon the achievement
of certain performance goals (as summarized above) and such other conditions as the Administrator shall determine. Except in the
case of retirement, death, disability or a change in control, these awards granted to employees will have a vesting period of at
least one year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Dividend Equivalent Rights</I>. The Administrator
may grant dividend equivalent rights to participants which entitle the recipient to receive credits for dividends that would be
paid if the recipient had held specified shares of common stock. Dividend equivalent rights granted as a component of another award
subject to performance vesting may be paid only if the related award becomes vested. Dividend equivalent rights may be settled
in cash, shares of common stock or a combination thereof, in a single installment or installments, as specified in the award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Cash-Based Awards</I>. The Administrator
may grant cash bonuses under the 2015 Plan to participants. The cash bonuses may be subject to the achievement of certain performance
goals (as summarized above).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Change of Control Provisions</I>. The 2015
Plan provides that upon the effectiveness of a &ldquo;sale event&rdquo; as defined in the 2015 Plan, except as otherwise provided
by the Administrator in the award agreement, all stock options, stock appreciation rights and other awards will be assumed or continued
by the successor entity and adjusted accordingly to take into account the impact of the transaction. To the extent, however, that
the parties to such sale event do not agree that all stock options, stock appreciation rights or any other awards shall be assumed
or continued, then such stock options and stock appreciation rights shall become fully exercisable and the restrictions and conditions
on all such other awards with time-based conditions will automatically be deemed waived. Awards with conditions and restrictions
relating to the attainment of performance goals may become vested and non-forfeitable in connection with a sale event in the Committee&rsquo;s
discretion. In addition, in the case of a sale event in which the Company&rsquo;s stockholders will receive cash consideration,
the Company may make or provide for a cash payment to participants holding options and stock appreciation rights equal to the difference
between the per share cash consideration and the exercise price of the options or stock appreciation rights in exchange for the
cancellation thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Adjustments for Stock Dividends, Stock Splits,
Etc.</I> The 2015 Plan requires the Administrator to make appropriate adjustments to the number of shares of common stock that
are subject to the 2015 Plan, to certain limits in the 2015 Plan, and to any outstanding awards to reflect stock dividends, stock
splits, extraordinary cash dividends and similar events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Tax Withholding</I>. Participants in the
2015 Plan are responsible for the payment of any federal, state or local taxes that the Company is required by law to withhold
upon the exercise of options or stock appreciation rights or vesting of other awards. Subject to approval by the Administrator,
participants may elect to have the minimum tax withholding obligations satisfied by authorizing the Company to withhold shares
of common stock to be issued pursuant to the exercise or vesting of such award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Amendments and Termination</I>. The Board
may at any time amend or discontinue the 2015 Plan and the Administrator may at any time amend or cancel any outstanding award
for the purpose of satisfying changes in the law or for any other lawful purpose. However, no such action may adversely affect
any rights under any outstanding award without the holder&rsquo;s consent. To the extent required under the rules of any exchange
on which the Company&rsquo;s stock is listed, any amendments that materially change the terms of the 2015 Plan will be subject
to approval by our stockholders. Amendments shall also be subject to approval by our stockholders if and to the extent determined
by the Administrator to be required by the Code to preserve the qualified status of incentive stock options or to ensure that compensation
earned under the 2015 Plan qualifies as performance-based compensation under Section&nbsp;162(m) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Effective Date of 2015 Plan</I>. The Board
adopted the 2015 Plan on April 16, 2015, and the 2015 Plan became effective on the date it was approved by stockholders, which
was June 1, 2016. Awards of incentive stock options may be granted under the 2015 Plan until April 16, 2025. No other awards may
be granted under the 2015 Plan after the date that is 10 years from the date of stockholder approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Summary of Federal income Tax Consequences of the 2015 Plan </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The following is a summary of the principal
federal income tax consequences of certain transactions under the 2015 Plan. The summary is intended only as a general guide and
it does not describe all federal tax consequences under the 2015 Plan, nor does it describe state or local, foreign, or other tax
consequences. The summary does not attempt to describe all possible federal income tax consequences based on particular circumstances.
Furthermore, the tax consequences are complex and subject to change, and a taxpayer&rsquo;s particular situation may be such that
some variation of the described rules&nbsp;is applicable. Recipients of awards under the 2015 Plan should consult their own tax
advisors to determine the tax consequences to them as a result of their particular circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Incentive Stock Options</I>. No taxable
income is generally recognized for regular income tax purposes by the optionee upon the grant or exercise of an incentive stock
option. If shares of common stock issued to an optionee pursuant to the exercise of an incentive stock option are sold or transferred
after two years from the date of grant and after one year from the date of exercise, then (i)&nbsp;upon sale of such shares, any
amount realized in excess of the option price (the amount paid for the shares) will be taxed to the optionee as a long-term capital
gain, and any loss sustained will be a long-term capital loss, and (ii)&nbsp;the Company will not be entitled to any deduction
for federal income tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The difference between the option exercise
price and the fair market value of the shares of common stock on the exercise date of an incentive stock option is treated as an
adjustment in computing the participant&rsquo;s alternative minimum taxable income and may be subject to the alternative minimum
tax, which is paid if such tax exceeds the regular tax for the year. Special rules&nbsp;may apply with respect to (i) certain subsequent
sales of the shares in a disqualifying disposition, (ii) certain basis adjustments for purposes of computing the alternative minimum
taxable income on a subsequent sale of the shares, and (iii) certain tax credits that may arise with respect to participants subject
to the alternative minimum tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">If shares of common stock acquired upon the
exercise of an incentive stock option are disposed of prior to the expiration of the two-year and one-year holding periods described
above (a &ldquo;disqualifying disposition&rdquo;), generally (i)&nbsp;the optionee will realize ordinary income in the year of
disposition in an amount equal to the excess (if any) of the fair market value of the shares of common stock at exercise (or, if
less, the amount realized on a sale of such shares of common stock) over the option price thereof, and (ii)&nbsp;we will be entitled
to deduct such amount (subject to the requirement of reasonableness, the provisions of Section&nbsp;162(m)&nbsp;of the Code, and
the satisfaction of a tax-reporting obligation). Any gain in excess of that amount will be a capital gain. If a loss is recognized,
there will be no ordinary income, and such loss will be a capital loss. Special rules apply where all or a portion of the exercise
price of the incentive stock option is paid by tendering shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">If an incentive stock option is exercised at
a time when it no longer qualifies for the tax treatment described above, the option is treated as a non-qualified stock option.
Generally, an incentive stock option will not be eligible for the tax treatment described above if it is exercised more than three
months following termination of employment (or one year in the case of termination of employment by reason of disability). In the
case of termination of employment by reason of death, the three-month rule does not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Non-Qualified Stock Options</I>. No income
is realized by the optionee at the time the option is granted. Generally (i)&nbsp;at exercise, ordinary income is realized by the
optionee in an amount equal to the difference between the option price and the fair market value of the shares of common stock
on the date of exercise (and withholding of income and employment taxes will apply if the participant is or was an employee), and
we receive a tax deduction for the same amount (subject to the requirement of reasonableness, the provisions of Section&nbsp;162(m)&nbsp;of
the Code, and the satisfaction of a tax-reporting obligation), and (ii)&nbsp;at disposition, appreciation or depreciation after
the date of exercise is treated as either short-term or long-term capital gain or loss depending on how long the shares of common
stock have been held. Special rules apply where all or a portion of the exercise price of the non-qualified stock option is paid
by tendering shares of common stock. Upon exercise, the optionee will also be subject to Social Security taxes on the excess of
the fair market value over the exercise price of the option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Stock Appreciation Rights.<B> </B></I>A
participant recognizes no taxable income upon the receipt of a stock appreciation right.&nbsp;Upon the exercise of a stock appreciation
right, the participant will recognize ordinary income in an amount equal to the excess of the fair market value of the underlying
shares of common stock on the exercise date over the exercise price.&nbsp;If the participant is an employee, such ordinary income
generally is subject to withholding of income and employment taxes.&nbsp;We generally should be entitled to a deduction equal to
the amount of ordinary income recognized by the participant in connection with the exercise of the stock appreciation right, except
to the extent such deduction is limited by applicable provisions of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Restricted Stock<B>. </B></I>A participant
acquiring restricted stock generally will recognize ordinary income equal to the difference between the fair market value of the
shares on the &ldquo;determination date&rdquo; (as defined below) and their purchase price, if any.&nbsp;If the participant is
an employee, such ordinary income generally is subject to withholding of income and employment taxes.&nbsp;The &ldquo;determination
date&rdquo; is the date on which the participant acquires the shares unless they are subject to a substantial risk of forfeiture
and are not transferable, in which case the determination date is the earlier of (i)&nbsp;the date on which the shares become transferable,
or (ii)&nbsp;the date on which the shares are no longer subject to a substantial risk of forfeiture.&nbsp;If the determination
date will be after the date on which the participant acquires the shares, the participant may elect, pursuant to Section&nbsp;83(b)&nbsp;of
the Code, to have the date of acquisition be the determination date by filing an election with the Internal Revenue Service, or
IRS, no later than 30 days after the date the shares are acquired.&nbsp;Upon the taxable disposition of shares acquired pursuant
to a restricted stock award, any gain or loss, based on the difference between the sale price and the fair market value on the
determination date, will generally be taxed as capital gain or loss ; however, for any shares returned to the Company pursuant
to a forfeiture provision, a participant&rsquo;s loss may be computed based only on the purchase price (if any) of the shares and
may not take into account any income recognized by reason of a Section 83(b) election.&nbsp;Such gain or loss will be long-term
or short-term depending on whether the stock was held for more than one year. We generally will be entitled (subject to the requirement
of reasonableness, the provisions of Section&nbsp;162(m)&nbsp;of the Code, and the satisfaction of a tax reporting obligation)
to a corresponding income tax deduction in the year in which such ordinary income is recognized by the participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Restricted Stock Units.<B> </B></I>No taxable
income is recognized upon receipt of a restricted stock unit award. In general, the participant will recognize ordinary income
in the year in which the units vest and are settled in an amount equal to any cash received and the fair market value of any nonrestricted
shares received. If the participant is an employee, such ordinary income generally is subject to withholding of income and employment
taxes. We generally will be entitled (subject to the requirement of reasonableness, the provisions of Section&nbsp;162(m)&nbsp;of
the Code, and the satisfaction of a tax reporting obligation) to an income tax deduction equal to the amount of ordinary income
recognized by the participant. In general, the deduction will be allowed for the taxable year in which such ordinary income is
recognized by the participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Other Awards</I>. The Company generally
will be entitled to a tax deduction in connection with an award under the 2015 Plan in an amount equal to the ordinary income realized
by the participant at the time the participant recognizes such income (subject to the requirement of reasonableness, the provisions
of Section&nbsp;162(m)&nbsp;of the Code, and the satisfaction of a tax-reporting obligation). Participants typically are subject
to income tax and recognize such tax at the time that an award is exercised, vests or becomes non-forfeitable, unless the award
provides for a further deferral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Parachute Payments</I>. The vesting of any
portion of an option or other award that is accelerated due to the occurrence of a change in control (such as a sale event) may
cause a portion of the payments with respect to such accelerated awards to be treated as &ldquo;parachute payments&rdquo; as defined
in the Code. Any such parachute payments may be non-deductible to the Company, in whole or in part, and may subject the recipient
to a non-deductible 20 percent federal excise tax on all or a portion of such payment (in addition to other taxes ordinarily payable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Limitation on Deductions</I>. Under Section&nbsp;162(m)
of the Code, the Company&rsquo;s deduction for certain awards under the 2015 Plan may be limited to the extent that the Chief Executive
Officer or other executive officer whose compensation is required to be reported in the summary compensation table (other than
the Principal Financial Officer) receives compensation in excess of $1 million a year (other than performance-based compensation
that otherwise meets the requirements of Section&nbsp;162(m) of the Code). The 2015 Plan is structured to allow certain awards
to qualify as performance-based compensation under Section 162(m) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp; The affirmative vote of a majority
of the votes cast at the meeting is required to approve the amendments to the 2015 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recommendation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The Board of Directors recommends that
you vote <B>FOR</B> approval of the amendments to the 2015 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>PROPOSAL NO.
4</B></FONT><B> &mdash; <FONT STYLE="font-size: 10pt">RATIFICATION OF APPOINTMENT OF INDEPENDENT </FONT></B><BR>
<FONT STYLE="font-size: 10pt"><B>REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our Board has appointed the firm EKS&amp;H
LLLP, Denver, Colorado, to serve as our independent registered public accounting firm for the fiscal year ending June 30, 2017.
While the Board is solely responsible for the appointment, compensation, retention and oversight of the independent registered
public accounting firm, the Board is requesting that the stockholders ratify this appointment. If the stockholders ratify this
appointment, the Board, in its discretion, may appoint a different independent registered public accounting firm at any time during
the year if it believes that doing so would be in the best interests of our stockholders. If the stockholders do not ratify this
appointment, the Board may reconsider, but might not change, its appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Representatives of EKS&amp;H LLLP are not
expected to be present at the annual meeting of stockholders due to the cost of travel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Information about Change of Independent Registered Public Accounting
Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">On April 16, 2015, we changed our independent
registered public accounting firm from HJ &amp; Associates, LLC to EKS&amp;H LLLP for the year ended June 30, 2015. The change
was approved by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">HJ &amp; Associates&rsquo; reports on our
financial statements dated November 26, 2014 relating to its audits of our balance sheets as of August 31, 2014 and 2013, and for
the two years then ended did not contain an adverse opinion or a disclaimer of opinion, and were not qualified or modified as to
uncertainty, audit scope or accounting principles, although the report contained an explanatory paragraph relating to our ability
to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">During the two years ended August 31, 2014
and through the date of their dismissal, there were no: (a)&nbsp;disagreements with HJ &amp; Associates, LLC on any matter of accounting
principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to
HJ &amp; Associates&rsquo; satisfaction, would have caused HJ &amp; Associates to make reference to the subject matter thereof
in connection with its reports on our financial statements as of June 30, 2013 and 2014, and for the two years then ended; or (b)&nbsp;&ldquo;reportable
events&rdquo;, as defined under Item 304(a)(1)(v) of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-weight: normal">HJ &amp;
Associates indicated to us that it agreed with the foregoing statements contained in the paragraphs above as they relate to HJ
&amp; Associates and furnished a letter dated April 22, 2015 to the United States Securities and Exchange Commission, or SEC, to
this effect. A copy of the letter from HJ &amp; Associates was Exhibit 16.1 to our Current Report on Form 8-K that we filed with
the SEC on April 22, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">During the two years ended December 31, 2013
and through April 16, 2015, neither we nor anyone acting on our behalf consulted with EKS&amp;H LLLP regarding any of the matters
or events set forth in Item 304(a)(2)(i) or (ii) of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Ratification of the appointment of EKS&amp;H
LLLP as our independent registered public accounting firm requires the affirmative vote of a majority of the votes cast at the
meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Recommendation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The Board unanimously recommends that stockholders
vote <B>FOR</B> the ratification of the appointment of EKS&amp;H LLLP as our independent registered public accounting firm for
the fiscal year ending June 30, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CORPORATE GOVERNANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Information about the Board of Directors </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Board Composition </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our Board currently consists of five members.
Directors elected at this meeting and each subsequent annual meeting will be elected for one-year terms or until their successors
are duly elected and qualified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Joshua Disbrow has served as our Chief Executive
Officers and as the Chairman of our Board of Directors since July 2016. The Board does not currently have a policy on whether the
same person should serve as both the Chief Executive Officer and Chairman of the Board or, if the roles are separate, whether the
Chairman should be selected from the non-employee directors or should be an employee. The Board believes that it should have the
flexibility to make these determinations at any given point in time in the way that it believes best to provide appropriate leadership
for us at that time.<B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Selection of Nominees for our Board of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">To be considered as a director nominee, an
individual must have, among other attributes: high personal and professional ethics, integrity and values; commitment to our company
and its stockholders; an inquisitive and objective perspective and mature judgment; availability to perform all Board and committee
responsibilities; and independence. In addition to these minimum requirements, the Board will also evaluate whether the nominee&rsquo;s
skills are complementary to the existing directors&rsquo; skills and the Board&rsquo;s need for operational, management, financial,
international, industry-specific or other expertise. We do not have a specific written policy with regard to the consideration
of diversity in identifying director nominees. We focus on identifying nominees with experience, qualifications, attributes and
skills to work with the other directors to serve the long-term interests of our stockholders. All those matters being equal, we
do and will consider diversity a positive additional characteristic in potential nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In addition to candidates submitted by Board
members, director nominees recommended by stockholders will be considered. Stockholder recommendations must be made in accordance
with the procedures described in the section titled &ldquo;Stockholder Proposals&rdquo; below and will receive the same consideration
that other nominees receive. All nominees are evaluated by the Board to determine whether they meet the minimum qualifications
and whether they will satisfy the Board&rsquo;s needs for specific expertise at that time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">No stockholder has nominated anyone for election
as a director at this annual meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Board Committees </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our Board has established an Audit Committee,
Compensation Committee and Nominating and Governance Committee.&nbsp;Our Audit Committee consists of Mr. Donofrio (Chair), Mr.
Cantrell and Mr. Dockery.&nbsp;Our Compensation Committee consists of Mr. Cantrell (Chair), Mr. Dockery and Mr. Donofrio.&nbsp;Our
Nominating and Governance Committee consists of Mr. Dockery (Chair), Mr. Cantrell and Mr. Donofrio.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Each of the above-referenced committees operates
pursuant to a formal written charter. The charters for these committees, which have been adopted by our Board, contain a detailed
description of the respective committee&rsquo;s duties and responsibilities and are available on our website at <U>http://aytubio.com</U>
under the &ldquo;Investor Relations&mdash;Corporate Governance&rdquo; tab.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Audit Committee</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Our audit committee consists
of Mr. Donofrio (Chair), Mr. Cantrell and Mr. Dockery. Each of Mr. Donofrio (Chair), Mr. Cantrell and Mr. Dockery satisfy the independence
requirements of Rule 803(A)(2) of the NYSE MKT listing rules and SEC Rule 10A-3. Our audit committee is responsible for, among
other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>appointing, terminating, compensating, and overseeing the work of any accounting firm engaged to prepare or issue an audit
report or other audit, review or attest services;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reviewing and approving, in advance, all audit and non-audit services to be performed by the independent auditor, taking into
consideration whether the independent auditor&rsquo;s provision of non-audit services to us is compatible with maintaining the independent
auditor&rsquo;s independence;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reviewing and discussing the adequacy and effectiveness of our accounting and financial reporting processes and controls and
the audits of our financial statements;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>establishing and overseeing procedures for the receipt, retention, and treatment of complaints received by us regarding accounting,
internal accounting controls or auditing matters, including procedures for the confidential, anonymous submission by our employees
regarding questionable accounting or auditing matters;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>investigating any matter brought to its attention within the scope of its duties and engaging independent counsel and other
advisors as the audit committee deems necessary;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>determining compensation of the independent auditors and of advisors hired by the audit committee and ordinary administrative
expenses;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reviewing and discussing with management and the independent auditor the annual and quarterly financial statements prior to
their release;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>monitoring and evaluating the independent auditor&rsquo;s qualifications, performance, and independence on an ongoing basis;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reviewing reports to management prepared by the internal audit function, as well as management&rsquo;s response;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reviewing and assessing the adequacy of the formal written charter on an annual basis;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reviewing and approving related-party transactions for potential conflict of interest situations on an ongoing basis; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>handling such other matters that are specifically delegated to the audit committee by our board from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our Board has determined Mr. Donofrio qualifies
as an audit committee financial expert, as defined in Item&nbsp;407(d)(5) of Regulation S-K promulgated by the SEC.&nbsp;The designation
does not impose on Mr.&nbsp;Donofrio any duties, obligations or liabilities that are greater than those generally imposed on members
of our audit committee and our board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Compensation Committee</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">Our compensation committee
consists of Mr. Cantrell (Chair), Mr. Dockery and Mr. Donofrio. Our compensation committee is responsible for, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reviewing and approving the compensation, employment agreements and severance arrangements, and other benefits of all of our
executive officers and key employees;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reviewing and approving, on an annual basis, the corporate goals and objectives relevant to the compensation of the executive
officers, and evaluating their performance in light thereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reviewing and making recommendations, on an annual basis, to the board with respect to director compensation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reviewing any analysis or report on executive compensation required to be included in the annual proxy statement and periodic
reports pursuant to applicable federal securities rules and regulations, and recommending the inclusion of such analysis or report
in our proxy statement and period reports;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reviewing and assessing, periodically, the adequacy of the formal written charter; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>such other matters that are specifically delegated to the compensation committee by our board from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 33.75pt">Pursuant to its written charter, our compensation
committee has the authority to engage the services of outside advisors as it deems appropriate to assist it in the evaluation of
the compensation of our directors, principal executive officer or other executive and non-executive officers, and in the fulfillment
of its other duties. Additionally, our compensation committee has the authority to review and approve the compensation of our other
officers and employees and may delegate its authority to review and approve the compensation of other non-executive officer employees
to specified executive officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Nominating and Governance Committee</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">Our nominating and governance
committee consists of Mr. Dockery (Chair), Mr. Cantrell and Mr. Donofrio. It is responsible for, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>identifying and screening candidates for our board, and recommending nominees for election as directors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>establishing procedures to exercise oversight of the evaluation of the board and management;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reviewing the structure of the board&rsquo;s committees and recommending to the board for its approval directors to serve as members
of each committee, and where appropriate, making recommendations regarding the removal of any member of any committee;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>developing and reviewing our code of conduct, evaluating management&rsquo;s communication of the importance of our code of conduct,
and monitoring compliance with our code of conduct;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reviewing and assessing the adequacy of the formal written charter on an annual basis; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>generally advising our board on corporate governance and related matters.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Risk Oversight</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our Board is responsible for our Company&rsquo;s
risk oversight. In fulfilling that role, the Board focuses on our general risk-management strategy, the most significant risks
facing our company, and ensures that risk-mitigation strategies are implemented by management. The Board oversees risks related
to our compensation and benefit plans and policies to ensure sound pay practices that do not cause risks to arise that are reasonably
likely to have a material adverse effect on our Company. The Board seeks to minimize risks related to governance structure by implementing
sound corporate governance principles and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Family Relationships&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Jarrett T. Disbrow, our Chief Operating Officer,
is the brother of Joshua R. Disbrow, our Chief Executive Officer and a director. There are no other family relationships among
or between any of our current or former executive officers and directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Involvement in Certain Legal Proceedings&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">None of our directors or executive officers
has been involved in any legal proceeding in the past 10 years that would require disclosure under Item 401(f) of Regulation S-K
promulgated under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Code of Ethics </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">We have adopted a written code of ethics that
applies to our officers, directors and employees, including our principal executive officer and principal accounting officer. We
intend to disclose any amendments to, or waivers from, our code of ethics that are required to be publicly disclosed pursuant to
rules of the SEC by filing such amendment or waiver with the SEC. This code of ethics and business conduct can be found in the
corporate governance section of our website, <I>http://aytubio.com</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Information Regarding Meetings of the Board</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The business of our Company is under the general
oversight of our Board as provided by the laws of Delaware and our bylaws. During the fiscal year ended June 30, 2016, the Board
held six meetings and also conducted business by written consent. Each person who was a director during fiscal 2016 attended
at least 75% of the Board meetings. We do not have a formal written policy with respect to Board members&rsquo; attendance at our
annual meetings of stockholders, but we encourage them to do so.<B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Director Independence&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our common stock is not listed on any exchange.
Consequently, no exchange rules regarding director independence are applicable to us. Audit Committee members must satisfy the
independence criteria set forth in Rule 10A-3 under the Securities Exchange Act of 1934, as amended, for listed companies. In order
to be considered to be independent for purposes of Rule 10A-3, a member of an audit committee of a listed company may not, other
than in his or her capacity as a member of the audit committee, the board of directors or any other board committee: (1) accept,
directly or indirectly, any consulting, advisory or other compensatory fee from the listed company or any of its subsidiaries;
or (2) be an affiliated person of the listed company or any of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Three of our five directors are independent
under the definition of the NYSE MKT. The other two directors are not independent under either definition due to (i) being an executive
officer of our Company, in the case of Josh Disbrow, and (ii) the payments we make to Ampio under the services agreement with Aytu,
in the case of Mr. Macaluso.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Stockholder Proposals</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our bylaws establish procedures for stockholder
nominations for elections of directors and bringing business before any annual meeting or special meeting of stockholders. A stockholder
entitled to vote in the election of directors may nominate one or more persons for election as directors at a meeting only if written
notice of such stockholder&rsquo;s intent to make such nomination or nominations has been delivered to our Corporate Secretary
at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary of the prior year&rsquo;s
annual meeting. In the event that the date of the annual meeting is more than 30 days before or more than 60 days after the anniversary
date of the prior year&rsquo;s annual meeting, the stockholder notice must be given not more than 120 days nor less than the later
of 90 days prior to the date of the annual meeting or, if it is later, the 10<SUP>th</SUP> day following the date on which the
date of the annual meeting is first publicly announced or disclosed by us. These notice deadlines are the same as those required
by the SEC&rsquo;s Rule 14a-8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Pursuant to the bylaws, a stockholder&rsquo;s
notice must set forth among other things: (a) as to each person whom the stockholder proposes to nominate for election or reelection
as a director all information relating to such person that is required to be disclosed in solicitations of proxies for election
of directors in an election contest, or is otherwise required, in each case pursuant to Regulation 14A under the Securities Exchange
Act of 1934, as amended, or the Exchange Act, and the rules and regulations thereunder; and (b) as to any other business that the
stockholder proposes to bring before the meeting, a brief description of the business desired to be brought before the meeting,
the reasons for conducting such business at the meeting and any material interest in such business of such stockholder and the
beneficial owner, if any, on whose behalf the proposal is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">There have been no changes to these nominating
procedures since the adoption of the bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Stockholder Communications with the Board</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Stockholders who wish to do so may communicate
directly with the Board or specified individual directors by writing to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">Board of Directors (or name of individual director)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">c/o Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">Aytu BioScience, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">373 Inverness Parkway, Suite 206</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">Englewood, Colorado 80112</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">We will forward all communications from stockholders
to the full Board, to non-management directors or to an individual director that is most closely related to the subject matter
of the communication, except for the following types of communications: (i) communications that advocate that we engage in illegal
activity; (ii) communications that, under community standards, contain offensive or abusive content; (iii) communications that
have no relevance to our business or operations; and (iv) mass mailings, solicitations and advertisements. The Corporate Secretary
will determine when a communication is not to be forwarded. Our acceptance and forwarding of communications to directors does not
imply that directors owe or assume any fiduciary duties to persons submitting the communications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">We describe below all transactions and series
of similar transactions, other than compensation arrangements, during the last three fiscal years, to which we were a party or
will be a party, in which:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>the amounts involved exceeded or will exceed $120,000; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>any of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the immediate family
of the foregoing persons, had or will have a direct or indirect material interest.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>April 2015 Merger&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">On April 16, 2015, pursuant to the Merger Agreement
entered into among Rosewind, Luoxis, Vyrix and two subsidiaries of Rosewind created solely for the purposes of the Merger, and
which did not survive the Merger, the Merger occurred in two stages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In the first stage, each of Vyrix and Luoxis
merged with one of Rosewind&rsquo;s merger subsidiaries. Vyrix and Luoxis survived these mergers. The outstanding shares of stock
of Vyrix and the outstanding shares of stock of Luoxis were converted into the right to receive shares of our common stock. The
Vyrix stock and the Luoxis stock were each converted at an exchange factor. The exchange factor for each of them was determined
upon the basis of a relative value opinion obtained by Ampio, the parent company of Vyrix and Luoxis. The outstanding shares of
Rosewind&rsquo;s merger subsidiary that merged with Vyrix were converted into shares of Vyrix as the surviving corporation. The
outstanding shares of Rosewind&rsquo;s merger subsidiary that merged with Luoxis were converted into shares of Luoxis as the surviving
corporation. After completion of the first stage, Vyrix and Luoxis became subsidiaries of Rosewind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In the second stage, which occurred on the
same day as the first stage, each of Vyrix and Luoxis merged with Rosewind with Rosewind surviving. The first and second stage
mergers are referred to collectively as the &ldquo;Merger.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Concurrently with the Merger:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>Ampio purchased 396,816 shares of our common stock for (i) issuance to Rosewind of a promissory note of Ampio in the principal
amount of $10,000,000, maturing on the first anniversary of the Merger; (ii) cancellation of indebtedness of Luoxis to Ampio in
the amount of $8,000,000; and (iii) cancellation of indebtedness of Vyrix to Ampio in the amount of $4,000,000.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Rosewind&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">On March 3, 2015, Rosewind accepted a cash
investment from two irrevocable trusts for estate planning of which Joshua Disbrow and Jarrett Disbrow are beneficiaries. None
of such persons have or share investment control over our shares held by such trusts. None of such persons, nor members of their
respective immediate families, are trustees of such trusts. None of such persons have or share power to revoke such trusts. Accordingly,
under Rule 16a-8(b) and related rules, none of such persons has beneficial ownership over our shares purchased and held by such
trusts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Luoxis and Vyrix&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Ampio Loan Agreements&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In November 2013, Vyrix entered into a loan
agreement with Ampio. Pursuant to the loan agreement, Ampio agreed to lend Vyrix up to an aggregate amount of $3,000,000 through
cash advances of up to $500,000 each. Unpaid principal amounts under the loan agreement bear simple interest at the &ldquo;Applicable
Federal Rate&rdquo; for long-term obligations prescribed under Section 1274(d) of the Internal Revenue Code of 1986, as amended
(or any successor provision with similar applicability). The initial term of this loan agreement is for one year, subject to automatic
extension of successive one-year terms. Vyrix may repay any outstanding balance at any time without penalty. Ampio has an option
of converting any balance outstanding under the loan agreement into shares of Vyrix common stock at the fair market value per share
of Vyrix common stock, as determined by the Ampio board of directors, as of such conversion date. On April 16, 2015, in connection
with the closing of the Merger, Ampio released Vyrix from its then outstanding obligation of $4,000,000 under the loan agreement
as consideration of its share purchase, and the loan agreement was terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In March 2014, Luoxis entered into a loan agreement
with Ampio. Pursuant to the loan agreement, Ampio agreed to lend Luoxis $3,000,000. Unpaid principal amounts under the loan agreement
bear simple interest at the &ldquo;Applicable Federal Rate&rdquo; for long-term obligations prescribed under Section 1274(d) of
the Internal Revenue Code of 1986, as amended (or any successor provision with similar applicability). The initial term of this
loan agreement is for one year, subject to automatic extension of successive one-year terms. Luoxis may repay any outstanding balance
at any time without penalty. Ampio has an option of converting any balance outstanding under the loan agreement into shares of
Luoxis common stock at the fair market value per share of Luoxis common stock, as determined by the Ampio board of directors, as
of such conversion date. On April 16, 2015, in connection with the closing of the Merger, Ampio released Luoxis from its then outstanding
obligation of $8,000,000 under the loan agreement as consideration of its share purchase, and the loan agreement was terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">On April 16, 2015, Ampio received 396,816 shares
of common stock of Aytu for (i) issuance to Aytu of a promissory note from Ampio in the principal amount of $10,000,000, maturing
on the first anniversary of the Merger, (ii) cancellation of indebtedness of Luoxis to Ampio in the amount of $8,000,000; and (iii)
cancellation of indebtedness of Vyrix to Ampio in the amount of $4,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Services Agreements&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In January 2013, Luoxis entered into a services
agreement with Ampio whereby Ampio provides corporate overhead services and a shared facility with Luoxis in exchange for $15,000
per month. The amount can be modified in writing upon the consent of both parties. The agreement may be terminated at any time
by either party. In January 2014, Vyrix entered into a services agreement with Ampio whereby Ampio provides corporate overhead
services to Vyrix in exchange for $7,000 per month. The amount can be modified in writing upon the consent of both parties. The
agreement may be terminated at any time by either party. Both agreements were assigned to us upon the closing of the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In July 2015, the prior service agreements
were canceled and Aytu entered into agreements with Ampio whereby Aytu agreed to pay Ampio $30,000 per month for shared overhead
which includes costs related to the shared facility, corporate staff, and other miscellaneous overhead expenses. This agreement
will be in effect until it is terminated in writing by both parties. This agreement was amended in April 2016, which reduced the
monthly amount to $18,000. This agreement was amended again in July 2016, which reduced the monthly amount to approximately $17,000
per month.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Sponsored Research Agreement&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In June 2013, Luoxis entered into a sponsored
research agreement with TRLLC, an entity controlled by Ampio&rsquo;s director and Chief Scientific Officer, Dr. Bar-Or. The agreement,
which was amended in September 2013 and provides for Luoxis to pay $6,000 per month to TRLLC in consideration for services related
to research and development of Luoxis&rsquo; RedoxSYS System. In March 2014, Luoxis also agreed to pay a sum of $615,000 which
is being amortized over the contractual term of 60.5 months and is divided between current and long-term on the balance sheet;
this amount has been paid in full. This agreement is set to expire March 2019 and cannot be terminated prior to March 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Review, Approval or Ratification of Transactions with Related
Persons </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.25in">Effective upon its adoption
in July 2016, pursuant to the Audit Committee Charter, the Audit Committee is responsible for reviewing and approving all related
party transactions as defined under Item 404 of Regulation S-K, after reviewing each such transaction for potential conflicts of
interests and other improprieties. Our policies and procedures for review and approval of transactions with related persons are
in writing in our Code of Conduct and Ethics available on our website at <U>http://aytubio.com</U> under the &ldquo;Investor Relations&mdash;Corporate
Governance&rdquo; tab.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Prior to the adoption of the Audit Committee
Charter, and due to the small size of our company, we did not have a formal written policy regarding the review of related party
transactions, and relied on our Board of Directors to review, approve or ratify such transactions and identify and prevent conflicts
of interest. Our Board of Directors reviewed any such transaction in light of the particular affiliation and interest of any involved
director, officer or other employee or stockholder and, if applicable, any such person&rsquo;s affiliates or immediate family members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The following table sets forth information
with respect to the beneficial ownership of our common stock as of August&nbsp;31, 2016 for:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>each beneficial owner of more than 5% of our outstanding common stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>each of our director and named executive officers; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>all of our directors and executive officers as a group.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Beneficial ownership is determined in accordance
with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared
voting power or investment power with respect to those securities and include common stock that can be acquired within 60 days
of August&nbsp;31, 2016. The percentage ownership information shown in the table is based upon 5,070,591 shares of common stock
outstanding as of August 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Except as otherwise indicated, all of the shares
reflected in the table are shares of common stock and all persons listed below have sole voting and investment power with respect
to the shares beneficially owned by them, subject to applicable community property laws. The information is not necessarily indicative
of beneficial ownership for any other purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In computing the number of shares of common
stock beneficially owned by a person and the percentage ownership of that person, we deemed outstanding shares of common stock
subject to options and warrants held by that person that are immediately exercisable or exercisable within 60 days of August 31,
2016. We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership of any other person.
Beneficial ownership representing less than 1% is denoted with an asterisk (*). The information in the table below is based on
information known to us or ascertained by us from public filings made by the stockholders. Except as otherwise indicated in the
table below, addresses of the director, executive officers and named beneficial owners are in care of Aytu BioScience, Inc., 373
Inverness Parkway, Suite 206, Englewood, Colorado 80112.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Percentage of</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Shares</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Number of Shares Beneficially</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Beneficially</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center">Name of Beneficial Owner</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Owned</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Owned</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">5% Stockholders:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 64%; text-align: left"><FONT STYLE="font-size: 10pt">Alpha Venture Capital Partners, L.P.<SUP>(1)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">837,300</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">16.5</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Directors and Named Executive Officers:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Joshua R. Disbrow <SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">296,863</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.8</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Jarrett T. Disbrow <SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">267,673</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.3</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Gregory A. Gould <SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">227,733</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.5</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Jonathan H. McGrael <SUP>(5)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">140,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.8</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Michael Macaluso <SUP>(6)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">119,156</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Carl C. Dockery<SUP>(7)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">912,301</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.6</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">John Donofrio<SUP>(8)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">68,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.4</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Gary Cantrell<SUP>(9)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.4</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All directors and executive officers as a group (eight persons)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,104,976</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37.6</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 9pt">* Represents beneficial ownership of less than 1%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 9pt">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 9pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><SUP>(1)</SUP></TD><TD>Carl C. Dockery is the President of the general partner of Alpha Venture Capital Partners, L.P. and therefore may be deemed
to beneficially own the shares beneficially owned by Alpha Venture Capital Partners, L.P. The address of Alpha Venture Capital
Partners, L.P. is 2026 Crystal Wood Drive, Lakeland, Florida 33801. For securities beneficially owned by Alpha Venture Capital
Partners, L.P., see footnote 7.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><SUP>(2)</SUP></TD><TD>Consists of (i)&nbsp;86,029 shares, (ii)&nbsp;190,000 restricted shares and (iii) 20,834 shares issuable upon the exercise
warrants. Does not include 46,548 shares held by an irrevocable trust for estate planning in which Mr. Disbrow is a beneficiary.
Mr. Disbrow does not have or share investment control over the shares held by the trust, Mr. Disbrow is not the trustee of the
trust (nor is any member of Mr. Disbrow&rsquo;s immediate family) and Mr. Disbrow does not have or share the power to revoke the
trust. As such, under Rule 16a-8(b) and related rules, Mr. Disbrow does not have beneficial ownership over the shares purchased
and held by the trust.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><SUP>(3)</SUP></TD><TD>Consists of (i)&nbsp;81,839 shares, (ii)&nbsp;165,000 restricted shares and (iii) 20,834 shares issuable upon the exercise
warrants. Does not include 46,548 shares held by an irrevocable trust for estate planning in which Mr. Disbrow is a beneficiary.
Mr. Disbrow does not have or share investment control over the shares held by the trust, Mr. Disbrow is not the trustee of the
trust (nor is any member of Mr. Disbrow&rsquo;s immediate family) and Mr. Disbrow does not have or share the power to revoke the
trust. As such, under Rule 16a-8(b) and related rules, Mr. Disbrow does not have beneficial ownership over the shares purchased
and held by the trust.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><SUP>(4)</SUP></TD><TD>Consists of (i)&nbsp;41,899 shares, (ii)&nbsp;165,000 restricted shares, and (iii)&nbsp;vested options to purchase 20,834 shares
of common stock.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><SUP>(5)</SUP></TD><TD>Consists of 140,000 restricted shares.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><SUP>(6)</SUP></TD><TD>Consists of (i)&nbsp;29,780 shares, (ii)&nbsp;65,000 restricted shares, and (iii)&nbsp;vested options to purchase 24,376 shares
of common stock.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><SUP>(7)</SUP></TD><TD>Consists of (i)&nbsp;65,000 restricted shares, (ii)&nbsp;vested options to purchase 10,001 shares of common stock, (iii)&nbsp;420,633
shares held by Alpha Venture Capital Partners, L.P and (iv) 416,667 shares issuable upon the exercise warrants held by Alpha Venture
Capital Partners, L.P. Mr. Dockery is the President of the general partner of Alpha Venture Capital Partners, L.P. and therefore
may be deemed to beneficially own the shares beneficially owned by Alpha Venture Capital Partners, L.P.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><SUP>(8)</SUP></TD><TD>Consists of (i)&nbsp;65,000 restricted shares, and (ii)&nbsp;vested options to purchase 3,750 shares of common stock.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><SUP>(9)</SUP></TD><TD>Consists of (i)&nbsp;65,000 restricted shares, (ii)&nbsp;3,750 shares issuable upon the exercise of warrants, and (iii)&nbsp;vested
options to purchase 3,750 shares of common stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DIRECTOR COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our current compensation package for non-employee
directors, effective July 1, 2017, consists of: an annual cash retainer of $25,000 for each director, $10,000 for each committee
chair and $5,000 for each other committee member; a one-time grant of 65,000 restricted shares of stock upon appointment to the
board; and an annual stock option grant of 15,000 shares thereafter. In April 2016, we prorated for the last quarter of fiscal
2016 the annual cash retainer (amounting to $6,250) and also made the annual grant of 100,000 stock options to our then two non-employee
directors. Prior to April 1, 2016, we paid no cash compensation and made no annual stock option grants.&nbsp; We also reimburse
directors for expenses incurred in connection with their service as director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The following table provides information regarding
all compensation paid to non-employee directors of Aytu during the fiscal year ended June 30, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">Name</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fees Earned<BR> or Paid in<BR> Cash</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Stock</B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>Option</B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>Awards<SUP>(1)</SUP></B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">All Other Compensation</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%">Michael Macaluso<SUP>(2)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">6,250</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">34,169</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">40,419</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Carl C. Dockery<SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">6,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">34,169</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">40,419</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gary V. Cantrell<SUP>(2) (3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">John A. Donofrio Jr<SUP>(2) (3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>This column reflects the aggregate grant date fair value computed in accordance with Financial Accounting Standards Board,
or FASB, issued Accounting Standards Update, or ASC, Topic 718.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>As of June 30, 2016, the number of shares underlying options held by each non-employee director was as follows: 18,750 shares
for Mr. Macaluso; 8,334 shares for Mr. Dockery; none for Mr. Cantrell; and none for Mr. Donofrio.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>Gary V. Cantrell and John A. Donofrio Jr. were each appointed a director in July 2016 and therefore received no compensation
or equity awards from Aytu in the fiscal year ended June 30, 2016.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXECUTIVE COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In accordance with Item 402 of Regulation S-K
promulgated by the SEC, we are required to disclose certain information regarding the makeup of and compensation for our company&rsquo;s
directors and named executive officers. On April 16, 2015, we acquired Luoxis and Vyrix in the Merger. Because for certain periods
some of our named executive officers were, prior to the Merger on April 16, 2015, employed by Luoxis and Vyrix, we are providing
past compensation information concerning such executive officers with respect to Luoxis and Vyrix.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In establishing executive compensation, our
Board is guided by the following goals:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>compensation should consist of a combination of cash and equity awards that are designed to fairly pay the executive officers
and directors for work required for a company of our size and scope;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>compensation should align the executive officers&rsquo; and directors&rsquo; interests with the long-term interests of stockholders;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>compensation should assist with attracting and retaining qualified executive officers and directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The following table sets forth all cash compensation
earned, as well as certain other compensation paid or accrued for the years ended June 30, 2016 and 2015 to each of the following
named executive officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Non-Equity</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Change in<BR> Pension Value<BR>
    and<BR> Nonqualified</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Option</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Incentive Plan</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Deferred</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">All Other</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Stock</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Award</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Compensation</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Compensation</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Compensation</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Name and Principal Position</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Year</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Salary ($)</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Bonus ($)</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Award ($)</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">($)(1)</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">($)</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Earnings ($)</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">($)</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Total ($)</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(a)</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(b)</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(c)</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(d)</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(e)</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(f)</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(g)</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(h)</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(i)</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(j)</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Named Executive Officers</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">Joshua R. Disbrow (2)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-left: 9pt; width: 28%"><FONT STYLE="font-size: 8pt">Chief Executive
    Officer</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; text-align: center"><FONT STYLE="font-size: 8pt">2016</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-size: 8pt">250,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-size: 8pt">312,500</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;(8)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-size: 8pt">559,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-size: 8pt">1,121,500</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; padding-left: 9pt"><FONT STYLE="font-size: 8pt">since December 2012</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2015</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">246,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">202,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">198,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">7,045</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(3)&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">653,545</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">Jarrett T. Disbrow (4)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Chief Operating Officer,
    Secretary</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">250,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">287,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;(8)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">559,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,096,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">and Treasurer</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2015</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">218,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">5,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">223,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">Gregory A. Gould (5)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Chief Financial Officer</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">250,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;(8)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">250,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; padding-left: 9pt"><FONT STYLE="font-size: 8pt">since June 2014</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2015</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">66,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">66,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">Jonathan H. McGrael (6)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">VP of Commercial Operations</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">140,417</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">237,737</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">186,337</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">13,233</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(7)&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">577,724</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2015</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-left: 0; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><SUP>(1)</SUP></TD><TD>Option awards are reported at fair value at the date of grant. See Item 15 of Part IV, &ldquo;Notes to the Financial Statements
&mdash; Note 10 &mdash; Equity Instruments.&rdquo; Pre-Merger option awards made in August 2014 to Joshua R. Disbrow and Gregory
A. Gould were cancelled in April 2015 and the expenses were reversed.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><SUP>(2)</SUP></TD><TD>Joshua R. Disbrow received a salary increase to $250,000 effective April 16, 2015 when he was appointed Chief Executive Officer
of Aytu.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><SUP>(3)</SUP></TD><TD>This was a cash payout of in-the-money options issued to Mr. Disbrow by Luoxis, which options were cashed out in the Merger.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><SUP>(4)</SUP></TD><TD>Jarrett T. Disbrow received a salary increase to $250,000 effective April 16, 2015 when he was appointed Chief Operating Officer
of Aytu.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><SUP>(5)</SUP></TD><TD>Mr. Gould was appointed to Chief Financial Officer, Secretary and Treasurer effective April 16, 2015. His compensation
                                                                       expense is part of the shared service agreement with Ampio, except for his bonus, which is paid directly by us to Mr. Gould.</TD></TR>
<TR STYLE="vertical-align: top">
<TD><SUP>(6)</SUP></TD><TD>Mr. McGrael was hired on September 16, 2015 and his annual salary was increased on May 15, 2016 from $175,000 to $190,000.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><SUP>(7)</SUP></TD><TD STYLE="text-decoration: none">Represents reimbursed relocation expenses.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><SUP>(8)</SUP></TD><TD>Of these bonuses, 60% was taken in common stock and 40% was taken in cash.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our executive officers are reimbursed by us
for any out-of-pocket expenses incurred in connection with activities conducted on our behalf. Executives are reimbursed for business
expenses directly related to Aytu business activities, such as travel, primarily for business development as we grow and expand
our product lines. On average, each executive incurs between $1,000 to $3,000 of out-of-pocket business expenses each month. The
executive management team meets weekly and determines which activities they will work on based upon what we determine will be the
most beneficial to our company and our shareholders. No interest is paid on amounts reimbursed to the executives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Outstanding Equity Awards</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The following table contains certain information
concerning unexercised options for the Named Executive Officers as of June 30, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Equity Incentive</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Number of</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Plan Awards:</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Number of</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Securities</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Number of</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Securities</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Underlying</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Securities</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Underlying</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Unexercised</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Underlying</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Unexercised</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Options</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Unexercised</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Option</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center">Option</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Options</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Unexercisable</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Unearned</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Exercise</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center">Expiration</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center">Name</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Exercisable (#)</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">(#)</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Options (#)</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Price ($)(1)</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center">Date</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(a)</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(b)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(c)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(d)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(e)<SUP></SUP></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(f)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; border-bottom: Black 1pt solid">Named Executive Officers</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: left">Joshua R. Disbrow</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">50,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">18.12</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 12%; text-align: center">11/11/2025</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Jarrett T. Disbrow</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18.12</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">11/11/2025</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gregory A. Gould</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18.12</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">11/11/2025</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Jonathan H. McGrael</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18.12</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">11/11/2025</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 97%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="text-align: justify">On July 7, 2016, the Board reset the option exercise
price on these options from $18.12 to $3.23.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Grants of Plan-Based Awards </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The following table sets forth certain information
regarding grants of plan-based awards to the Named Executive Officers during the year ended June 30, 2016:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 92%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">All Other Option</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Awards: Numbers of</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Exercise Price</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Grant Date</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Securities</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">of Option</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Fair Value of</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Underlying Options</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Awards</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Option Awards</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center">Name</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center">Grant Date</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">(#)</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">($/Share)(3)</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">($)(1)</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-bottom: 1pt">Named Executive Officers</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; text-align: left">Joshua R Disbrow</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 12%; text-align: center">11/11/2015</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">50,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">18.12</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">559,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Jarrett T Disborw</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">11/11/2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18.12</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">559,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gregory A Gould</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">11/11/2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18.12</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">(2)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Jonathan H McGrael</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">11/11/2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18.12</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">186,337</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>The amounts reported in this column represent the aggregate grant date fair value computed in accordance with FASB ASC 718,
excluding the effect of any estimated forfeitures and may not correspond to the actual value that will be realized by the named
executive officer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>The fair value of this award was recognized by Ampio Pharmaceuticals as at the date of grant, Ampio was the parent company
and in accordance with GAAP, since Mr. Gould is still an Ampio employee, it was appropriate for Ampio to recognize the expense.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>On July 7, 2016, the Board reset the option exercise price on these options from $18.12 to $3.23.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Employment Agreements </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">We entered into an employment agreement with
Joshua Disbrow in connection with his employment as our Chief Executive Officer. The agreement is for a term of 24 months beginning
on April 16, 2015, subject to termination by us with or without Cause or as a result of officer&rsquo;s disability, or by the officer
with or without Good Reason (as discussed below). Mr. Disbrow is entitled to receive $250,000 in annual salary, plus a discretionary
performance bonus with a target of 125% of his base salary. Mr. Disbrow is also eligible to participate in the benefit plans maintained
by us from time to time, subject to the terms and conditions of such plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">We entered into an employment agreement with
Jarrett Disbrow, our Chief Operating Officer, in connection with his employment with us. The agreement is for a term of 24 months
beginning on April 16, 2015, subject to termination by us with or without Cause or as a result of the officer&rsquo;s disability,
or by the officer with or without Good Reason (as discussed below). Mr. Disbrow is entitled to receive $250,000 in annual salary,
plus a discretionary performance bonus with a target of 125% of his base salary. Mr. Disbrow is also eligible to participate in
the benefit plans maintained by us from time to time, subject to the terms and conditions of such plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In September 2015, we entered into an employment
agreement with Jonathan McGrael, our Vice President of Sales, in connection with his employment with us. The agreement is at will,
subject to termination by us with or without Cause or as a result of the officer&rsquo;s disability, or by the officer with or
without Good Reason (as discussed below). Mr. McGrael is entitled to receive $175,000 in annual salary, plus a discretionary performance
bonus with a target of 43% of his base salary. Mr. McGrael will also receive up to $20,000 for relocation reimbursement. Mr. McGrael
is also eligible to participate in the benefit plans maintained by us from time to time, subject to the terms and conditions of
such plans. On May 15, 2016, we amended Mr. McGrael&rsquo;s contract to increase his salary to $190,000 and to name him our Vice
President of Commercial Operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Payments Provided Upon Termination for Good Reason or Without
Cause </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Pursuant to the employment agreements, in the
event Joshua Disbrow&rsquo;s or Jarrett Disbrow&rsquo;s employment is terminated without Cause by us or either officer terminates
his employment with Good Reason, we will be obligated to pay him any accrued compensation and a lump sum payment equal to two times
his base salary in effect at the date of termination, as well as continued participation in the health and welfare plans for up
to two years. All vested stock options shall remain exercisable from the date of termination until the expiration date of the applicable
award. So long as a Change in Control is not in effect, then all options which are unvested at the date of termination Without
Cause or for Good Reason shall be accelerated as of the date of termination such that the number of option shares equal to 1/24<SUP>th</SUP>
the number of option shares multiplied by the number of full months of such officer&rsquo;s employment shall be deemed vested and
immediately exercisable by the officer. Any unvested options over and above the foregoing shall be cancelled and of no further
force or effect, and shall not be exercisable by such officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&ldquo;Good Reason&rdquo; with respect to the
agreements with Joshua Disbrow and Jarrett Disbrow, means, without the officer&rsquo;s written consent, there is:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>a material reduction in the officer&rsquo;s overall responsibilities or authority, or scope of duties (it being understood
that the occurrence of a Change in Control shall not, by itself, necessarily constitute a reduction in the officer&rsquo;s responsibilities
or authority);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>a material reduction of the level of the officer&rsquo;s compensation (excluding any bonuses) (except where there is a general
reduction applicable to the management team generally, provided, however, that in no case may the base salary be reduced below
certain specified amounts); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>a material change in the principal geographic location at which the officer must perform his services.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&ldquo;Cause&rdquo; with respect to the agreements
with Joshua Disbrow and Jarrett Disbrow, means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>conviction of, or entry of a plea of guilty to, or entry of a plea of nolo contendere with respect to, any crime, other than
a traffic violation which is a misdemeanor;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>willful malfeasance or willful misconduct by the officer in connection with his employment;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>gross negligence in performing any of his duties;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>willful and deliberate violation of any of our policies;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>unintended but material breach of any written policy applicable to all employees adopted by us which is not cured to the reasonable
satisfaction of the board;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>unauthorized use or disclosure of any proprietary information or trade secrets of us or any other party as to which the officer
owes an obligation of nondisclosure as a result of the officer&rsquo;s relationship with us;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>willful and deliberate breach of his obligations under the employment agreement; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>any other material breach by officer of any of his obligations which is not cured to the reasonable satisfaction of the board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In the case of Mr. McGrael&rsquo;s termination
without Cause or with Good Reason, we will be obligated to pay him any accrued compensation and continue his salary for six months.
In addition, all unvested options will receive accelerated vesting in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&ldquo;Good Reason&rdquo; with respect to the
agreement with Mr. McGrael, means, without the officer&rsquo;s written consent, there is:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>a material reduction in the officer&rsquo;s overall responsibilities or authority, or scope of duties;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>a material reduction of the level of the officer&rsquo;s compensation (excluding any bonuses) (except where there is a general
reduction applicable to the management team generally, provided, however, that in no case may the base salary be reduced below
certain specified amounts); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>the Company&rsquo;s material breach of the employment agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&ldquo;Cause&rdquo; with respect to the agreement
with Mr. McGrael means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>conviction of, or entry of a plea of guilty to, or entry of a plea of nolo contendere with respect to, a felony or misdemeanor
involving moral turpitude;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>willful malfeasance or willful misconduct by the officer in connection with his employment;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>gross negligence in performing any of his duties;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>material failure to comply with our workplace rules, policies or procedures which is not cured within fifteen days of written
notice;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>material breach of our Proprietary Information and Inventions Agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>material breach of the employment agreement which is not cured within fifteen days of written notice;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>unauthorized use or disclosure of any proprietary information or trade secrets of us or any other party as to which the officer
owes an obligation of nondisclosure as a result of the officer&rsquo;s relationship with us; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>willful failure or refusal to perform his material duties under the employment agreement or failure to follow any specific
lawful instructions of the Chief Executive Officer or his designee which is not cured within fifteen days of written notice.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The severance benefits described above are
contingent on each officer executing a general release of claims.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Payments Provided Upon a Change in Control </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Pursuant to the employment agreements for Joshua
Disbrow and Jarrett Disbrow, in the event of a Change in Control of us, all stock options, restricted stock and other stock-based
grants granted or may be granted in the future by us to the officers will immediately vest and become exercisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&ldquo;Change in Control&rdquo; means: the
occurrence of any of the following events:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>the acquisition by any individual, entity, or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act)
(the &ldquo;Acquiring Person&rdquo;), other than us, or any of our Subsidiaries, of beneficial ownership (within the meaning of
Rule 13d-3- promulgated under the Exchange Act) of 50% or more of the combined voting power or economic interests of the then outstanding
voting securities of us entitled to vote generally in the election of directors (excluding any issuance of securities by us in
a transaction or series of transactions made principally for bona fide equity financing purposes); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>the acquisition of us by another entity by means of any transaction or series of related transactions to which we are party
(including, without limitation, any stock acquisition, reorganization, merger or consolidation but excluding any issuance of securities
by us in a transaction or series of transactions made principally for bona fide equity financing purposes) other than a transaction
or series of related transactions in which the holders of the voting securities of us outstanding immediately prior to such transaction
or series of related transactions retain, immediately after such transaction or series of related transactions, as a result of
shares in us held by such holders prior to such transaction or series of related transactions, at least a majority of the total
voting power represented by the outstanding voting securities of us or such other surviving or resulting entity (or if we or such
other surviving or resulting entity is a wholly-owned subsidiary immediately following such acquisition, its parent); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>the sale or other disposition of all or substantially all of the assets of us in one transaction or series of related transactions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our only obligation to Joshua Disbrow and Jarrett
Disbrow had a Change in Control occurred as of June 30, 2016, would be the acceleration of the vesting of all options held by them
at that date. On June 30, 2016, the closing price of our common stock was below the exercise price for all of the options held
by Joshua Disbrow and Jarrett Disbrow and therefore there would have been no economic benefit to them upon the acceleration of
vesting of those options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>STOCKHOLDER COMMUNICATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Stockholders may send any communications regarding
Company business to the Board in care of our Corporate Secretary at our principal executive offices located at 373 Inverness Parkway,
Suite 206, Englewood, Colorado 80112. The Secretary will forward all such communications to the addressee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AUDITOR MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The Board has reviewed and discussed with management
our audited financial statements for the fiscal year ended June 30, 2016, which were audited by EKS&amp;H LLLP, our independent
registered public accounting firm. The Board discussed with EKS&amp;H LLLP the matters required to be discussed pursuant to Public
Company Accounting Oversight Board (United States) Auditing Standard 16 (Communication with Audit Committee). The Board received
the written disclosures and letter from the independent registered public accounting firm required by applicable requirements of
the PCAOB regarding the independent registered public accounting firm&rsquo;s communications with the Board concerning independence,
and discussed with the independent registered public accounting firm the independent registered public accounting firm&rsquo;s
independence. The Board also considered whether the provision of services other than the audit of our financial statements for
the fiscal year ended June 30, 2015 were compatible with maintaining EKS&amp;H LLLP&rsquo;s independence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Based on the review and discussions referred
to in the foregoing paragraph, the Board approved the inclusion of the audited financial statements in our Annual Report on Form
10-K for the fiscal year ended June 30, 2016 for filing with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Fees Paid to the Independent Registered Public Accounting Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">EKS&amp;H LLLP has served as our independent
auditors since April&nbsp;2015, and was appointed by the Board of Directors to continue as our independent auditors for the fiscal
years ended June&nbsp;30, 2015 and 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The following table presents aggregate fees
for professional services rendered by our independent registered public accounting firm, EKS&amp;H LLLP, for the audit of our annual
financial statements for the respective periods, all of which were approved by the full Board of Directors because we did not appoint
an independent Audit Committee until July 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.4in">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center">Year&nbsp;Ended&nbsp;June&nbsp;30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left; text-indent: -12pt; padding-left: 12pt">Audit fees (1)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">199,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">70,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -12pt; padding-left: 12pt">Audit-related fees (2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,319</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,100</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -12pt; padding-left: 12pt; padding-bottom: 1pt">Tax fees (3)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">4,000</TD><TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">975</TD><TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -12pt; padding-left: 0.5in; padding-bottom: 2.5pt">Total Fees</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">293,319</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">94,075</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in"><SUP>&nbsp;</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-left: 0.4in; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><SUP>(1)</SUP></TD><TD>Audit fees are comprised of annual audit fees and quarterly review fees.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><SUP>(2)</SUP></TD><TD>Audit-related fees for fiscal year 2016 were comprised of fees related to registration statements, including for our May 2016
public offering. The 2015 fees were related to registration statements and consultation fees.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><SUP>(3)</SUP></TD><TD>Tax fees are comprised of tax compliance, preparation and consultation fees.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Policy on Pre-Approval of Services of Independent Registered
Public Accounting Firm </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our Audit Committee has
responsibility for appointing, setting compensation and overseeing the work of the independent registered public accounting
firm. In recognition of this responsibility, the Audit Committee pre-approves all audit and permissible non-audit services
provided by the independent registered public accounting firm although, it has no written policy on this matter. Prior to
engagement of the independent registered public accounting firm for the following year&rsquo;s audit, management will submit
to the Audit Committee for approval a description of services expected to be rendered during that year for each of the
following four categories of services:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Audit services</I> include audit work performed
in audit of the annual financial statements, review of quarterly financial statements, reading of annual, quarterly and current
reports, as well as work that generally only the independent auditor can reasonably be expected to provide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Audit-related services</I> are for assurance
and related services that are traditionally performed by the independent auditor, including the provisions of consents and comfort
letters in connection with the filing of registration statements, due diligence related to mergers and acquisitions and special
procedures required to meet certain regulatory requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Tax services</I> consist principally of
assistance with tax compliance and reporting, as well as certain tax planning consultations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>Other services </I>are those associated
with services not captured in the other categories. We generally do not request such services from our independent auditor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Prior to the engagement, the Audit Committee
pre-approves these services by category of service. The fees are budgeted, and the Audit Committee requires the independent registered
public accounting firm and management to report actual fees versus the budget periodically throughout the year by category of service.
During the year, circumstances may arise when it may become necessary to engage the independent registered public accounting firm
for additional services not contemplated in the original pre-approval. In those instances, the Audit Committee requires specific
pre-approval before engaging the independent registered public accounting firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DEADLINE FOR STOCKHOLDER PROPOSALS FOR THE
2017 ANNUAL MEETING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Under our bylaws, stockholder proposals
to be considered at our 2017 annual meeting must be received by us not less than 90 days nor more than 120 days prior to the
first anniversary of the prior year&rsquo;s annual meeting. However, in the event that the date of the annual meeting is more
than 30 days before or more than 60 days after the anniversary date of the prior year&rsquo;s annual meeting, or if no annual
meeting was held in the prior year, the stockholder notice must be given not more than 120 days nor less than the later of 90
days prior to the date of the annual meeting or, if it is later, the 10<SUP>th</SUP> day following the date on which the date
of the annual meeting is first publicly announced or disclosed by us. Under SEC Rule 14a-8, in order for a stockholder
proposal to be included in our proxy solicitation materials for our 2017 Annual Meeting of Stockholders, it must be delivered
to our Corporate Secretary at our principal executive offices by June 7, 2017; provided, however, that if the date of the
2017 annual meeting is more than 30&nbsp;days before or after November 15, 2017, notice by the stockholder must be delivered
not later than the close of business on the later of (1)&nbsp;the 90<SUP>th</SUP> day prior to the 2017 annual meeting or
(2)&nbsp;the 10<SUP>th</SUP> day following the first public announcement of the date of the 2017 annual meeting. All
submissions must comply with all of the requirements of our bylaws and Rule 14a-8 of the Exchange Act. Proposals should be
mailed to Gregory A. Gould, Corporate Secretary, Aytu BioScience, Inc., 373 Inverness Parkway, Suite 206, Englewood, Colorado
80112.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Management&rsquo;s proxy holders for the next
annual meeting of stockholders will have discretion to vote proxies given to them on any stockholder proposal of which we do not
have notice prior to August 21, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">We anticipate holding our next annual meeting
in November 2017 following the end of our current fiscal year on June 30, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>DELIVERY OF DOCUMENTS TO STOCKHOLDERS SHARING
AN ADDRESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The SEC has adopted rules that permit companies
to deliver a single copy of proxy materials to multiple stockholders sharing an address unless a company has received contrary
instructions from one or more of the stockholders at that address. Upon request, we will promptly deliver a separate copy of proxy
materials to one or more stockholders at a shared address to which a single copy of proxy materials was delivered. Stockholders
may request a separate copy of proxy materials by contacting us either by calling (720) 437-6580 or by mailing a request to 373
Inverness Parkway, Suite 206, Englewood, Colorado 80112. Stockholders at a shared address who receive multiple copies of proxy
materials may request to receive a single copy of proxy materials in the future in the same manner as described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>ANNUAL REPORT ON FORM 10-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our Annual Report on Form 10-K for the fiscal
year ended June 30, 2016 as filed with the SEC is accessible free of charge on its website at www.sec.gov. It contains audited
financial statements covering the fiscal years ended June 30, 2016 and 2015. <B>You can request a copy of our Annual Report on
Form 10-K free of charge by calling (720) 437-6580 or by mailing a request to our Corporate Secretary, 373 Inverness Parkway, Suite
206, Englewood, Colorado 80112. Please include your contact information with the request. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING
COMPLIANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Section&nbsp;16(a) of the Securities Exchange
Act requires our officers and directors and persons who own more than 10% of our outstanding common stock to file reports of ownership
and changes in ownership with the Securities and Exchange Commission.&nbsp;These officers, directors and stockholders are required
by regulations under the Securities Exchange Act to furnish us with copies of all forms they file under Section&nbsp;16(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Based solely on our review of the copies of
forms we have received, we believe that all such required reports have been timely filed during fiscal 2016, except for the following:
a Form 4 for each of Joshua Disbrow, Jarrett Disbrow and Carl Dockery to report the purchase of shares of our common stock in our
May 2016 public offering, which reports were due on May 10, 2016, and were filed on May 16, 2016.</P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.25in"><B>DIRECTIONS TO AYTU BIOSCIENCE,
INC. ANNUAL MEETING AT THE OFFICES OF </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>WYRICK ROBBINS YATES &amp; PONTON LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AT 4101 LAKE BOONE TRAIL, SUITE 300, RALEIGH,
NORTH CAROLINA </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Driving directions (from I-40):</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>From the East &ndash; Wilson / Rocky Mount / Greenville</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Travel US 264 west towards Raleigh. Take exit 419, outer beltline
I-440 heading toward northern Raleigh. Continue on I-440 for 9 miles to exit 5, Lake Boone Trail. Turn right onto Lake Boone Trail.
The Summit building is 0.4 mile on your left.&nbsp;<BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>From the West &ndash; RTP / Durham / Chapel Hill / RDU Airport</B>&nbsp;<BR>
Travel I-40 east toward Raleigh. Take exit 289, Wade Avenue and continue to the Blue Ridge Road exit. Turn left onto Blue Ridge
Road and travel 0.8 mile to Lake Boone Trail. Turn right onto Lake Boone Trail. The Summit building is 0.4 mile on your right.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.25in"><B>Appendix A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">CERTIFICATE OF AMENDMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">OF</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">CERTIFICATE OF INCORPORATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">OF</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">AYTU BIOSCIENCE, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 15pt">Aytu BioScience, Inc., a corporation organized
and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the &ldquo;General
Corporation Law&rdquo;),</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 15pt">DOES HEREBY CERTIFY:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 15pt">FIRST: The name of the corporation is Aytu BioScience,
Inc. and that this corporation was originally incorporated pursuant to the General Corporation Law on June 8, 2015 under the name
Aytu BioScience, Inc. This Certificate of Amendment as duly adopted in accordance with the provisions of Section 242 of the General
Corporation Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 15pt">SECOND: That Article IV, Section 1 of the Certificate
of Incorporation of this corporation shall be deleted in its entirety and replaced with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 15pt">RESOLVED, that Article IV, Section 1 of the Certificate
of Incorporation of this corporation shall be amended by adding the following paragraph:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;Effective as of 4:30 p.m. Eastern Standard
Time on the date of the filing of this Certificate of Amendment to the Certificate of Incorporation of the Corporation (the &ldquo;<U>Effective
Time</U>&rdquo;), a one-for- reverse stock split of the Corporation&rsquo;s common stock shall become effective, pursuant to which
each share of common stock, par value $0.0001 per share, issued and outstanding or held as treasury shares at the Effective Time
(hereinafter called &ldquo;<U>Old Common Stock</U>&rdquo;), shall be reclassified and combined into one share of common stock,
par value $0.0001 per share (hereinafter called &ldquo;<U>Common Stock</U>&rdquo;), automatically and without any action by the
holder thereof, subject to the treatment of fractional shares, shall represent one share of Common Stock from and after the Effective
Time. No fractional shares of Common Stock shall be issued as a result of such reclassification and combination, rather stockholders
who otherwise would be entitled to receive fractional share interests of Common Stock as a result of the reclassification and combination
shall be entitled to receive in lieu of such fractional share interests, upon the Effective Time, one whole share of Common Stock
in lieu of such fractional share interests. As soon as practicable following the Effective Time, the Corporation will notify its
stockholders of record as of the Effective Time to transmit outstanding share certificates to the Corporation&rsquo;s exchange
agent and registrar (&ldquo;<U>Exchange Agent</U>&rdquo;) and the Corporation will cause the Exchange Agent to issue new certificates
or book entries representing one share of common stock for every [___] shares transmitted and held of record as of the Effective
Time; and in settlement of fractional interests that might arise as a result of such combination as of the Effective Time, cause
the Exchange Agent to issue one whole share to such holders in lieu of a fractional share interest. The Corporation&rsquo;s authorized
shares of Common Stock, each having a par value of $0.0001 per share, shall not be changed.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">THIRD: That said Certificate of Amendment,
which amends the provisions of this corporation&rsquo;s Certificate of Incorporation, has been duly adopted by the Board of Directors
and stockholders of the Corporation in accordance with Section 242 of the General Corporation Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">IN WITNESS WHEREOF, this Certificate of Amendment
of Certificate of Incorporation has been executed by a duly authorized officer of this corporation on this __ day of _____ 201__.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Joshua R. Disbrow, Chief Executive Officer</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.25in"><B>Appendix B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">AYTU BIOSCIENCE, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">2015 STOCK OPTION AND INCENTIVE PLAN</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 1.</FONT></TD><TD><U>GENERAL PURPOSE OF THE PLAN; DEFINITIONS</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The name of the plan is the Aytu Bioscience,
Inc. 2015 Stock Option and Incentive Plan (the &ldquo;Plan&rdquo;). The purpose of the Plan is to encourage and enable the officers,
employees, Non-Employee Directors and Consultants of Aytu Bioscience, Inc. (the &ldquo;Company&rdquo;) and its Subsidiaries upon
whose judgment, initiative and efforts the Company largely depends for the successful conduct of its businesses to acquire a proprietary
interest in the Company. It is anticipated that providing such persons with a direct stake in the Company&rsquo;s welfare will
assure a closer identification of their interests with those of the Company and its stockholders, thereby stimulating their efforts
on the Company&rsquo;s behalf and strengthening their desire to remain with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following terms shall be defined as
set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Act&rdquo;</I> means the Securities
Act of 1933, as amended, and the rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Administrator&rdquo;</I> means
either the Board or the compensation committee of the Board or a similar committee performing the functions of the compensation
committee and which is comprised of not less than two Non-Employee Directors who are independent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Award&rdquo;</I> or <I>&ldquo;Awards,&rdquo;</I>
except where referring to a particular category of grant under the Plan, shall include Incentive Stock Options, Non-Qualified Stock
Options, Stock Appreciation Rights, Restricted Stock Units, Restricted Stock Awards, Unrestricted Stock Awards, Cash-Based Awards,
Performance Share Awards and Dividend Equivalent Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Award Certificate&rdquo;</I> means
a written or electronic document setting forth the terms and provisions applicable to an Award granted under the Plan. Each Award
Certificate is subject to the terms and conditions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Board&rdquo;</I> means the Board
of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Cash-Based Award&rdquo;</I> means
an Award entitling the recipient to receive a cash-denominated payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Code&rdquo;</I> means the Internal
Revenue Code of 1986, as amended, and any successor Code, and related rules, regulations and interpretations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Consultant&rdquo;</I> means any
natural person that provides bona fide services to the Company, and such services are not in connection with the offer or sale
of securities in a capital-raising transaction and do not directly or indirectly promote or maintain a market for the Company&rsquo;s
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Covered Employee&rdquo;</I> means
an employee who is a &ldquo;Covered Employee&rdquo; within the meaning of Section&nbsp;162(m) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Dividend Equivalent Right&rdquo;</I>
means an Award entitling the grantee to receive credits based on cash dividends that would have been paid on the shares of Stock
specified in the Dividend Equivalent Right (or other award to which it relates) if such shares had been issued to and held by the
grantee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Effective Date&rdquo;</I> means
the date on which the Plan is approved by stockholders as set forth in Section&nbsp;21.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Exchange Act&rdquo;</I> means
the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Fair Market Value&rdquo;</I> of
the Stock on any given date means the fair market value of the Stock determined in good faith by the Administrator; provided, however,
that if the Stock is admitted to quotation on the National Association of Securities Dealers Automated Quotation System (&ldquo;NASDAQ&rdquo;),
NASDAQ Global Market or another national securities exchange, the determination shall be made by reference to market quotations.
If there are no market quotations for such date, the determination shall be made by reference to the last date preceding such date
for which there are market quotations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Incentive Stock Option&rdquo;</I>
means any Stock Option designated and qualified as an &ldquo;incentive stock option&rdquo; as defined in Section&nbsp;422 of the
Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Non-Employee Director&rdquo;</I>
means a member of the Board who is not also an employee of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Non-Qualified Stock Option&rdquo;</I>
means any Stock Option that is not an Incentive Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Option&rdquo;</I> or <I>&ldquo;Stock
Option&rdquo;</I> means any option to purchase shares of Stock granted pursuant to Section&nbsp;5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Performance-Based Award&rdquo;</I>
means any Restricted Stock Award, Restricted Stock Units, Performance Share Award or Cash-Based Award granted to a Covered Employee
that is intended to qualify as &ldquo;performance-based compensation&rdquo; under Section 162(m) of the Code and the regulations
promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Performance Criteria&rdquo;</I>
means the criteria that the Administrator selects for purposes of establishing the Performance Goal or Performance Goals for an
individual for a Performance Cycle. The Performance Criteria (which shall be applicable to the organizational level specified by
the Administrator, including, but not limited to, the Company or a unit, division, group, or Subsidiary of the Company) that will
be used to establish Performance Goals are limited to the following: achievement of research and development, publication, clinical
and/or regulatory milestones, total shareholder return, earnings before interest, taxes, depreciation and amortization, net income
(loss) (either before or after interest, taxes, depreciation and/or amortization), changes in the market price of the Stock, economic
value-added, funds from operations or similar measure, sales or revenue, acquisitions or strategic transactions, operating income
(loss), cash flow (including, but not limited to, operating cash flow and free cash flow), return on capital, assets, equity, or
investment, return on sales, gross or net profit levels, productivity, expense, margins, operating efficiency, customer satisfaction,
working capital, earnings (loss) per share of Stock, sales or market shares and number of customers, any of which may be measured
either in absolute terms or as compared to any incremental increase or as compared to results of a peer group. The Committee may
appropriately adjust any evaluation performance under a Performance Criterion to exclude any of the following events that occurs
during a Performance Cycle: (i) asset write-downs or impairments, (ii) litigation or claim judgments or settlements, (iii) the
effect of changes in tax law, accounting principles or other such laws or provisions affecting reporting results, (iv) accruals
for reorganizations and restructuring programs, (v) any extraordinary non-recurring items, including those described in the Financial
Accounting Standards Board&rsquo;s authoritative guidance and/or in management&rsquo;s discussion and analysis of financial condition
of operations appearing the Company&rsquo;s annual report to stockholders for the applicable year, and (vi) any other extraordinary
items adjusted from the Company U.S. GAAP results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 43; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Performance Cycle&rdquo;</I> means
one or more periods of time, which may be of varying and overlapping durations, as the Administrator may select, over which the
attainment of one or more Performance Criteria will be measured for the purpose of determining a grantee&rsquo;s right to and the
payment of a Restricted Stock Award, Restricted Stock Units, Performance Share Award or Cash-Based Award, the vesting and/or payment
of which is subject to the attainment of one or more Performance Goals. Each such period shall not be less than 12 months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Performance Goals&rdquo;</I> means,
for a Performance Cycle, the specific goals established in writing by the Administrator for a Performance Cycle based upon the
Performance Criteria.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Performance Share Award&rdquo;</I>
means an Award entitling the recipient to acquire shares of Stock upon the attainment of specified performance goals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Restricted Shares&rdquo;</I> means
the shares of Stock underlying a Restricted Stock Award that remain subject to a risk of forfeiture or the Company&rsquo;s right
of repurchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Restricted Stock Award&rdquo;</I>
means an Award of Restricted Shares subject to such restrictions and conditions as the Administrator may determine at the time
of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Restricted Stock Units&rdquo;</I>
means an Award of stock units subject to such restrictions and conditions as the Administrator may determine at the time of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Sale Event&rdquo;</I> shall mean
(i) the sale of all or substantially all of the assets of the Company on a consolidated basis to an unrelated person or entity,
(ii) a merger, reorganization or consolidation pursuant to which the holders of the Company&rsquo;s outstanding voting power and
outstanding stock immediately prior to such transaction do not own a majority of the outstanding voting power and outstanding stock
or other equity interests of the resulting or successor entity (or its ultimate parent, if applicable) immediately upon completion
of such transaction, (iii) the sale of all of the Stock of the Company to an unrelated person, entity or group thereof acting in
concert, or (iv) any other transaction in which the owners of the Company&rsquo;s outstanding voting power immediately prior to
such transaction do not own at least a majority of the outstanding voting power of the Company or any successor entity immediately
upon completion of the transaction other than as a result of the acquisition of securities directly from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<I>Sale Price</I>&rdquo; means the
value as determined by the Administrator of the consideration payable, or otherwise to be received by stockholders, per share of
Stock pursuant to a Sale Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Section 409A&rdquo;</I> means
Section 409A of the Code and the regulations and other guidance promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Stock&rdquo;</I> means the Common
Stock, par value $0.0001 per share, of the Company, subject to adjustments pursuant to Section&nbsp;3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Stock Appreciation Right&rdquo;</I>
means an Award entitling the recipient to receive shares of Stock having a value equal to the excess of the Fair Market Value of
the Stock on the date of exercise over the exercise price of the Stock Appreciation Right multiplied by the number of shares of
Stock with respect to which the Stock Appreciation Right shall have been exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Subsidiary&rdquo;</I> means any
corporation or other entity (other than the Company) in which the Company has at least a 50 percent interest, either directly or
indirectly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Ten Percent Owner&rdquo;</I> means
an employee who owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the Code) more than 10 percent
of the combined voting power of all classes of stock of the Company or any parent or subsidiary corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&ldquo;Unrestricted Stock Award&rdquo;</I>
means an Award of shares of Stock free of any restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 2.</FONT></TD><TD><U>ADMINISTRATION OF PLAN; ADMINISTRATOR AUTHORITY TO SELECT
GRANTEES AND DETERMINE AWARDS</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Administration of Plan</U>. The
Plan shall be administered by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Powers of Administrator</U>. The
Administrator shall have the power and authority to grant Awards consistent with the terms of the Plan, including the power and
authority:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to select the individuals to whom Awards
may from time to time be granted;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to determine the time or times of
grant, and the extent, if any, of Incentive Stock Options, Non-Qualified Stock Options, Stock Appreciation Rights, Restricted Stock
Awards, Restricted Stock Units, Unrestricted Stock Awards, Cash-Based Awards, Performance Share Awards and Dividend Equivalent
Rights, or any combination of the foregoing, granted to any one or more grantees;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to determine the number of shares
of Stock to be covered by any Award;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to determine and modify from time
to time the terms and conditions, including restrictions, not inconsistent with the terms of the Plan, of any Award, which terms
and conditions may differ among individual Awards and grantees, and to approve the forms of Award Certificates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to accelerate at any time the exercisability
or vesting of all or any portion of any Award;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;subject to the provisions of Section&nbsp;5(c),
to extend at any time the period in which Stock Options may be exercised; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;at any time to adopt, alter and repeal
such rules, guidelines and practices for administration of the Plan and for its own acts and proceedings as it shall deem advisable;
to interpret the terms and provisions of the Plan and any Award (including related written instruments); to make all determinations
it deems advisable for the administration of the Plan; to decide all disputes arising in connection with the Plan; and to otherwise
supervise the administration of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All decisions and interpretations of the
Administrator shall be binding on all persons, including the Company and Plan grantees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delegation of Authority to Grant
Awards</U>. Subject to applicable law, the Administrator, in its discretion, may delegate to the Chief Executive Officer of the
Company all or part of the Administrator&rsquo;s authority and duties with respect to the granting of Awards to individuals who
are (i) not subject to the reporting and other provisions of Section&nbsp;16 of the Exchange Act and (ii) not Covered Employees.
Any such delegation by the Administrator shall include a limitation as to the amount of Stock underlying Awards that may be granted
during the period of the delegation and shall contain guidelines as to the determination of the exercise price and the vesting
criteria. The Administrator may revoke or amend the terms of a delegation at any time but such action shall not invalidate any
prior actions of the Administrator&rsquo;s delegate or delegates that were consistent with the terms of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Award Certificate</U>. Awards
under the Plan shall be evidenced by Award Certificates that set forth the terms, conditions and limitations for each Award which
may include, without limitation, the term of an Award and the provisions applicable in the event employment or service terminates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification</U>. Neither the
Board nor the Administrator, nor any member of either or any delegate thereof, shall be liable for any act, omission, interpretation,
construction or determination made in good faith in connection with the Plan, and the members of the Board and the Administrator
(and any delegate thereof) shall be entitled in all cases to indemnification and reimbursement by the Company in respect of any
claim, loss, damage or expense (including, without limitation, reasonable attorneys&rsquo; fees) arising or resulting therefrom
to the fullest extent permitted by law and/or under the Company&rsquo;s articles or bylaws or any directors&rsquo; and officers&rsquo;
liability insurance coverage which may be in effect from time to time and/or any indemnification agreement between such individual
and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Foreign Award Recipients</U>.
Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws in other countries in which the Company
and its Subsidiaries operate or have employees or other individuals eligible for Awards, the Administrator, in its sole discretion,
shall have the power and authority to: (i) determine which Subsidiaries shall be covered by the Plan; (ii) determine which individuals
outside the United States are eligible to participate in the Plan; (iii) modify the terms and conditions of any Award granted to
individuals outside the United States to comply with applicable foreign laws; (iv) establish subplans and modify exercise procedures
and other terms and procedures, to the extent the Administrator determines such actions to be necessary or advisable (and such
subplans and/or modifications shall be attached to this Plan as appendices); provided, however, that no such subplans and/or modifications
shall increase the share limitations contained in Section 3(a) hereof; and (v) take any action, before or after<B> </B>an Award
is made, that the Administrator determines to be necessary or advisable to obtain approval or comply with any local governmental
regulatory exemptions or approvals. Notwithstanding the foregoing, the Administrator may not take any actions hereunder, and no
Awards shall be granted, that would violate the Exchange Act or any other applicable United States securities law, the Code, or
any other applicable United States governing statute or law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 3.</FONT></TD><TD><U>STOCK ISSUABLE UNDER THE PLAN; MERGERS; SUBSTITUTION</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Issuable</U>. The maximum
number of shares of Stock reserved and available for issuance under the Plan shall be two million (2,000,000) shares, subject to
adjustment as provided in this Section&nbsp;3. For purposes of this limitation, the shares of Stock underlying any Awards that
are forfeited, canceled, held back upon exercise of an Option or settlement of an Award to cover the exercise price or tax withholding,
reacquired by the Company prior to vesting, satisfied without the issuance of Stock or otherwise terminated (other than by exercise)
shall be added back to the shares of Stock available for issuance under the Plan. In the event the Company repurchases shares of
Stock on the open market, such shares shall not be added to the shares of Stock available for issuance under the Plan. Subject
to such overall limitations, shares of Stock may be issued up to such maximum number pursuant to any type or types of Award; provided,
however, that Stock Options or Stock Appreciation Rights with respect to no more than one million (1,000,000) shares of Stock may
be granted to any one individual grantee during any one calendar year period, and no more than two million (2,000,000) shares of
the Stock may be issued in the form of Incentive Stock Options. The shares available for issuance under the Plan may be authorized
but unissued shares of Stock or shares of Stock reacquired by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect of Awards</U>. The grant
of an Award shall be deemed, for purposes of determining the number of shares of Stock available for issuance under Section 3(a),
as an Award for one share of Stock for each such share of Stock actually subject to the Award. Any forfeitures, cancellations or
other terminations (other than by exercise) of such Awards shall be returned to the reserved pool of shares of Stock under the
Plan in the same manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Changes in Stock</U>. Subject
to Section&nbsp;3(d) hereof, if, as a result of any reorganization, recapitalization, reclassification, stock dividend, stock split,
reverse stock split or other similar change in the Company&rsquo;s capital stock, the outstanding shares of Stock are increased
or decreased or are exchanged for a different number or kind of shares or other securities of the Company, or additional shares
or new or different shares or other securities of the Company or other non-cash assets are distributed with respect to such shares
of Stock or other securities, or, if, as a result of any merger or consolidation, sale of all or substantially all of the assets
of the Company, the outstanding shares of Stock are converted into or exchanged for securities of the Company or any successor
entity (or a parent or subsidiary thereof), the Administrator shall make an appropriate or proportionate adjustment in (i) the
maximum number of shares reserved for issuance under the Plan, including the maximum number of shares that may be issued in the
form of Incentive Stock Options, (ii) the number of Stock Options or Stock Appreciation Rights that can be granted to any one individual
grantee and the maximum number of shares that may be granted under a Performance-Based Award, (iii) the number and kind of shares
or other securities subject to any then outstanding Awards under the Plan, (iv) the repurchase price, if any, per share subject
to each outstanding Restricted Stock Award, and (v)&nbsp;the exercise price for each share subject to any then outstanding Stock
Options and Stock Appreciation Rights under the Plan, without changing the aggregate exercise price (i.e., the exercise price multiplied
by the number of Stock Options and Stock Appreciation Rights) as to which such Stock Options and Stock Appreciation Rights remain
exercisable. The Administrator shall also make equitable or proportionate adjustments in the number of shares subject to outstanding
Awards and the exercise price and the terms of outstanding Awards to take into consideration cash dividends paid other than in
the ordinary course or any other extraordinary corporate event. The adjustment by the Administrator shall be final, binding and
conclusive. No fractional shares of Stock shall be issued under the Plan resulting from any such adjustment, but the Administrator
in its discretion may make a cash payment in lieu of fractional shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Mergers and Other Transactions</U>.
In the case of and subject to the consummation of a Sale Event, the parties thereto may cause the assumption or continuation of
Awards theretofore granted by the successor entity, or the substitution of such Awards with new Awards of the successor entity
or parent thereof, with appropriate adjustment as to the number and kind of shares and, if appropriate, the per share exercise
prices, as such parties shall agree. To the extent the parties to such Sale Event do not provide for the assumption, continuation
or substitution of Awards, upon the effective time of the Sale Event, the Plan and all outstanding Awards granted hereunder shall
terminate. In such case, except as may be otherwise provided in the relevant Award Certificate, all Options and Stock Appreciation
Rights that are not exercisable immediately prior to the effective time of the Sale Event shall become fully exercisable as of
the effective time of the Sale Event, all other Awards with time-based vesting, conditions or restrictions shall become fully vested
and nonforfeitable as of the effective time of the Sale Event, and all Awards with conditions and restrictions relating to the
attainment of performance goals may become vested and nonforfeitable in connection with a Sale Event in the Administrator&rsquo;s
discretion or to the extent specified in the relevant Award Certificate. In the event of such termination, (i) the Company shall
have the option (in its sole discretion) to make or provide for a cash payment to the grantees holding Options and Stock Appreciation
Rights, in exchange for the cancellation thereof, in an amount equal to the difference between (A) the Sale Price multiplied by
the number of shares of Stock subject to outstanding Options and Stock Appreciation Rights (to the extent then exercisable at prices
not in excess of the Sale Price) and (B) the aggregate exercise price of all such outstanding Options and Stock Appreciation Rights;
or (ii) each grantee shall be permitted, within a specified period of time prior to the consummation of the Sale Event as determined
by the Administrator, to exercise all outstanding Options and Stock Appreciation Rights (to the extent then exercisable) held by
such grantee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 4.</FONT></TD><TD><U>ELIGIBILITY</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Grantees under the Plan will be such full
or part-time officers and other employees, Non-Employee Directors and Consultants of the Company and its Subsidiaries as are selected
from time to time by the Administrator in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 5.</FONT></TD><TD><U>STOCK OPTIONS</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Award of Stock Options</U>. The
Administrator may grant Stock Options under the Plan. Any Stock Option granted under the Plan shall be in such form as the Administrator
may from time to time approve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Stock Options granted under the Plan may
be either Incentive Stock Options or Non-Qualified Stock Options. Incentive Stock Options may be granted only to employees of the
Company or any Subsidiary that is a &ldquo;subsidiary corporation&rdquo; within the meaning of Section&nbsp;424(f) of the Code.
To the extent that any Option does not qualify as an Incentive Stock Option, it shall be deemed a Non-Qualified Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Stock Options granted pursuant to this Section&nbsp;5
shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent
with the terms of the Plan, as the Administrator shall deem desirable. If the Administrator so determines, Stock Options may be
granted in lieu of cash compensation at the optionee&rsquo;s election, subject to such terms and conditions as the Administrator
may establish.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise Price</U>. The exercise
price per share for the Stock covered by a Stock Option granted pursuant to this Section&nbsp;5 shall be determined by the Administrator
at the time of grant but shall not be less than 100 percent of the Fair Market Value on the date of grant. In the case of an Incentive
Stock Option that is granted to a Ten Percent Owner, the option price of such Incentive Stock Option shall be not less than 110
percent of the Fair Market Value on the grant date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Option Term</U>. The term of each
Stock Option shall be fixed by the Administrator, but no Stock Option shall be exercisable more than ten years after the date the
Stock Option is granted. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the term of such Stock
Option shall be no more than five years from the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercisability; Rights of a Stockholder</U>.
Stock Options shall become exercisable at such time or times, whether or not in installments, as shall be determined by the Administrator
at or after the grant date. The Administrator may at any time accelerate the exercisability of all or any portion of any Stock
Option. An optionee shall have the rights of a stockholder only as to shares acquired upon the exercise of a Stock Option and not
as to unexercised Stock Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Method of Exercise</U>. Stock
Options may be exercised in whole or in part, by giving written or electronic notice of exercise to the Company, specifying the
number of shares to be purchased. Payment of the purchase price may be made by one or more of the following methods except to the
extent otherwise provided in the Option Award Certificate:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In cash, by certified or bank check
or other instrument acceptable to the Administrator;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Through the delivery (or attestation
to the ownership following such procedures as the Company may prescribe) of shares of Stock that are not then subject to restrictions
under any Company plan. Such surrendered shares shall be valued at Fair Market Value on the exercise date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By the optionee delivering to the
Company a properly executed exercise notice together with irrevocable instructions to a broker to promptly deliver to the Company
cash or a check payable and acceptable to the Company for the purchase price; provided that in the event the optionee chooses to
pay the purchase price as so provided, the optionee and the broker shall comply with such procedures and enter into such agreements
of indemnity and other agreements as the Company shall prescribe as a condition of such payment procedure; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With respect to Stock Options that
are not Incentive Stock Options, by a &ldquo;net exercise&rdquo; arrangement pursuant to which the Company will reduce the number
of shares of Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the
aggregate exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment instruments will be received subject to collection.
The transfer to the optionee on the records of the Company or of the transfer agent of the shares of Stock to be purchased pursuant
to the exercise of a Stock Option will be contingent upon receipt from the optionee (or a purchaser acting in his stead in accordance
with the provisions of the Stock Option) by the Company of the full purchase price for such shares and the fulfillment of any other
requirements contained in the Option Award Certificate or applicable provisions of laws (including the satisfaction of any withholding
taxes that the Company is obligated to withhold with respect to the optionee). In the event an optionee chooses to pay the purchase
price by previously-owned shares of Stock through the attestation method, the number of shares of Stock transferred to the optionee
upon the exercise of the Stock Option shall be net of the number of attested shares. In the event that the Company establishes,
for itself or using the services of a third party, an automated system for the exercise of Stock Options, such as a system using
an internet website or interactive voice response, then the paperless exercise of Stock Options may be permitted through the use
of such an automated system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Annual Limit on Incentive Stock
Options</U>. To the extent required for &ldquo;incentive stock option&rdquo; treatment under Section&nbsp;422 of the Code, the
aggregate Fair Market Value (determined as of the time of grant) of the shares of Stock with respect to which Incentive Stock Options
granted under this Plan and any other plan of the Company or its parent and subsidiary corporations become exercisable for the
first time by an optionee during any calendar year shall not exceed $100,000. To the extent that any Stock Option exceeds this
limit, it shall constitute a Non-Qualified Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 6.</FONT></TD><TD><U>STOCK APPRECIATION RIGHTS</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Award of Stock Appreciation Rights</U>.
The Administrator may grant Stock Appreciation Rights under the Plan. A Stock Appreciation Right is an Award entitling the recipient
to receive shares of Stock having a value equal to the excess of the Fair Market Value of a share of Stock on the date of exercise
over the exercise price of the Stock Appreciation Right multiplied by the number of shares of Stock with respect to which the Stock
Appreciation Right shall have been exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise Price of Stock Appreciation
Rights</U>. The exercise price of a Stock Appreciation Right shall not be less than 100 percent of the Fair Market Value of the
Stock on the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant and Exercise of Stock Appreciation
Rights</U>. Stock Appreciation Rights may be granted by the Administrator independently of any Stock Option granted pursuant to
Section&nbsp;5 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Terms and Conditions of Stock
Appreciation Rights</U>. Stock Appreciation Rights shall be subject to such terms and conditions as shall be determined from time
to time by the Administrator. The term of a Stock Appreciation Right may not exceed ten years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 7.</FONT></TD><TD><U>RESTRICTED STOCK AWARDS</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Nature of Restricted Stock Awards</U>.
The Administrator may grant Restricted Stock Awards under the Plan. A Restricted Stock Award is any Award of Restricted Shares
subject to such restrictions and conditions as the Administrator may determine at the time of grant. Conditions may be based on
continuing employment (or other service relationship) and/or achievement of pre-established performance goals and objectives. The
terms and conditions of each such Award Certificate shall be determined by the Administrator, and such terms and conditions may
differ among individual Awards and grantees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights as a Stockholder</U>. Upon
the grant of the Restricted Stock Award and payment of any applicable purchase price, a grantee shall have the rights of a stockholder
with respect to the voting of the Restricted Shares and receipt of dividends; provided that if the lapse of restrictions with respect
to the Restricted Stock Award is tied to the attainment of performance goals, any dividends paid by the Company during the performance
period shall accrue and shall not be paid to the grantee until and to the extent the performance goals are met with respect to
the Restricted Stock Award. Unless the Administrator shall otherwise determine, (i) uncertificated Restricted Shares shall be accompanied
by a notation on the records of the Company or the transfer agent to the effect that they are subject to forfeiture until such
Restricted Shares are vested as provided in Section 7(d) below, and (ii) certificated Restricted Shares shall remain in the possession
of the Company until such Restricted Shares are vested as provided in Section&nbsp;7(d) below, and the grantee shall be required,
as a condition of the grant, to deliver to the Company such instruments of transfer as the Administrator may prescribe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictions</U>. Restricted Shares
may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of except as specifically provided herein or
in the Restricted Stock Award Certificate. Except as may otherwise be provided by the Administrator either in the Award Certificate
or, subject to Section 18 below, in writing after the Award is issued, if a grantee&rsquo;s employment (or other service relationship)
with the Company and its Subsidiaries terminates for any reason, any Restricted Shares that have not vested at the time of termination
shall automatically and without any requirement of notice to such grantee from or other action by or on behalf of, the Company
be deemed to have been reacquired by the Company at its original purchase price (if any) from such grantee or such grantee&rsquo;s
legal representative simultaneously with such termination of employment (or other service relationship), and thereafter shall cease
to represent any ownership of the Company by the grantee or rights of the grantee as a stockholder. Following such deemed reacquisition
of Restricted Shares that are represented by physical certificates, a grantee shall surrender such certificates to the Company
upon request without consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Vesting of Restricted Shares</U>.
The Administrator at the time of grant shall specify the date or dates and/or the attainment of pre-established performance goals,
objectives and other conditions on which the non-transferability of the Restricted Shares and the Company&rsquo;s right of repurchase
or forfeiture shall lapse. Subsequent to such date or dates and/or the attainment of such pre-established performance goals, objectives
and other conditions, the shares on which all restrictions have lapsed shall no longer be Restricted Shares and shall be deemed
&ldquo;vested.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 8.</FONT></TD><TD><U>RESTRICTED STOCK UNITS</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Nature of Restricted Stock Units</U>.
The Administrator may grant Restricted Stock Units under the Plan. A Restricted Stock Unit is an Award of stock units that may
be settled in shares of Stock upon the satisfaction of such restrictions and conditions at the time of grant. Conditions may be
based on continuing employment (or other service relationship) and/or achievement of pre-established performance goals and objectives.
The terms and conditions of each such Award Certificate shall be determined by the Administrator, and such terms and conditions
may differ among individual Awards and grantees. Except in the case of Restricted Stock Units with a deferred settlement date that
complies with Section 409A, at the end of the vesting period, the Restricted Stock Units, to the extent vested, shall be settled
in the form of shares of Stock. Restricted Stock Units with deferred settlement dates are subject to Section 409A and shall contain
such additional terms and conditions as the Administrator shall determine in its sole discretion in order to comply with the requirements
of Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Election to Receive Restricted
Stock Units in Lieu of Compensation</U>. The Administrator may, in its sole discretion, permit a grantee to elect to receive a
portion of future cash compensation otherwise due to such grantee in the form of an award of Restricted Stock Units. Any such election
shall be made in writing and shall be delivered to the Company no later than the date specified by the Administrator and in accordance
with Section 409A and such other rules and procedures established by the Administrator. Any such future cash compensation that
the grantee elects to defer shall be converted to a fixed number of Restricted Stock Units based on the Fair Market Value of Stock
on the date the compensation would otherwise have been paid to the grantee if such payment had not been deferred as provided herein.
The Administrator shall have the sole right to determine whether and under what circumstances to permit such elections and to impose
such limitations and other terms and conditions thereon as the Administrator deems appropriate. Any Restricted Stock Units that
are elected to be received in lieu of cash compensation shall be fully vested, unless otherwise provided in the Award Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights as a Stockholder</U>. A
grantee shall have the rights as a stockholder only as to shares of Stock acquired by the grantee upon settlement of Restricted
Stock Units; provided, however, that the grantee may be credited with Dividend Equivalent Rights with respect to the stock units
underlying his Restricted Stock Units, subject to the provisions of Section 11 and such terms and conditions as the Administrator
may determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>. Except as may
otherwise be provided by the Administrator either in the Award Certificate or, subject to Section&nbsp;18 below, in writing after
the Award is issued, a grantee&rsquo;s right in all Restricted Stock Units that have not vested shall automatically terminate upon
the grantee&rsquo;s termination of employment (or cessation of service relationship) with the Company and its Subsidiaries for
any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 9.</FONT></TD><TD><U>UNRESTRICTED STOCK AWARDS</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><U>Grant or Sale of Unrestricted Stock</U>.
The Administrator may grant (or sell at par value or such higher purchase price determined by the Administrator) an Unrestricted
Stock Award under the Plan. An Unrestricted Stock Award is an Award pursuant to which the grantee may receive shares of Stock free
of any restrictions under the Plan. Unrestricted Stock Awards may be granted in respect of past services or other valid consideration,
or in lieu of cash compensation due to such grantee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 10.</FONT></TD><TD><U>CASH-BASED AWARDS</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><U>Grant of Cash-Based Awards</U>. The Administrator
may grant Cash-Based Awards under the Plan. A Cash-Based Award is an Award that entitles the grantee to a payment in cash upon
the attainment of specified Performance Goals. The Administrator shall determine the maximum duration of the Cash-Based Award,
the amount of cash to which the Cash-Based Award pertains, the conditions upon which the Cash-Based Award shall become vested or
payable, and such other provisions as the Administrator shall determine. Each Cash-Based Award shall specify a cash-denominated
payment amount, formula or payment ranges as determined by the Administrator. Payment, if any, with respect to a Cash-Based Award
shall be made in accordance with the terms of the Award and may be made in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 11.</FONT></TD><TD><U>PERFORMANCE SHARE AWARDS</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Nature of Performance Share Awards</U>.
The Administrator may grant Performance Share Awards under the Plan. A Performance Share Award is an Award entitling the grantee
to receive shares of Stock upon the attainment of performance goals. The Administrator shall determine whether and to whom Performance
Share Awards shall be granted, the performance goals, the periods during which performance is to be measured, which may not be
less than one year except in the case of a Sale Event, and such other limitations and conditions as the Administrator shall determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights as a Stockholder</U>. A
grantee receiving a Performance Share Award shall have the rights of a stockholder only as to shares of Stock actually received
by the grantee under the Plan and not with respect to shares subject to the Award but not actually received by the grantee. A grantee
shall be entitled to receive shares of Stock under a Performance Share Award only upon satisfaction of all conditions specified
in the Performance Share Award Certificate (or in a performance plan adopted by the Administrator).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>. Except as may
otherwise be provided by the Administrator either in the Award agreement or, subject to Section&nbsp;18 below, in writing after
the Award is issued, a grantee&rsquo;s rights in all Performance Share Awards shall automatically terminate upon the grantee&rsquo;s
termination of employment (or cessation of service relationship) with the Company and its Subsidiaries for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 12.</FONT></TD><TD><U>PERFORMANCE-BASED AWARDS TO COVERED EMPLOYEES</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Performance-Based Awards</U>.
The Administrator may grant one or more Performance-Based Awards in the form of a Restricted Stock Award, Restricted Stock Units,
Performance Share Awards or Cash-Based Award payable upon the attainment of Performance Goals that are established by the Administrator
and relate to one or more of the Performance Criteria, in each case on a specified date or dates or over any period or periods
determined by the Administrator. The Administrator shall define in an objective fashion the manner of calculating the Performance
Criteria it selects to use for any Performance Cycle. Depending on the Performance Criteria used to establish such Performance
Goals, the Performance Goals may be expressed in terms of overall Company performance or the performance of a division, business
unit, or an individual. Each Performance-Based Award shall comply with the provisions set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant of Performance-Based Awards</U>.
With respect to each Performance-Based Award granted to a Covered Employee, the Administrator shall select, within the first 90
days of a Performance Cycle (or, if shorter, within the maximum period allowed under Section&nbsp;162(m) of the Code) the Performance
Criteria for such grant, and the Performance Goals with respect to each Performance Criterion (including a threshold level of performance
below which no amount will become payable with respect to such Award). Each Performance-Based Award will specify the amount payable,
or the formula for determining the amount payable, upon achievement of the various applicable performance targets. The Performance
Criteria established by the Administrator may be (but need not be) different for each Performance Cycle and different Performance
Goals may be applicable to Performance-Based Awards to different Covered Employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment of Performance-Based Awards</U>.
Following the completion of a Performance Cycle, the Administrator shall meet to review and certify in writing whether, and to
what extent, the Performance Goals for the Performance Cycle have been achieved and, if so, to also calculate and certify in writing
the amount of the Performance-Based Awards earned for the Performance Cycle. The Administrator shall then determine the actual
size of each Covered Employee&rsquo;s Performance-Based Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Maximum Award Payable</U>. The
maximum Performance-Based Award payable to any one Covered Employee under the Plan for a Performance Cycle is one million (1,000,000)
shares of Stock (subject to adjustment as provided in Section&nbsp;3(c) hereof) or five million dollars ($5,000,000) in the case
of a Performance-Based Award that is a Cash-Based Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 13.</FONT></TD><TD><U>DIVIDEND EQUIVALENT RIGHTS</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Dividend Equivalent Rights</U>.
The Administrator may grant Dividend Equivalent Rights under the Plan. A Dividend Equivalent Right is an Award entitling the grantee
to receive credits based on cash dividends that would have been paid on the shares of Stock specified in the Dividend Equivalent
Right (or other Award to which it relates) if such shares had been issued to the grantee. A Dividend Equivalent Right may be granted
hereunder to any grantee as a component of an award of Restricted Stock Units, Restricted Stock Award or Performance Share Award
or as a freestanding award. The terms and conditions of Dividend Equivalent Rights shall be specified in the Award Certificate.
Dividend equivalents credited to the holder of a Dividend Equivalent Right may be paid currently or may be deemed to be reinvested
in additional shares of Stock, which may thereafter accrue additional equivalents. Any such reinvestment shall be at Fair Market
Value on the date of reinvestment or such other price as may then apply under a dividend reinvestment plan sponsored by the Company,
if any. Dividend Equivalent Rights may be settled in cash or shares of Stock or a combination thereof, in a single installment
or installments. A Dividend Equivalent Right granted as a component of an Award of Restricted Stock Units or Performance Share
Award shall provide that such Dividend Equivalent Right shall be settled only upon settlement or payment of, or lapse of restrictions
on, such other Award, and that such Dividend Equivalent Right shall expire or be forfeited or annulled under the same conditions
as such other Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>. Except as may
otherwise be provided by the Administrator either in the Award Certificate or, subject to Section&nbsp;18 below, in writing after
the Award is issued, a grantee&rsquo;s rights in all Dividend Equivalent Rights shall automatically terminate upon the grantee&rsquo;s
termination of employment (or cessation of service relationship) with the Company and its Subsidiaries for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 14.</FONT></TD><TD><U>TRANSFERABILITY OF AWARDS</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transferability</U>. Except as
provided in Section&nbsp;14(b) below, during a grantee&rsquo;s lifetime, his or her Awards shall be exercisable only by the grantee,
or by the grantee&rsquo;s legal representative or guardian in the event of the grantee&rsquo;s incapacity. No Awards shall be sold,
assigned, transferred or otherwise encumbered or disposed of by a grantee other than by will or by the laws of descent and distribution
or pursuant to a domestic relations order. No Awards shall be subject, in whole or in part, to attachment, execution, or levy of
any kind, and any purported transfer in violation hereof shall be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Administrator Action</U>. Notwithstanding
Section&nbsp;14(a), the Administrator, in its discretion, may provide either in the Award Certificate regarding a given Award or
by subsequent written approval that the grantee (who is an employee or director) may transfer his or her Non-Qualified Options
to his or her immediate family members, to trusts for the benefit of such family members, or to partnerships in which such family
members are the only partners, provided that the transferee agrees in writing with the Company to be bound by all of the terms
and conditions of this Plan and the applicable Award. In no event may an Award be transferred by a grantee for value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Family Member</U>. For purposes
of Section&nbsp;14(b), &ldquo;family member&rdquo; shall mean a grantee&rsquo;s child, stepchild, grandchild, parent, stepparent,
grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law,
or sister-in-law, including adoptive relationships, any person sharing the grantee&rsquo;s household (other than a tenant of the
grantee), a trust in which these persons (or the grantee) have more than 50 percent of the beneficial interest, a foundation in
which these persons (or the grantee) control the management of assets, and any other entity in which these persons (or the grantee)
own more than 50 percent of the voting interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Designation of Beneficiary</U>.
To the extent permitted by the Company, each grantee to whom an Award has been made under the Plan may designate a beneficiary
or beneficiaries to exercise any Award or receive any payment under any Award payable on or after the grantee&rsquo;s death. Any
such designation shall be on a form provided for that purpose by the Administrator and shall not be effective until received by
the Administrator. If no beneficiary has been designated by a deceased grantee, or if the designated beneficiaries have predeceased
the grantee, the beneficiary shall be the grantee&rsquo;s estate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 15.</FONT></TD><TD><U>TAX WITHHOLDING</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment by Grantee</U>. Each grantee
shall, no later than the date as of which the value of an Award or of any Stock or other amounts received thereunder first becomes
includable in the gross income of the grantee for Federal income tax purposes, pay to the Company, or make arrangements satisfactory
to the Administrator regarding payment of, any Federal, state, or local taxes of any kind required by law to be withheld by the
Company with respect to such income. The Company and its Subsidiaries shall, to the extent permitted by law, have the right to
deduct any such taxes from any payment of any kind otherwise due to the grantee. The Company&rsquo;s obligation to deliver evidence
of book entry (or stock certificates) to any grantee is subject to and conditioned on tax withholding obligations being satisfied
by the grantee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment in Stock</U>. Subject
to approval by the Administrator, a grantee may elect to have the Company&rsquo;s minimum required tax withholding obligation satisfied,
in whole or in part, by authorizing the Company to withhold from shares of Stock to be issued pursuant to any Award a number of
shares with an aggregate Fair Market Value (as of the date the withholding is effected) that would satisfy the withholding amount
due. The Administrator may also require Awards to be subject to mandatory share withholding up to the required withholding amount.
For purposes of share withholding, the Fair Market Value of withheld shares shall be determined in the same manner as the value
of Stock includible in income of the Participants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 16.</FONT></TD><TD><U>SECTION 409A AWARDS</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To the extent that any Award is determined
to constitute &ldquo;nonqualified deferred compensation&rdquo; within the meaning of Section 409A (a &ldquo;409A Award&rdquo;),
the Award shall be subject to such additional rules and requirements as specified by the Administrator from time to time in order
to comply with Section 409A. In this regard, if any amount under a 409A Award is payable upon a &ldquo;separation from service&rdquo;
(within the meaning of Section 409A) to a grantee who is then considered a &ldquo;specified employee&rdquo; (within the meaning
of Section 409A), then no such payment shall be made prior to the date that is the earlier of (i) six months and one day after
the grantee&rsquo;s separation from service, or (ii) the grantee&rsquo;s death, but only to the extent such delay is necessary
to prevent such payment from being subject to interest, penalties and/or additional tax imposed pursuant to Section 409A. Further,
the settlement of any such Award may not be accelerated except to the extent permitted by Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 17.</FONT></TD><TD><U>TERMINATION OF EMPLOYMENT, TRANSFER, LEAVE OF ABSENCE,
ETC.</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-transform: uppercase; text-indent: -76.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination of Employment</U>.
If the grantee&rsquo;s employer ceases to be a Subsidiary, the grantee shall be deemed to have terminated employment for purposes
of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For purposes of the Plan, the following
events shall not be deemed a termination of employment:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a transfer to the employment of the
Company from a Subsidiary or from the Company to a Subsidiary, or from one Subsidiary to another; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an approved leave of absence for military
service or sickness, or for any other purpose approved by the Company, if the employee&rsquo;s right to re-employment is guaranteed
either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Administrator
otherwise so provides in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 18.</FONT></TD><TD><U>AMENDMENTS AND TERMINATION</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board may, at any time, amend or discontinue
the Plan and the Administrator may, at any time, amend or cancel any outstanding Award for the purpose of satisfying changes in
law or for any other lawful purpose, but no such action shall adversely affect rights under any outstanding Award without the holder&rsquo;s
consent. The Administrator is specifically authorized to exercise its discretion to reduce the exercise price of outstanding Stock
Options or Stock Appreciation Rights or effect the repricing of such Awards through cancellation and re-grants. To the extent required
under the rules of any securities exchange or market system on which the Stock is listed, to the extent determined by the Administrator
to be required by the Code to ensure that Incentive Stock Options granted under the Plan are qualified under Section&nbsp;422 of
the Code, or to ensure that compensation earned under Awards qualifies as performance-based compensation under Section&nbsp;162(m)
of the Code, Plan amendments shall be subject to approval by the Company stockholders entitled to vote at a meeting of stockholders.
Nothing in this Section&nbsp;18 shall limit the Administrator&rsquo;s authority to take any action permitted pursuant to Section&nbsp;3(c)
or 3(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 19.</FONT></TD><TD><U>STATUS OF PLAN</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">With respect to the portion of any Award
that has not been exercised and any payments in cash, Stock or other consideration not received by a grantee, a grantee shall have
no rights greater than those of a general creditor of the Company unless the Administrator shall otherwise expressly determine
in connection with any Award or Awards. In its sole discretion, the Administrator may authorize the creation of trusts or other
arrangements to meet the Company&rsquo;s obligations to deliver Stock or make payments with respect to Awards hereunder, provided
that the existence of such trusts or other arrangements is consistent with the foregoing sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 20.</FONT></TD><TD><U>GENERAL PROVISIONS</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Distribution</U>. The Administrator
may require each person acquiring Stock pursuant to an Award to represent to and agree with the Company in writing that such person
is acquiring the shares without a view to distribution thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery of Stock Certificates</U>.
Stock certificates to grantees under this Plan shall be deemed delivered for all purposes when the Company or a stock transfer
agent of the Company shall have mailed such certificates in the United States mail, addressed to the grantee, at the grantee&rsquo;s
last known address on file with the Company. Uncertificated Stock shall be deemed delivered for all purposes when the Company or
a Stock transfer agent of the Company shall have given to the grantee by electronic mail (with proof of receipt) or by United States
mail, addressed to the grantee, at the grantee&rsquo;s last known address on file with the Company, notice of issuance and recorded
the issuance in its records (which may include electronic &ldquo;book entry&rdquo; records). Notwithstanding anything herein to
the contrary, the Company shall not be required to issue or deliver any certificates evidencing shares of Stock pursuant to the
exercise of any Award, unless and until the Administrator has determined, with advice of counsel (to the extent the Administrator
deems such advice necessary or advisable), that the issuance and delivery of such certificates is in compliance with all applicable
laws, regulations of governmental authorities and, if applicable, the requirements of any exchange on which the shares of Stock
are listed, quoted or traded. All Stock certificates delivered pursuant to the Plan shall be subject to any stop-transfer orders
and other restrictions as the Administrator deems necessary or advisable to comply with federal, state or foreign jurisdiction,
securities or other laws, rules and quotation system on which the Stock is listed, quoted or traded. The Administrator may place
legends on any Stock certificate to reference restrictions applicable to the Stock. In addition to the terms and conditions provided
herein, the Administrator may require that an individual make such reasonable covenants, agreements, and representations as the
Administrator, in its discretion, deems necessary or advisable in order to comply with any such laws, regulations, or requirements.
The Administrator shall have the right to require any individual to comply with any timing or other restrictions with respect to
the settlement or exercise of any Award, including a window-period limitation, as may be imposed in the discretion of the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stockholder Rights</U>. Until
Stock is deemed delivered in accordance with Section 20(b), no right to vote or receive dividends or any other rights of a stockholder
will exist with respect to shares of Stock to be issued in connection with an Award, notwithstanding the exercise of a Stock Option
or any other action by the grantee with respect to an Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Other Compensation Arrangements;
No Employment Rights</U>. Nothing contained in this Plan shall prevent the Board from adopting other or additional compensation
arrangements, including trusts, and such arrangements may be either generally applicable or applicable only in specific cases.
The adoption of this Plan and the grant of Awards do not confer upon any employee any right to continued employment with the Company
or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Trading Policy Restrictions</U>.
Option exercises and other Awards under the Plan shall be subject to the Company&rsquo;s insider trading policies and procedures,
as in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Clawback Policy</U>. Awards under
the Plan shall be subject to the Company&rsquo;s clawback policy, as in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 21.</FONT></TD><TD><U>EFFECTIVE DATE OF PLAN</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Plan shall become effective upon stockholder
approval in accordance with applicable state law, the Company&rsquo;s bylaws and articles of incorporation, and applicable stock
exchange rules. No grants of Stock Options and other Awards may be made hereunder after the tenth anniversary of the Effective
Date and no grants of Incentive Stock Options may be made hereunder after the tenth anniversary of the date the Plan is approved
by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="text-transform: none">SECTION 22.</FONT></TD><TD><U>GOVERNING LAW</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Plan and all Awards and actions taken
thereunder shall be governed by, and construed in accordance with, the laws of the State of Delaware, applied without regard to
conflict of law principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DATE APPROVED BY BOARD OF DIRECTORS: April 16, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DATE APPROVED BY STOCKHOLDERS: June 1, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DATE AMENDED BY BOARD OF DIRECTORS: August 25, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DATE AMENDED BY STOCKHOLDERS: November 15, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><IMG SRC="image_007.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><IMG SRC="image_008.jpg" ALT=""></P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 61; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Y Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLK9=2TF*WL[W[=%$FF2E?,R3CYK@X7))VC JV?#NH3>(/[5.IZ ^J-;-!O\
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M/S?*WKY@7=LSSCIG'I0 ^BHFNK=)A"\\2RG'R%P&YSCCWVG'T/I4M !1110
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M75K#;64Q+W1MIMSQGRB(C)G*N0>,=">_>EL_%,$]I!,8+B2,K#YUPD:JD;2
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M;L75\-6:PWD0EGVW47E/\PR!O=^..N9&_ "I9="A9S+%<W,$_GM.LL97<I8
M,,,I!! '4&L::YU6763&FK3PPR:F;41I%$0D8@\S@E"<[AU.>#TJG!XAU.6Y
MM8VN0)ML.R)S"B7()(<_,=Y; X"<9'/7% [=3H(_#5E%$T:O/AFA9B6!),4A
MD!Z=2Q.?TQ3KKPY9WD#Q223A6DED.U@.9%*MVZ88X_K7*IK%[J.E+--JK(J2
MVDDYWP!H&,H#J0N=J#_;Y^4Y)YJ:'4]1$%_-!?F**SMS.L,<,021C<3 [OES
M@A .".YZU5F)Z(Z&'PW##*)OMUV\PN1<"1O+'(C\O;@( %V\=,^],@\*VEO%
M'!%=7:VZB+S(=R[9C& %+';G.%7." <#BLZRUBYEU^S@DU;,TMS<QSZ?LC_=
MHH;8?N[QP%.2>=V1Q47BB_=9[BVFU/[*JR6P@M=B'[0"XW'D;CZ?*1C&34WV
M_KM_F.^Z_KJ=':Z/;VDMI)&\I-K#)"FXCE7*DYXZ_(/UK*U'PDMQ:7*6]]<A
MGBG2&*1U$<9E.6.0N[KTR3BL.?6Y[];E(]6E^S!89SEXO,@'G@$/M0!/E/(;
M) 7GOG4T_7YI-9F6YOHTAB>;S8II855(D^[(N#OY&TDGY</QVH6M@9MQZ+!]
MDO+>XGGNC>)LGDE*AF7;MQ\H '&>@[U!;^'(H;Y+V6^O+F='1PTQ3^%'0#"J
M!C$C'ZXHUYI1+I#0(CR?;AM#N5!_=R=P#_*N>O-6FT^/4MUW]@N7O)7#+*GE
M?+#'P6D0Y/(( &3@]@:+VU"VR.@D\,VDD1B%Q<HC1RQ.%*_,LCESG*]B>,8]
M\UHV5E'80/#$SE7EDE)8C.7<N?PRQKC)O$>L*DL2R-O@C2YFD6-.(9=@4C(Q
M\NZ4\_\ /+G@FNATRXO-1T*Z:*]5Y2TB6UR&B<]."VS*9!R,#TIO1,2UMY_U
M^I;&CVXTB#3-\ODP^7M;(W'8P89XQU [5)<6<\ZN(]2NH-S[@8UB.T;<;1N0
M\9^;GG/?'%<C:^([V_$=U>:@VD6,ZRF)FC0$/&$4H2ZD?>\TXZD*,< T]/$]
MZMGLN[E+?49;BUV6Y50P1XXR^%(SC=YG)Z8(SQ2>BN,Z+^P8?(MK;[5=?8X-
MG^C97:Y4Y!8[=QY /W@#CTXJ+4="?4M4>9[N:&V>U^SR1PL 9 6)(.5.!CC(
M(/6JCWM_:?#U]1?4'DO?L/VC[0\2?*Q3/"@ 8'I@_C5./4K^XOH+:RUE[FU-
MS@72)$3*!"SF/(7;]X#D#/.*;5G;L)2TOW.@FT:&XE\R6>9B(9H%^Z J2%<@
M8';:,?KFGPZ7';W)GBGF5F2-&'RD,J!@ <C_ &N<>@KDO^$@U#["DEMJGVJZ
M>T$LD/E)^ZN-Z!8, 97<6=,-EAMSG@FK-KK6J2W>DVHN7E.HJKM((5 @,;$S
MH>./X4 .2.><\T6U_KS&]CHWTL-J4E\EU<1M+&D4D:;-K*I8CJI(^\>A%9L7
MA*&&&2*/4KX(\"V^TK"0(U#87!CQU8DD\G YIU_J1@UQX;G46LH(X4DAC4)F
MY8L=P&X$G&%&%P?F]QC!LM<U"_U."RM]9=H9)H<RKY$DBJT4S%"50(#^[4]#
MC)YI)7T'L;\OA*QE7:9[@ 2I*@81N$98Q'GYU.<J,'.?48-6%\/VJV[0F64A
MG@D8@(N6B*E>%4 9*C.!W.,5AZ=?/=^)].\_4_.N?+N3+9;4'V<A@ . &'''
MS$YZBIFGO9_$EU9V]ZUI&;I][0PQ[F MXB,EE.>6ZG)QQTQ@OI<+?@=);6<=
MJ]RZ,Q-Q+YK[CT.T+Q[845G2>&K.2S@MC+/LAM7M%(89*/MR3QU^0?K6?=SW
M.J>$-&N&G,-Q<RV;M+&H)5BZDD Y'YYK.U;Q#=V%E.O]INEU;-.4:4Q(LP5P
M%!!0EF[83;UY(XIVL[?+\A=U_77_ ".DN_#ME>K=).962ZF$TB[A@GRQ'CIT
MVC\ZETO1X=*MY(8Y6D5\9+1QH0 ,8^15S^.3S7-RZMK%O:27D=Z\[RW%[$D#
M0H501^9LQM 8D;!U)SDU>\.S)<ZUK!@U8Z@OE6ZBX^0X.'XR@"GKGIWQ2MH#
M>I=B\,VD5E-:FXN726T2T)8KD1H6VXPHY^<C/L*ETS0+72;F26V=MK[L(T<?
MRY.3A@H8_BQKE+7Q)K4VKVMBTQVW,3V6X0 %+N)E\R3IC!4L0.GR>]217NI:
M1I7FP7<DRRM>,(FC3$6V4X9> 3@$GYB0?:G?K_7]?YB>]C=F\)VLQP][>^2L
M<D<4&Y-D8<@G'RY/08W$C''2H9O"B27=F6F>XCCOOMTLD[@.65 JJJHH7;PI
MY_N]#VS[;4=3O[J.&'67%OY5S(DT?V>1Y-@BV[RH9 07;IC(QFM+4=:NK/PM
M9:YAF5$CFNHHTSO1EP0._!8-Q_=H^'4>[L7M2T*+4KIIGN[J$/ ;>6.%E"R1
MDY(.5)'ID$&H%\*V*2W;1O(B72RAXUCB^4R?>(;9O[D_>QR>.E8\&K:K%*D5
MWJ(.I)<6\7V$1H!*C!-[@8W'&YSD' V8/0YN^']>?4KK3[9KQ)IO[.,EW&H7
M*S!D!W8'RG.X8X^E%@O;4T&\/6[7!?[1<B%I4G>W#+Y;R(!M8_+N_A4X! RH
MXZY@_P"$3L0;(I)*K6L$=N&9(G+HAR V]#CORN.I]L8U_P"([N+5YX[*\9P/
M.5K>7RV:+8 -X15#;1@D;F.[/3&*O_VFGVJVA'B0FS:-G6[W0?OI,C]WNV;>
M!S@#)SUP*2?7^OZ_X8'II_7]?\.:VJ:+!JK$RS3Q9MY;9O**_,D@&<Y!] 1B
MH-0\-66HW'VB5Y1*"A5@$8+M##HRD'(=@<@]L8KG+?Q!J-Q9O,VJPV[A%>>.
M>:WC:%]W,:=<<!A^\&<KVSD:V@:PU[JC0OJ$ERLD FB3,7[M?EXD55#))D],
MX/.,8P! ]#5DT>-[>S1+F:&6T&(YX@BMTP<C;LP>XVX],57'AR(7T-RU]>,L
M4S7 A)0(9&0H2<+GD,3C.,G\*P9TFF\0_9QJ<R2C6@RC]V6C0VC'@%>AY'(/
M3UR:;%X@U)KV"WDO CKM6/S#"BW1\]XVW;L$G"KPG0MTY IVO\P>AT*>&=-&
MGI:R1>:\<(@2Y=5$RH.@#@#IVI\.@PQW<=Y+=7-Q<I)YGFRE,MA&0 A5 P [
M'@#DUF^(]0U2UU"&QT^<QRZC'Y=LQB#+%*AW,3QSE">O'R5COXIU"YBCO%NV
ML[6Y$S6[.(D :,(NQS+C@MYA./F('! !H6NH-'7-HUN=*6P$DRHCB1) 1O1P
M^\$<8X/J,>N:S9?!]O-'.&U+4/-G\T239CW,) H8?<P.$ X -9VD:A,FM&"/
M40\LNHS+/8 (1&FPMOR!N^\!R3CG&,U)XFU26TGOX#>HZ/92F.U3RGVL(G8F
M5&4MM.!SG'0$<\I=/,:5W_7<TKGPI9W4S2M/.K&02@;8G"ML"' =".0HZYZ<
M8K:@B6"".%3E44*#@#H/0  ?@!7%3ZI<:?>7T?\ :,R+)J*K(P,(:!# K+C>
M JAF&W+9]N3FNMTF>:YTFTGN'C>62)69XF!5LCJ""1@]>#3Z$ERBBBD,****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** //_ !WK27.K
M67AE+>]N;=F6XU3[%;/.RPCE4(0$C>1S[?6F^"8K;6?AE?:3=(Z00R75HZR(
M49%W$C*GD$!AQVQ797$NC:*\U]<R6%@URP$L\A2(RD<#<QQN/IFJUQJ/AG1X
MV%S>:38I?%I6\R6.(7&>"QR1OSQD\TK>ZUW_ #'?5/L<Q\.--FU+1+7Q'K<@
MN[V:V%O;[E^6*!>. >[8W$]\BLS2 D?@3QAXC@MXVFN;B[DMF5!E44%%QZ="
M:[R+6/#MEIEJ8=1TN"PD'EVQ2>-8F XVI@X/I@5>M[:QT^P$5M#;VUFBDA(E
M5(U!Y)P. .IISUOZ6_5_UYBCI;UO_7]=#SF3['>:/X'\,:?<1W(+P7-P(V#8
MBB7<2V.@+8'/>M'Q\\EWXA\-:9#<6<++++>L]XI:(>6F!N 9<\MZUTNG2>&;
M.XB33'TB":_4R1BV,:M<@=6&WEQQUYIM_%X6U2]C&H)H]W=QR_9XQ<"*1UDQ
MNV#.2&QSCKWIR=W?SO\ UZ:"6BMY6_KUU/,=#6/4+3PQ9(HWW^O7%_<;/]4_
MDY.Z,=D)VX'ZUJ:9>:(F@^*-7\0_9I]3DNKB":*<*TH525CB4'G!&, =<UZ%
M<2Z'9WL;7+Z=!=VT#/&9"BO%#_$1GE4]3TJ@NJ>#+JXEU5;[09IK<#S+P30L
MT0)P,OG(&>!S2>JM_73]%8K6]_ZZO]3A+FRFTCP?H&L75]9-JN@V),VG7Q!#
MHX^[C.5?  !Q[5J22V%Y\0='76+>*UTXZ2+C3[6X 6(3EOG&#QO"D5UQ/A?4
MT.MDZ/=K;@DWQ\J01 =3YG;\ZGO'T'5;.U%\VFWEK=,!;B<I(DS$9&S.0QP#
MTIWUOY_G_5R4M+>1PGB"\L[?QA/>V20"VT?0[B\#0A0IED.T'CJ<+5;2WO=
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M3ZWIT<*2M<':\23(!&Q+*QPN !DDGL.?:J<OB&UEFGM!'<)M6'+RQRPY$KE
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M>PNT;QMMCMRF_;'*F6)=B6/FYR?2KTN@B70'TS[20QE,R2A2-K>;YB\ @\'
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M+BUD+W5WN:2!CA(V.% #]>V>WOW>?$ETXL8X_LJS7=M;R;F!*QO(2,D9Y''
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT!M#@TV+^S&)9K>0F0$DYR2Q)SGWXJ&'P3X?M[6\MH[%O+O8O)GW7$K,T?\
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M$2N#* NT#.?EXXXQ4.B>$=%\./NTNWFA^0H$:[ED0#.>%=B!^ HCI;R7^?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1SS5J;PU93VL\#/+B6:.;<=K%71%08!4CH@X(/4TAEZTU"*\L/M:*ZJ-X9'
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MF!\Q/' R35X:G9G2WU+SO]$1&D=]IRH7.[*XR",'(QGC%']?U]PO(HZ3Y_\
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M8(!.0,<'TK6BECGA2:)U>.10R,IR&!Y!%'05[ZCZ***0!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5+VR^V2V;
M^9L^SS^=C&=WRLN/;[WZ5C#PM*UO;VTFH*UO:1^5;*L&&5=RGYSN^8X4#@#J
M3S3?&-S-9V]M=6[[)X4N9(WP#M86\A!P>#S52^GO(;@6]SJ\WE07%I(9V6-"
M Y8$'"@;<J/SZT)?U]P-Z?UV.AUC33JEHD23F"6.598Y!NX(]=I4XQD<$5CM
MX0)D2=+U8YTV,#&D@7>&E+$_O-QW"9OXNO.3TK+_ +>U6X618M0\J5I4CE0^
M07MB;A$ 1!EL;6;)<=<$8S5FXU+6+"-[E+V6];[5<6Z6SQ1@,$B=E^ZH.XL@
M[XYZ4+:_<I)WLC8L-#GTZ0F"Z@6.91]IC\ACN89RR$N2N<G.2W\\P6_AAH[*
M2WEO0Q:SAM4=(=NWRF8JV"QR?F&1[>_&3#J4]X;"9]89[6.^C!F\R#.6B?*O
MLRH&=N,X/S?0U>US6Y;/7;>WM[TQMYUO&]O(T860.^"57:78X)R=P Q]11L3
M?0OPZ%-_:L>I75XDMRKY;RX2B%0C*  6)'WR<Y-5[;PO)9^7)!?*+B*59$9X
M<KPA0@KN&<@GH1@XZ]#D0ZOJT.F:=+/JCO\ ;+.*>:=X8Q]G!DC#,N% P%<_
M>R!@'UK6\+7<#_VB!J*79EOY/+E)4&4!$S@+@''J![T[6?I_F)Z.WF:U[8S7
MEI OVA$NH72591$2F\=?EW9P<GC/?K6%'X0G6XEN)=1CFDN"?M*M"ZI(N\L
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MAKJ>=FO0L;N\D86'YD9@O));!P4!Z#TJ:'0IO[5CU*ZO$EN5?+>7"40J$90
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)#;8^#N/!5=I&/ESV%"!]?Z_K_AB_<SZ#;ZLZW%M$+V0(DDOV0MQ)E5#2!<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#<HKCKWX@?8K^XM?^$1\5S^3*T?G0:;NCDP<;E.[E3C(/I4'_"R?^I*\9?\
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M?,W9^YR<XQSZ9%4=8\;_ -D:K-8_\(OXEO?*V_Z196'F1/E0?E;<,XS@^X-
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MJ>CZ=J=KX\3Q=-HTZV.IW,L"VH@?S;0$*%G9/X=^SYN. 15V5[?UY?>1TO\
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M21$<G 5G52JG/J>*X:"+Q'J#Z*MW!J5S:6FNH;:YN[4QS^1Y39:10. &.-Q
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M[,:=G=G+1ZUK4UGFQO'FE\VV ^U0HC,QC+NF HPK +AL9R3@G%=#H^IMK/\
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M_+_[*C_A2/\ U-VJ?E_]E0!ZS17DW_"D?^INU3\O_LJ/^%(_]3=JGY?_ &5
M'K-%>3?\*1_ZF[5/R_\ LJ/^%(_]3=JGY?\ V5 'K-%>3?\ "D?^INU3\O\
M[*C_ (4C_P!3=JGY?_94 >LT5Y-_PI'_ *F[5/R_^RH_X4C_ -3=JGY?_94
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M1QP1R,F"&?D#;T'7&0!T MD,@FU/5;2*\WW$3P375S!'A6$D96-W#!MV,93
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M33"%L,@17P%W_*WS8Y)['VIS>(=-NW8G3+B>%DCBDG:)-H$N-J,"V[&2 1C
M[^M,L&NY]*L[C2=(L;,^9(&22-0$&[!*[#WZGUQCN#27]?>-E[7]2N+"%19R
M1?:2DDHC> R;E4<G.] H!*Y)/?&*S+?7=7N29D%DL+W"V\49C<L"T(<,6W8/
MS'&,=.];>L064ED9;W3HKY(CD1ND9QG@D>80H_.L6+Q'I,D)-MIDXB2,7$DL
M446V#YFBW'YN2/+;E0W XS0NH/N:'AS6Y->@GN?*6.%&6(#!SY@4&0=>S';]
M5-8\>OZHJ7CQ?91;V<)G=9%D=Y/W\JD!B_'RQ^AP3TQQ5S1]12"[LM-L[2Y%
MI-]HE^U3JO[Y@V68;3QEF)Y49SQ4UYJNC:?--;36&&>>.U=5@4AP^7#'_8&7
M))[AN/5IJ_\ 7E_7W":T?]?UM^9C:OK>I&!+SSX$M_\ 3@MO&71_W4<@&Y@X
MSRN> I!Q@]ZL7/B.\:X-ELA,EM<QK<[2ZE5:>,18PP/S(Q)SD':1C'%/GU/1
M9[VY:+0P\P&)KM[2)E*M(T)R2P9MVQA]/;BI4URS(N)+G19#-YLAD$<<;,8X
M'P)&^;G:<8')ST!H3T*L46U_5!=Z=?236WDW%A).MLBLNS,L(^?YOF(#$9P,
M'/K5^_\ $-W'/J,%J]OY]K*P2,P&0NBPH[$GS%"X:09)/3 QGFK.JQ:=IUL+
MZWT6UN'NY8X)"D,8+I*X#9)QD'/3N>M94%[HJVLT>H>';>. 7=RL;+:1F.5T
M8KPN2=Y50,D $@^U)[#NM^AM^';R6^BO9Y68[K@%5+$A 8HS@>V2:V:S])N+
M:>*=8+,V;Q2[)H&5596VJ1G:2#\I7D$\8K0IO<B*:6H4444AA1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y;\%/^/'Q'_V$V_E7
MJ5>6_!3_ (\?$?\ V$V_E0!ZE1110 4444 %%%% !7DWCO\ Y+/X+_#_ -#-
M>LUY-X[_ .2S^"_P_P#0S0!ZS1110!'-/%;023SRI%#&I9Y)&"JH'4DGH*S(
M?%7AVYW^1K^ER[ "VR\C;:"0 3@\<D#ZD5K$!E*L 0>"#WKRV^T.]?P9XGMX
M].N5GGUTO$(X"':/SHSN7C)7 )R..*%O;^MTOU#I?^MF_P!#U.BO+[]/$ME%
M?VMO'JUQI\6K@9:XG$K6YB!^655>4KYG=03VZ9QV_A3^T#X8LO[4=GN]AW,X
M<,1N.W=O56SMQG*@YHZ7!Z,M6>MZ3J-S);6.J65U<19\R*"X1V3!P<@'(YJ_
M7C'A_3_$$.J*UOIMRMU;Q:BL#26+P+$\CED9I'XER<8 QC/>M>QGUN"TO)([
M7Q'<VW]F(+F*X>5)C=E@&\IF!8#&23&".FT9H6R8VM6CU"H9KJWMY(8YIXHY
M)VV1*[@&1L9PH/4X!.!Z5Y=8P^)-2%G9S'7;*T;6'4LD]P76V,&1F5U5RN_H
M6 P>.HIUO9ZO+XOTEKZ'6IKJWU>=IGE25K5(-CB)E.-@X(&1SDG/.*:6J0GL
MSU6J]W?V=@D;7EW!;+(XC0S2! S'HHSU)]*P?&7V_P"S:=]F^W?8OM:_;_L&
M_P _R=I^[L^?&[;G;SBN6M])U74+SPK/J,.J.D&I7)1I9)0\=OM8Q&7!&&Z#
M+<D'!ZD4EJP>B/1K[4++3+8W-_>6]I " 99Y!&H)Z#).*C35],DLDO8]1M'M
M9&").LZE&8G  ;."2>,5@_$"&:70[-H;6XN1#J5M+)'!"TK;%D!8[5!)XKF)
M;#4Y!J^I:9IM]8VE[JEBT-N(6CD8*RB64H.5!'7(' R:(ZO^O+_/\ >BO_77
M_(]2HKS&:U\2Q:+K-[')K,MP^K/']G:>5,6@ESF(!2PR.-R G!XZ"BV;71'I
M!U8ZRVE"2YW"R^U&<'(\D2'8DS #<,E<'C-"U_#\0>GXGIBR(Y8*ZL5.& .<
M'WIU>6-IVJ:8_B5+*#6$:?58II'B:9F>T(3>8F)(+_>'R_/@8["I%M-?OWL;
M59]>@TN35Y%CE,DJ7"VODG_6,?F WYP7YZ>U"UL#T/3Z*XGPX-5A\;:K%<-J
M-W9L':.ZN!-&D1W "((_[MN 2'0=.O6K&JV>J7?CZU\F?48K"'3VE AD9(7G
M$@VJ_8Y&>.XH[/\ KK_D%M_Z[?YG745Y%8OXW;2-2VKJ$=W]C7STDDG=S-Y@
MW-#YD:HIV;P%C9APN/6M#5C?$Q_8AXH_LT6$GV/R_M/G?;-QQYN[Y\8QC?\
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MN>]<M_PT/_U*W_E0_P#M=>WT4 >(?\-#_P#4K?\ E0_^UT?\-#_]2M_Y4/\
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M\J)I@#&KY.[)R.@(&1G%0^(O%5WH_B?3=.CM56RDAEN;JZD4,%CCQNVC>I&
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M !1110 4444 %%%% %>YL;.\>%[JU@G>!_,B:6,,8V_O+GH?<58HHH ****
M"BBB@ HHHH **** "BBB@ HJKJ5ZFFZ7=WSJ62VA>9E'4A03C]*Y^SN/%5]H
MD.J)?Z-&)K<7"VYL)6P"NX*7\X9],[?PI7W?8=CJJ*SM!U0:WH%AJ@B\K[5
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M2#_&C_A&/'?_ $47_P HD'^- '<45P__  C'CO\ Z*+_ .42#_&C_A&/'?\
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M2]=TW[3_ &WXC_MCS-OE?Z$EOY6,[ONGYLY'7ICWK<H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *\0_:'_YES_MY_\ :5>WUXA^T/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGV ''3I3TL-CZ***0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRWX*?\>/B/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJJ**/(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *\M^"G_'CXC_ .PFW\J]2KRWX*?\>/B/_L)M_*@#U*BB
MB@ HHHH **** "O)O'?_ "6?P7^'_H9KUFO)O'?_ "6?P7^'_H9H ]9HHHH
M**CN)TM;:2>7=Y<:EVV(7.!Z* 23[ 9KGK?Q[X<NM_EW=P DJPLSV,Z 2%@H
M4ED SEAQ1OH'F=+116=K&N:?H-M%<:C,\<<LHACV0O*S.<X 5 3V/:@#1HJI
MIFJ66LZ?'?:?.)K:3.UP".AP00<$$$8P:MT %%(2%4D]!R:JZ;J5IJ^G0W]C
M+YMK,-T;[2NX9QT(![4 6Z*HZGK%CH\<+WLK)Y\HAB5(VD9W.2 %4$GH>W:J
MFK^*M'T*ZBMM0N9(YI(S*JI;R2?(#@L2BG &1R<4 ;-%4K35K&^E2.UG\[?
MMPCHC%&0G (?&T_3.:NT %%07=[;6$:274Z0H\BQ*7.,NQPH'N34] !1110
M4444 %%%% !1110 454FU.SM]2M=.EFVW=TKM#'M)W!,%N<8&,CK5N@ HHHH
M **** "BH+>]MKN2XCMYTE>WD\J8*<['P#@^^"/SIFI:C::1IT^H7TOE6L"[
MY'VEMH^@!)_"@"U16"_C+0XK.&ZDN)T29S'%&UG,)9"!D[8]F\@ ]0,4RX\<
M^';:VM+A[]GCNP[0F&WEE)"??R%4E<9YSC% '0T5#:W4%[:0W5M*LL$R!XY%
M.0RD9!%34 %%%% !11534M2M-'TZ:_OYO)M81F1]I; SCH 3WH MT4@((!'0
MUE6OB32;S5WTJ&Y;[:@8^6\+H&VG#;690K8/7:31Y!TN:U%4M4U:TT>U%S>M
M*L9;:/*@>5LX)^Z@)['M4EA?VNJ6$-]93+-;3KOCD7HPH LT454U+4[/1[%K
MR_F\FW5E4OM+8+,%' !/4B@"W16?K.MZ=X>TU]0U6Z6VM4(4N5+<DX   )/X
M"KT;K+&LB'*L P/J#0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **P-.\5V^I7]] EA>Q6]E-)#->S>6L(=.HSOW?
MB5JY_P ))H7V1;O^VM.^S.Q19OM2;&8#) ;.,@<T!Y&G12 A@"""#R"*Q-*\
M5Z=K&O:EH]L)OM%@<2.Z@))V.PYYVG@],&CR#I<W**S%\1:&[S(NLZ>6A#&4
M"Z3,87[Q;GC&1G/3-0/XKT99;79?VTMO<)*XNDN8C$HC +9.[W[ X[XH VJ*
MS1XBT0V<MX-9T_[+$_ER3?:DV(W]TMG /M4.F^*=%UC5+K3M/U&WN+FV56D6
M.0,"#W4@\@<9QT) H V**H:UJ]KH.CW.IWF\P6Z;F6, LW8!02,DD@#ZUF2^
M--)@T?2M5F:2.TU*58D>3:OE,02?,R<+C:0>N#0!T5%9K>(=$1;=FUC3PMR"
M8";E,2CU7GYOPJG9>-?#=]8"]CUJQC@:5H0TTZQY<'IR?Q'J"#0!O45C?\)3
MHZ37<=U?6UF+:7RB]Q<1J'.T,2OS>C#K@^V.:UH9HKB%)H9$EB=0R.C!E8'H
M01U% #Z\M^"G_'CXC_[";?RKU*O+?@I_QX^(_P#L)M_*@#U*BBB@ HHHH **
M** "O)O'?_)9_!?X?^AFO6:\F\=_\EG\%_A_Z&: /6:*** "O.;OPIJESX?U
M6R>RW&Z\0B\5/-3YH/-0ELYXX!XZ^U>C44+>_P#6Z?Z!TM_6S7ZGD5_X)U]9
MKF&VTV&32EO+HV]GM201JZILD1#+&%P0^/FRI.0O-=/XIT;6KKPSH$-HMQ=7
MUE=6\T[PM$DOR(0S#S"4W9/0Y_&NVHHZ6_K0=];_ -:GD\/A#6DL;0:AH8U&
M!8KM5LS<1[XY9'W),Y+!"^,@E3QG@4\>&?%(U?2'FTNT>:SDMA-J:%3-,BIM
M?,AD#8ZC9LP>N<UZK10(\HLO EY8:)X?\W0_MC1"4ZC8B=,O(01')EFVG;['
M(SQTK6A\-:PGPMTK1VM<W5N\;75EYR_OHUDW-%NSMY'J<'H:]!HIW#K?^M3S
M&+P5>3W.FS3:+!':1:TUS'9R&)_LEL8R"O4C!<!MJD@<>E;VO6VL6_C.SU?3
M]'?484T^6V8)/''M=G4C.]@<?+V!KL**72W];6#^OQN>/3?#W7HM->S6V6?=
MI\$3-',JJ'^UF5T7)! 53P?;CFM6]\&ZM#XMC?3[:./3XY;<VES'&KO:QI]]
M 6F4JK'=D!'R#7IE%.X/4\ID\%7<OAU+:Y\,Q7.JV]]'<7%X[0,;]1*2V&9L
M\J>C[1VJ:#PIK0U-)!I?DW8O)YYM2\Z/]];LK!(,!MW&5&"-HVY!KU"BETM_
M6UAWZGDUEX"O=,A\,S6FCDZA D?VT3O%);JV5W,06W"0!1AHP>@'2NG\3>&)
M]<\5Z?=_9U:WM[&=4F9\".<LAC. <G!&>G:NRHIMW_'\1+0\ALO!?B./2YHI
M+)47_1OM-E&$C2_V.3(=WG/N9AU+!-W&0*NZCX4U6ZO+E[30/L[3"W_LV;S8
ME_LH(?G7"MQGD_N\@YP:]1HHOK?^OZ_KJ!Y2O@"]FU19[K28Y%EU#4)+AFD0
M[X74F+(SR-V#M['D@53M_ .N2VH>^TS?=HNF(CM.A91'Q/@[N/EX/J.F:]BH
MI+2W]=O\@>IY%=^"O$"VPMXM.BDT^.[O?*M-J2>6DC Q2(IEC48&['S97/3T
MLR>"=9-S=WK6OG:B+O3W@O&= Y6-$69A\QV]#D9Y]Z]4HH6G]>G^0/7^O7_,
M\AMO!.KK<VJW&BW"21VM[%>WUO=1"2[>3[C*2V<D=V QT/%=)INAM;_#74-*
MUZ*UTV!EE4-B.()&?NN^PE _0G!QFNZHH>S0[^]S'DNE:#J^KZ'IFN:CI_\
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MKF_CUS38[.[AAW6=S(XG5F1BIBQ\H9>1D\]@346B>)KK5=2ALGMXXY/*^TS
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M<8JC%XBL9M\BF0P+"DP;R)=^UBXR5V<+\AP>_MP2Z/Q)I,I4"Z*AD#[GB=%
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MDVC)4[8E;!]F!H'8Z^BH[>4SVT4I&"Z!L>F1FI*&K:$IW5PKRWX*?\>/B/\
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MV$</EJ/WDK\#)P/WN,>WO6%>:[J=I?7%D=0*F!Y!!-+Y""=P$(1RVT8&['R
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M4L3LC "EL; -N,8]<GW[4GV_KI_F'P_UV-";P\[WT-[#>*D\$<*1;HMR@H)
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M+#'#< 6Q#.J#:-IW_*2H .0?48IMCJEO*M^MWJD>HZ7'9K+//*J;8R=V]"5
M&-H!VGD=^HI?#;6D-C>75M):6Z7D^Z"UB=0L7R!47 X#-MW$#UQVH>GR%N2S
M^%VNK*+3Y[U6L89Q-$JPD2+@D@%MV#@G^[V&<\YT;O3I[NP@1KM5O('66.X$
M7&\=RN>002",CJ<$5Q$7V'R]-\H1_93!'_;73&_>O^N]]V_=N[9SQ4KC3=DX
MNQ'_ &:(KC^R\_=W;^/*_P!K^YMYQTXH>G]=O^&T[@M7_77^M3<O="U-]1L[
M]+N&2]%TK22^1B..)8Y0!L+Y/,AS\V<MGH*E;PPYCB5;Y1\C"8F'.]FE$I*_
M-\OS9XYX-5M2FLII=,76I+9[.."1;H3,I1+C:A ;/ ;:7(SSS6)IN[R(#.#_
M ,)#]HMO)\W_ %_D^6F[KSMQYF>V[=WIO3Y?U_P?34-TG_7]=#HIO"TMQ:BS
MDU!?LT2R"W4089-X(^8[OFP"0, >]:C::Q;4F2Z>-[U0%=%PT1";<CU/>N>\
M,FV6XM38F-7_ +.)U!AC(GRN/-_V\^9G//6J-I=7>IZM;;=9E:XM[6ZWW,'D
MR1N<0$;"$QMY!P1N'3.*35M/7^OP"*N[_P!=_P!3=T[PP]EJ*7DEW"S+('V0
MVYC!Q&R<Y=B3\V22:B3PG<00K;P:DBV[7,-S,K6VYG:-E. =WR@A%'0]_6L*
M[\67Q@6:VU#9-);2,T#^4=CBV,FY4V[MNX#EF.<GC&*T7U;4K;5WL7U3$D;(
MJ?:C BRH4W-(1PQ();&T8^3GN:;NM06UU_7]7-VYT7[1K2ZC]HV[?)_=[,_Z
MLR'KGOYGZ>]5[;P]-97,T]M>Q@W!<3K) 6#(TKR +AA@CS&&><\<4OAS54O+
M4Q37XN;I792QDC82;0NXQE%4,HW#G&03@USTEPP%JS+$\EQ)NG\V)7._[9$A
M7)!Z#Y1_N@]0#1;7E'S,V]/\+/9?91)>++]E:/RV,;[RB!@%):1AW'0 9!XY
MX2X\+/+$Z)?*F\72N6AS\LTGF<?,,$$ =\^U4)+RXMM!TQHF'[NZN8X7= Y\
MM(Y_+()![*O/<>Q-*VJ:E9SQVMQJCF"2.VEFO7CC4P!Q+DCY=H!:- -P.-QY
MHOK<+:6_KL7I_"2RRZC*M\Z-<S1RP#:0+<JV\CA@2&?)."#SUXS5MM 6;2%L
M)Y(F_P!)2>1A&Q63;('P0[,><8))/K[5@SZO?0O<RIK$TUDMY%;"9!;X2,PJ
M_F;BH7+,0,GCYN!TJ*Z\2W<:V9758HYR858/)"8I5=R X 4EOEY)5@HQQT-+
M8&M=3H+_ ,/-<WC7%M=1P*8XH_):$M&RH9#A@&7(/F#C(^Z.O2H+/PJ;73Y;
M4WBL9$B4LL.T#8[/P,]]V,=L5AOXEO%@BC&J,"HE#79>V,4DRJA"AR%4IAB3
M@!N".,&K?B]YMWSWC0&72K@"+*E&DS'TR,D\D]>WUIVU)>JN^ANZQHC:I/'*
MMT(=L+Q']WN/S,C CD8(*#KG-,?0YKBTU-;N[22YOHA$9(HO+5  0N%+-W)/
M)K&U#5K_ $VZ>RFU*<0+,%-X5@5US$&"DL%09.>V>U7;BZU2XDTJ,7_V5Y=/
MFN)S;+&X9U$>,%@PVY<].M3?2_\ 7]:%)7=OZ_K4F@TF[>_BN)\*);@7DZC'
MR.L*QA <\C(+9XZ8JU'HGEZU+J/VC/F2-)Y>SIF-$QG/^QG\:P+;Q1/+!!'+
M>1I>S7*;80%W>4T ?@8SMW9Y_#-,M[_64A6:36)IMEE9W+(T,0#M*Y# X0';
MA>,'//4U36Z)4KJ_D:4/A6>VTBXTR#4(Q!<VHAF+VY9BPB$6Y2'&.%7@YZ=>
M:LW/AYI]5-VMT!$YC:2%U<Y9.C+APH/ ZJW(%<O9ZW=66D1BQU(W:K"YN(PD
M>;/]\JAN@QA6<_.2#MST!K;T._O]1U?:VIF2SBC9U">2YF^8CYV0$ CD84CH
M/<4KWU_K8J3?4:GA"Y03[KZSE>6*.(O)9,6RFX[R?-R7RP.[(QC@=ZNZ5X;?
M3+Q9&O/M,2/)(HE5RX=_O-G?MY);HG?KZY4NK7L[O"NIO]HDEN8Y[-$0&VC5
M7VN/EW#[J<L2#OX[8EDN3HNB:&L=^L$'E+YD*>4DTN=OW%*X;!;D  G(YSP6
MA/M_6AKKHCKK)OOM2F/[0;@1>5SN,7ED;MW3@'I5*V\*&VN8G%XLD(,;2Q2(
M^&9#D$ 2  ].H;D"LFTO[G2=,M%EU"X,%Q:3.-J1 P,)8U4J2N /WG)?<.,T
MR+7=7GBN);?4?/%K!=2*(5CD$Y1DV@L$&0-Q^Z%SQSW*71@U;?K_ ,,=1=:+
M]I>Z;[1M\^XMYON9V^4RG'7G.W\,]ZSSX5N'DA634D-O!$\4*+;88!I$?+-O
MY(" < =<UFKK]PL<4QUM)+19MORRVQN)@0G "AE;!;[H 8AE[_>?XB$C:O?0
M#4)(VD&GF*/Y#M_TG!901SCCUZ\]J:6MA[Z&Q=^'/M7F_P"E[-]T]Q_J\XW0
M&+'7WSG\/>JS^%;F?R9KC4U:[MQ$L,D<+1J%0..0KY)(D;)##MQUSDZMXAO-
M.BOH?[4D6XLWD,;S>2BS !&"D;,LV6QA-O'4YP:T/M=Q:Z/XEDAU!VNX9I&3
M>$8PY4%3MQT^OI27E_6W^8KV_']38TG1_P"S)99/-1C+&B,$0J-REB6^9F/)
M<GDGZFJ+^&99;?[+)?J;:*.9+=1!AD\Q2N6;=\V Q P![U0DU'4=-N;R2?5+
MJX@M;Q8"GD1;F0P"0GY4&6R>,<<#@UGGQ-J=O;W%Q!>#4(HI$@4!HY"7E3"9
M:-%'$FT'' WGDX&#=_U_74+<O]?UV.KU32);^VMXHKF-!%D,LT)DCD^7 RH9
M<XZC)(]O3.M?"MQ:1V\$>I)]F22WED4VWS.T2(O#;L*"$7C!QSS5/7;N73M5
M+?VN;>\32\Q@HA^TRACA<$<Y/\*X)SQ5G2=9OKOQ ]O-,%82S)):.\0\M%^Z
MR@'S"3\I.>/G^E-:BM[I93PPXTV>S>]4B2Q:Q1A#C:ISAB-W)Y]L^U)+X9EE
MC:V^WJ++S99UC\CYP[ALY;=RH+L<8!Z#/KC0:Q<Q-)%_:UM;^8+@0HIB5865
MI#NE7;D+P#N!QG&1SRI\52065^SZD0PM ;5IC$3),))%;854!QPG0=,9 )-)
M*ZM_7]:E<S6OS-J]\.37+DQWT:1O#!!-&\!82)&7.#AAPQ<9]@1WXBG\*&ZN
M+HW%VCV]V2TL020;6,>PE/WFT= >5)Z\\\9*>(=2D\T_;A$-^VY#^26LQYRK
MN51E@ I;)D!' /3BK6GZBEOHNLW*ZE+.K:CY:7D?E G(C4')78 .A.,8&:=[
MZ_UT_P Q7LTOZT_X8V;'2;VWOKN\NK^&XEGMXX$"VQ14V;SDC>=V2_J.E06'
MAM[.X$SWB$+'-&D,4)2.,2>7P@+' 'EYQGJQZ=*Q])\07-Q=V7VC5XIHI)I(
M%BMWB+R$2.%<C8"R$+]Y-N-I.".DDMYJ+7MXEM?-:QPI>3;8H8_G9'4+NRI]
M3GN?6D_/L_Z_$:NG;T_K\!\G@B:6!('U.-D2)XU=K8F0!H3%C=OP%&2=H ^O
M>M2Y\/--JIO%N4\IS$TD,J.P+)]TC;(H[#J#TK%E\070TZ>ZDU(PW8F"/9KY
M0\F$R*OF@.,_<.[+':-W(P*:^K:K)9W=S%JIV6EE+<1F-87$Q5VV[RH(Z+@A
M2.<]*;NW_7]?UY"2T21N0>'G32KRRENHP+A@Z"WA,<<) 'W4+-@9&<9Q3H]#
MF:^2^NKQ)+D3)(QCA*(55'4* 6)'WR<Y-<_//?+JU[#:7N^\-X[0QRI&QC_T
M7<N/ER 2,9]C[YC?Q/J%RJ7<5V;:WNE>:Q$HAC5\$*J.9,':2"W'S8?MBA"N
M=->Z+)=37H2Z5+:_B\JYB:(LQX*Y1@PVG![@]![YB30;F2^AO+R_26:$QA?+
MM]B[5W=1N/)+=>G XJIKE]/'JHM!J)C6>W*I;V[1F17VN=S*REBIQP5(P1TK
M-L];N1;0B/5]\J&V2VML1M]K5@N]N!N/)<94C&S)[TD-FS)X7\Q(%^V8\H3#
M_5=?,F27U[;,?CGVI=1\+IJ,<T<EVR++=/<':G(W0F+ Y[9SG\,5@7FJW<MO
MI%U'>_:=1^UYFL\(?L9,,P;Y% <[>>"23MXZUNZCJ/DC35_MG[-930NSZA^Z
M^=@%VC+*4&06/3^'BGLKC:U_KS7ZDJ:!/)JL&I7E]'+<Q.A_=0%%*JDB@8+$
M@YE8YSV QWI\VA.^B?V<D]N3YKR>9- 7QN9F&T!U(8%A@Y[>_'.Z9K^HW=R5
MFU0B[^TV\:V B1=T;QH7?!7?_$S=>,8-,L]2GMHD0:C@ ".XNW2-GMP9W!R=
MO&./O<#.<4GV$]'Z'0-X>N!<">/4 94ECG1Y8=Q\Q8_*);##(*YXXP3G/:ET
M_0+G3KR6ZAOXVDNCNNP]N2'.XME,,-G#$<[N@]\XXU/5+F698-7D^SP6]S+%
M.D41^T["FUB2N, LP^7&<5HZ'J<U]?7EM-J(FD,9D3[.T;)"I.,$!=RN#QAB
M0<$CN  6]#T#^P])&FQ77F6XB"@&/!#D?,P.>A/.#TR><8 K2>%23;;+M2J6
MD5I.DB.5E1"<<+(N.K==PY'IS@:;<:A8Z8OV>_D2&*QMII!Y,9^:65UDE8[<
MG:HW?ASGFM!=1O[N]:UM-:D>U5Y2EY''$QD"QJ=N=NTX8D9 ]NH)H;MJQM._
M]=RW)X4N'O6NX]1BADWEECAADCB&0=Q*K*#N.1DA@/E'%3'PN%TB^LH+I8'G
M>.2&2.+BW>-(U4@%CD Q@X)[X]ZJZ;J-ZUC=B]N)[P?V7#>8CC59 SB3<J;0
M/[HQG)]S6+I,FC1V]U'<Q^'VW0P%1YZ&U+A6Y8E?];C<3QDJ!3:Y;Q_K^M 3
MOKW_ *_4WU\'PQRE$G!LG$?F0.')RD80%2'"@X53RIY!_"_IFDW=G?M<W5_'
M< 6R6\:);^7@*2<D[CDG/L..E<Q-]A_L'28RFGG40L6"[ 7*(9./)7&XCAMO
M(X'UK3\87&E7&E29;2I[L)(D1FD4RH00&\H8)+A@  ,?,!1U_K^NHEK_ %_7
M8N#P]<0;FM-02.203)(9+?>"LDC.,#<,$;B,\@^E7](TE-(@EABD+QNX901R
MH"*@'O\ =Z^]<[=2VT?B2WFTNULKB\196D2UD07,L@CQMEZ!5R "2?O!*M^%
M8IX-0U=+F&9;AY(Y)I)"N&D*#. &.!Z#L *$)ZZ_UJ=/1112&<IK\<MGXPT3
M6FMKF:RMX+B"9K:!YF1GV%3L0%B/E/(!Q4=S<G7O%>@2V-I?""QDFFN);FRE
MMU4-&44#S%7<26[9Z<UU]%"TMY PHHHH *YCQK:7%Q::5<P02SK8ZE#=3)"A
M=_+7(8JHY8C.<#FNGHH\P.,\1Z@OB*QMM.TVRU-IVO;>0F?3IX$1$E5V8O(B
MCHIXSDUV=%%'2P!1110!SOCK3KK5?!NH6EG$9;A@CI&.K;75B![X!K.\2:U%
MK/A74=,L+#5WO+NV:&*.32[B(;F&.7= H SR2:[.BCR'?9D5K&T-I#$V-R1J
MIQZ@5+113;N[DI65@KRWX*?\>/B/_L)M_*O4J\M^"G_'CXC_ .PFW\J0SU*B
MBB@ HHHH **** "O)O'?_)9_!?X?^AFO6:\F\=_\EG\%_A_Z&: /6:*** "B
MBB@ HHHH SK[6;:R>:'$DEQ%"92B1.5 PQ&YP"%SM/4U#;>(["ZM1.@NB=J,
MT:VDK. P.#MVY*\'Y@,<=:;JNARZE>K,MS# HC:,E(#YC JP*EMV"N6!VE>H
MZ^E>\\-RW%TD\5\B[88HC%+ 7C?8)/O ,,C,@.,_P]Z!EL>)M)8.5N794C24
MLL$A&'QM&0N"QR,+U/I4MMKFGWEPL%O)+)(PY"P2?)RPPYVX0Y5AAL'(K*@\
M)&#138"_/F#R&258RNUH@N#A6!P=O0$=>O>I[7P]-!?6UR;FV4Q,S.T4#K)+
MG=D,[2-E>0<'/(SQGAZ"9.OB2Q$]U#(MPCP7'V<*+>1FD;8&^4!23P>WIGH1
M4]SJ,ITU+[38[:YB*ERTTYA4* 3G.QN<\8(&.?3%5)-"N5U.6_M;Z*.1IC*B
MR6Y<#,:HP.'&1\JD8Q@^M)/X?FDTBVTZ*]00K(7N1)"6%QDEBI 884L<D<Y'
M'3-+H'4L-K+-HME?16C&:\$0BMY&V$,X!PQP<8&2>#TZ50;Q1.$N=NG*TMC&
MTE\GG_ZM0Q'R?+\Y(5B,[>,=*NW=CJ%Z_EM-;Q+!Y4MO*L9),H)W97=]S&!C
M.>3STJDWA:8K=%=1"RW\;1WK^0?G4L3\@W?(0&8#.[MUQ3Z_U_7?\ 7F6H->
M>>^B46J_8IKA[:*X$N6,B!B<IMP%RC#.X\@<<T3Z\\-[*IM5^Q0W"6TEP9<,
M)& (PFW!7YE&=P.2>.*A?0KFV)>TN(WB@EENK:V="O[YE;AGSRF78XVYYZ\4
M]] EFN',UVGV::>.YG@6(Y,JA1\K;N%RJG&">#SS2Z:?U_7^0?U_7]=R!?%$
MY6V#:<JRWR+)9)]H^^I('SG;\A 8$XW=^M:$&MQ?83/>1M!*DYMWBC#2GS <
M87:,L#U' XZ@5GKX7F"VI;40TMC&L=D_D8V*"#\XW?.2% .-O?&,U;;1)&TF
M6T::WEFGF,TLDUN60L3GY5#@KCC'S9&/7FA^7]?T@7F%GXEL[N^GM&6:*1)A
M"FZ&0!B8PX!)4!6P3\I.>/>G-XFTM-H>2X21I%C$36DPD+,&(^0KNP0K<XQP
M:KP>&Y(K)8&U&1Y1<+.9RGSDB,)Z]>,YJ"P\)R6NI17DM["[1M&Q6.W*;]L<
MJ98EV)8^;G)]*?4$:(\1Z60VV>1B&"@""0E\D@%!M^<9!Y7(K0:X1;0W)67R
MPF_ B8OC&?N8W9]L9]JYV#PD]O9FU%S:S(D8AA-S;R2%$!SCF7&>%Y4+RN?I
M?CT_49-'N-/N+P*P58H+E<EV4*H+/R.2V[H1QWSS2Z!U&S^(]'>,P323MYHD
M5H?LDI?"@;]RA<CAEZ@<$4DWB/3K5[:UM<S%YH8%$<;>6N_&/G"[<A2#MSG&
M/6H-.\+M8WLMTUU"3()ALAM_+4>8(AP-QZ>5^.ZFP>%[BV2W@BU)!:QSP3R(
MUOEG:-57 ;=P#L!Q@D'/-/03O;0LWWB*.SN+I-D8CMPP:21V +B,R%0%1NBA
M23[G )&#8M]86;4%M3&NUS(J2(Q(+(1E3E1@X.>XX/I6;J'AN6_N+Z/S_*@G
M+R*^W<0SPF)AC(Z<-[Y(XJU;:/+#JL3LX:WB>6X#8P3))P!UZ!=WUR/2DN@W
MU'+XGTU7\N:8K* 6;RXI'5%\QD!9M@"C*GKC&#VYJ27Q'ID(8M).5$GE!DM9
M75WSC:I"D,<Y'&>E4U\+[;?4(OMF?M<'DY\K[G[R5\]>?];C\/?B>#0[B$6T
M!O8VM+:?SH4\@AP.?E+;L'[QYVCM0!877M/>2:-)97>(,2J6\C%MI ;9A?G(
M) (7)!X-)!X@TVYG\B*65I1G>OV>0>7@D?/E?DZ'[V,XK,_X169//6/4 J,[
MO$2DA:/>X<KGS-NT_,IPJD@]>,F.+PA*IVO>6JHTKNQM[,Q/M;.Y =Y 4\<$
M'H3UP0#-B+7;&XL[FYMWDD6W3S&7R75BN"00",D'!P1D'%9]OXCTS4+R)+F"
M2-XVBD@>2%R%:1<+D[<(?F*C)YSQUJQIFA/8VUQ%/<K.\L*P>:%<-L ( .YV
MS]XGC Y/%11>')%L6@FO4=VDMG+I"5'[DJ0,;CUV>O&:.HD:-KK%C>M*L$Q8
MQ+N.8V4%<D;E)'S#(/(R*IP>+-&N6C$=Q-\ZHZEK651M<X5B2H 4GH3P:9I'
MATZ7&T1N5F18/L\#%7WHGH2SD'HO0+T_)%\-X@,7VOK:6UMGR_\ GBS-NZ]]
MW3M[T!W)AK.CV$TL+,]JS2%G\VWDC#,6"ELLH!&X@;@<<CGD4G_"3Z:-K&5F
M21E6'RH99'?*;_NA,] 3WXK,G\&27<\GVK44>":-X9@MN1++&[AB&<N>RA>
M, G ':]9^'9;>[@N9K_SY(F#$^5M+8B,8SSUP<T= ?D6;7Q'I5XBO#<L5<IL
M+0NN_>=JE<@9!/&1Q3;KQ/I%G))'-<R Q[C)MMY&"!3@EB%( ![GBJB^%VCM
M+.*.^ EM;>")':'(+1,&#$;NAQC&?QIL?A>8P7ZW&H+)+>1NC.L&T*6<MD#<
M>!G&,]NM'4'I>QI_V[IW]GSWQF=8+<[9=\+JZ'@X*$;NC ].XIUMK-C=R+'%
M*_F%F7RWB=&!4 D$, 1PP//4&H)=%\U-27[1C[;<1S?<^YM6,8Z\Y\OVZ^U0
MS:#<?VC-?VE]'%/),9!YD!=0#$D9& PR?D!SGVQ0QD8\2Z!)=)<+)))-M6))
M$M)6XD4.%!"]2-IQUZ4R/Q%I$=[/;@.D$T*7+3JDA&79D.["_N\%!DG')/3!
MI=+\+G3;2" WOFF*>&8MY6W=LA6+&,]]N?QQ[U$?"DX:Y1-206]U"8)T-OEB
MIED<[6W<'$A'0],T[*]N@/K8O#Q!HMC;M&LQCAM@(PJP/@C<(P$POS@,0ORY
MP2,U9NM:L;)8C.\JF1#(%$$C,$&,LRA25 R,DXQ63%X2,85#>*T<4BM"6C<N
MBB59"N3(5P=@'"CL>U:6H:7<7-W]IM+Q+>1X#!)YD/F J3D$?,,$<^HYZ4GM
M?K_7ZBT(X?$$$MQJ6Y3':6*@O<,&^;*AL@;<$8(Y!.?3I3)?%%C;W@BF2XCB
M,!F\Q[:4%0&*G<NW*@8SN.!4MKH@LK2\@@DC99U1$6>+>JA8UC 89&X?+SR.
MM4T\+N+"\MGO@QN+22V!$1VQABQ&T%B<#=@#/;KZ/J"\_P"MO^"7KCQ#IMH\
MRW,LT1B4LQ>VD 8 @$J=N'Y8?=SUI#XDTI2X>X>/8A9C)!(H&%W%<E?O!>=O
MWO:LM_",TMZ9Y=1C8 . ?LQ\P[I%?#.7Y "!0  *LOX;?[=<3K<0212.\J17
M,+R!'92I./,"D<GC;G!(S2 TWU:TCLTNI#,D;OL16MY!(S9Q@(5W'H>W3GI5
M2W\007NK06=I&\D;Q/(\K(Z;-K;=N"O7.002,8]>*9'H,T6GVL*WJ_:+6X:>
M%S$2BYW#9L+9VA7( W<<?2I--T1K"\-U)=>=*Z.),1[06=]Q(&3@#H!S]31U
M![$C:_IR[_WDQ"OY89;>1@[9QM0A<.<YX7/0^AJ&7Q5H\,:N]S)M*&0D6\AV
M*&VDOA?DP1@[L8[U$-!NHX[>**_B"6DQFM=UL24R&&'.\;AM=AP%/3TY8/##
M&WO5DOMTMW"Z2.(L ,SEB0,].< 9[=30@>VA8?Q5I$8&^><,0Y*?99=ZA I8
MLNW*X#J>0."*D3Q'I;Q;UGD.65%3[/)O8L"1M3;N8$ G(!& ?0U7D\-^9JE[
M>_:\?:8Y4V>7]W>D29SGG'E9_P"!>W))X>E^W17MO>K'<0K$$WP[E^574Y&X
M$Y#GH1@@=>E /R)E\3Z0\RQ)<NS$(21!)M3<Q5=QVX4[@1AL'(-3W6LVEK+/
M$1/)+#'YCK' [@#!."P! .!TSZ>M9UOX7\BWO(S>;GNRCR/Y6/G$C2,0,]"7
M.!V]35J\T:2\U5;O[1%$@C:-A'"1)(I4C:S[L%03D#;P1UZY3VT_K3_,%OK_
M %K_ )!!XDTZ5("TDL;3+&<-"^$+_=5FVX4GC&2,Y'J*9/XFL8I+?:7,,DQC
M>=T=(U 1VW!BNUQ\F.#WS5:+PS<QP&W;48S!*T3W"K;$,YC"@;27.T$(H/![
MXQGALOA1[BSL+&:^4VEA,LEL$@Q(NU65<L6()&Y3G;@[>1S5.UP6VO\ 6G^9
MKR:D@EL8XHW=KO+ ,"A1 ,EB",CJ!C&<D5F6GBI;JQU"Z%FRK9L'"^9DRVYZ
M2CCN Q _V>M2ZKI5[>+:O%<JMR(9+:69$QA) ,NJD]054XSZU6N?"ZVJ,=)D
MDC+V?V%DDD:0;"0%;+,<; 6.!US2#0VKC4[.U69IIMHA@-PYVDXC&?FX'/0\
M=:J)XETEVE'VIE$1D#.\+HF8_O@,0 2,'H>QJOJ_A^>_AEBL[Y+59K,V;[X/
M-^0]"/F&#R>N>M,F\+)<:>EH]VP437$I94P?WN_@<]M_XX]Z>@=/,DC\6:>U
MU<Q,)T6$1XS;R^8Y8,V/+V[N N<XZ&H-2U[1Y2C_ +RZ^R3PLVQ9/+7?M*MD
M#:Y 8,!R?2F3>%[ZXU%M1FU:/[6=JJ8[=XT"A2""%E#'.<_>[59B\.+;6DD4
M<B[3<P7 CCCP!Y21KL&6[^7W/&>^*0NC)[CQ)IMLY+W*>5'"9Y7PYVIM# C"
MD'@YQG/3UI__  D6F^7N\R?=O\OROLLOF;MN[_5[=W3G.,5A:=X.==&,,LS0
M2R&?(90Y17PL:D@X^5%1>/3K5_5--O(+]M3T\2373/\ *BQ(P5?+VG(:1,Y(
M&,'@^V:'_7]?@/\ K^OS-$:[I[6=K=)++)%=C=!Y<$CLXQG.T*2/Q%00^);&
M2%I'6Y0B:2%8Q;2,[%"02%"Y(XZXXS51= O)O#5A82W$$5S"@+S&$NZ/C[T9
M#+M89//(]L5*N@74%U]IM;^))5DF:,R6Y<!92&8, XR=R@@C'3&#0!)=>)["
M*SFGM6:[,<7F_NHW*<KN ,@4JI(P<$YY'J*NMJ]BME)>&8_9XW\LN$8[FSC"
MC&6R3@;<Y/ K%3PD\.DWFE0WZ_8KQ")A+!N?<4"L0P8  X!QCUYY&-!]%D.D
MI8)=X\B1'M7,>?+",&56&?F QCL2/?FGH'4'\3:5&45IIB[;_P!VMK*7&S&[
M<H7*XW*>0.HIL7B.TGN)(X^$CF2+S7#*CADW@J=N#Q[@=\]*SWT#5$UR.\@O
M(1),EP;B=K?* L(5553?D<1]<GD'/6IQX418_LZW7^B9C.PQ_/\ )%Y?WLXY
M ';K2>V@]"U_PE&D! _GR_,5"#[-+NDW9VE1MRP..HR*GM]=T^ZFBA@EEDDD
M&<+!(=GS%?G^7Y.58?-CD'TJA'X=N&O+*YN]029[,*D6R#9E!UW?,<L>.1@<
M=.:6/P[+%>03)=PJL5Q)/N6W(E(>1G*;]^-OS 8*GIGJ1AZ"Z%V;7M-M[B2"
M6=E:,E7;RG*!@N[;O V[L<XSGVH_MVP^Q6]V&G,5P2(0+:4N_!/";=V, G..
ME4;WPW+>+<6_VY5LIIC<>7Y&7#X_O;ON[N<8SVS5O4](DOM*BLHYH$,8 \V2
M$NRD+@,F&4JPZYR:2#J,C\26+";>MPACN#;JGV>1FD8#)VJ%R>,]!QWIMYXG
ML(+">YMR]TT5NTX6.-RO"E@&<*0A./XN?:HQH-W%<FYM]0C$JS-+&9;<O]Y0
MK!L.,YP"",8]ZKIX4E@TZ_L(-000:A&_VDR6Y9C(R;2RD,,#H<8/3K0AQWU-
MJ/4[66UFN8VDDCA)5S%$[DD=0H RV.GRYY!'453?Q1I,94-/,&(D8J+64LH0
M@,6&W*@9')QU% T26+1'TN"],<2[1 VPY1 0=C8(+#@CL<'KGFLB+POJ5M?X
MM[RVCBEAN!+(EIA1YC)A53?D$!3SDCU%'70E;*YJ1ZWH=K>WBI,RRO+F=_*D
M*%Q&#C=C;G8JG -31^(]+D\C;/(//"LA:WD4 ,=JELK\H8\ MC/;-9,?AB[E
M^W6LMRL5@UQOAC\K<YQ$J [MW3(SC&>.N#5R?PV9;Z.X6Z7RS%%%-%(KE7$9
M)!&UU /)ZANWIRPNRT?$%FTL2PF1U>0IO,,H#85V_=D(0Y^0]#^/0%A\2V+7
M%K#$MRSSSF AK>1#&P0O\P*@CC'7USV-4Y/#-T^GVMBFJ+%!9D_9F2 B11Y;
MQ@%M_) <<@#I[\+9^&)K6<3B\MQ(+S[3B.U*ICRO**XWDYQSN)Z]J13MT+=O
MXDTZ6*V9Y@&F2-B8XY&C4N/E!?: ,Y&-V"<CCFI].UW3]6P;.9W#1B5=\+Q[
MTSC<NX#(^GMZUE6WA26ULEL8]07[*WD&<&#YW:-57Y6W84$(N1@]\'FM#3M$
M_L_[!_I'F?9++[)]S&_[OS=>/N]/?K3=M;?UO_P =NA%'XITR9(9HYF-O+&7
MC8PRAY/F4#8FS+ [AR/R/.(SXOTP74: S&%XYG:06\N4,;!6#)MR ,\DX''O
M5:Y\.S6MGI;VTLD]QIL"0Q!(E^8@K\Q#.HQA3D;L\\'(I=+T&]>VFGU"81W-
MQ'<HR",?+YK@@\,1P . 3]3UI/K;^NPNOS+_ /PDM@+JX@<7 :&41+LMY'\T
ME-_RA5.>/3TJ#4M<L_#J/;QVCX6VFO,*C!/E8%LM@X)+$_\ ZQ4=SX:N)4GB
MBO+98YMC9EM69XW6,(&1A(NT\ ^W-6=6T*34]FV\$9^RR6SEXMY8/M.1@C!R
M@]>M/070G&O6#6[S+]J94;8ZK9S%U.W=RFW<!CN1BG:;K-MJL]S';"0K 4Q(
M48*X90P()&#P:IZCX?EO+J:>*\C02N&:*: R1G";1D!AG'49X]N]3:'HKZ,A
MB%RLT9BB4CRMIW(BIG.3P0HXQQZTEYC9KT444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7EOP4_X\?$?_ &$V_E7J5>6_!3_CQ\1_]A-OY4 >I444
M4 %%%% !1110 5Y-X[_Y+/X+_#_T,UZS7DWCO_DL_@O\/_0S0!ZS1110 444
M4 %%%% '+:Y=ZDFIWJVNHR6T=O;6[K&L4; L\KJ2=RD]%' (K.U?7[O3;2]A
M.JR)<6KS&*:7R464*B,%;*'<V7P @!/ZUV4]_9VLT4-Q=P0RS'$:22!6<Y X
M!Z\D#\:A.MZ2$E<ZG9!(2%E8W"80DX ;GCD8YH'U3,?0M3U*^U:[M+IFV6*$
M2-Y8 E:0[HR./X4P#CNU<YI>N7-GH.EQVNJ-<6YM(A<NJPYLCN4  D #(W#Y
M\_=S79V5_H4(NGM-1LVW$W%P_P!J#GH!N8DG  P/0#%6/[9TO[(;O^TK/[,&
MV>=YZ[-WINSC-,72W];&(VJW7]D:9+/J26\,UPZ37R-$W[L;]A+<Q@MA03TR
M2!C(K-TW6[Z:QO+RYUFXDMX8$5&ABA7<S2R()"2F!PJ_[(&20:ZB[NM)O)A8
M3:E&LZMGRHKTQ29VY_@8-T.<?C3;?5="L[*!(-2L$ML^7&?M*D$@ D9)Y/()
M[\Y[T"?0Y2'7-6N;;5)X]7W)86\TR&)8I%F*DD;FV#(P,?*!]>YEN=5N+#4K
M^)M3FB26]R[[H 85\A"H'F84 G/7.=O'))KJHM<L)[R6VBG1Y(93#+B11L8)
MOZ$Y/'H#T/H:=_;FD_9Q<?VI9>07$8D^T)MW8SMSG&<<XI=!G(RZI=7<UDFH
M:G'%<_;[0+8Q!"DBD(Q=3@L1N+?,#CY<5;N;^6RU^\A?5WMH9KR,2._E_N8_
M)R"-RX +@+DY';J<UT4FLVZW=C!&DLZWH9HYX0&C  SDMGH<\=:M275O$9!)
M<1(8D#R!G V*<X)]!P>?8TQ?U^9S<FM3+X=M9I[YX))KB2..[!CC5T4OM=BZ
MLH#*H/ YR,5GV.L:O>:='J!U)EYLD\I8H]C>:4#L<KG^+(Y&".G:NNCU?3)G
MF2+4;1WA!,JK.I,8'4MSQCOFJT?B+2)TN7&H6XMX'6-IS.HC+$9P&SUI=2C%
ML=:U:XT75+R3<LEF%M>8ACS4XEE  R1D\#I\OO38]0OKO5+>RL]<DFLVN /M
ML:0LS_NG8H"%V<%5.0.^*Z"TGTJQ66QM;B'? K2R0B;?( ?F+,"2QSNSD]<T
MEOK5O)IXO[I&L+5@K)+=21JKANA!#'&>.N#S1U_K^MR7Y?U_2.:TKQ#J5WJ-
MO#/=!9-\2"%S"BSH5RS@$[RV=V-O'R?6IWN;^77[JTM[YK2,-<R,888\N42#
M;DLIS]\\]>GH*Z*ZUG3++'VB_MHV,?F*C2J&9<$Y SST-1Q:]ILEK]J:\@BM
ML)B629 IW#('7@^QQ1T'UN<>VL3Z@=,DN]25+E[E6&GA$QL\DL'QC=CG.<XY
MQBBWUC49;*.Q=T/V>&&XD)@3:T<GE^6N-N  3(./^>8KMCJ^FK<10-J-H)I0
M&CC,R[G!Z$#.2#VI+G4HK74+.R>*8O=,RHZI\BD*6Y/T4\#)I]16T^1Q5UK%
MP-0M;DZMNNXXYWFM?+3_ $4!U!Z#(&W/WB<XR*M:AXIWG4?LVKB-([AUMYD>
M)8L+!&2I9D;<=SD@#DG/85TL6L?:?/:UT^[GBB+J)4\L+(RG!5=S@YR",D <
M=:CB\16CAQ+%-!*ES]F>*7;E6V[R20Q7:$.[.>GOQ4I:6*OJ8UCJ%POAW[5]
MH%MY]_\ O[@*#Y2L<D_-D#GC)R!FJ%AKXTZTNY7U9'MG6]>*Y<(!-*KKM(P,
M$X)X'!Z@5U\.NZ1<RI%!JMC+(YPB1W",S'T !YI\6JV<FG"^DF2"#)#&9@FQ
M@=I5CG (((^M-]1+I<XZ[U35$TU]0-\7E#7/DAH(R(=D#D%?ESG(YYZ<>N;]
MQJ-]9:@+*YUAX[;?$TM[(D2M&&20[<[=@!9%&2/XL9Y%;O\ ;U@^HV=C!,D\
MEU&TL;12(5V+CGKSG/&,]_2J-]KNAW.V"XOC&@NF@:2.Z,(20*3AF5@<$9 '
MK3N*UC-_MR7_ (1>QGDU9TFFDF"WF8HE<*7P6+(0. #A5R2/3-06.JZQ?61O
M?[3>-GGM8%B6&/8OFPQECRN[.Z0D<]AVKJK2YTNV%M86MU; M&&AB$P+.G7<
M.<MGDY[\U'+KFF1O=07=W':^3)Y+-/*L88E%?Y3GT<4=QJ]C#LM=U2[\/7NI
M.#"4E2W *#]UM*I/)C'.&,G7(P@J'4=?^RW%M'9:ZUR?,A!,DD&R</+M(4*F
M6( .=I &!DYK?M=2T6P,NGPW<$2VL2S/OE& KD_,6)YR>23ZCUJP^M:5&5#Z
MG9KOB\Y=TZC='S\PY^[P>>G%'7^OZ[_T@Z?U_78XVSUF^MUMK6&Y$)1(_*A=
MHE2968[S\QWD@9P%[@9SFK46J:I!:V0N=6=EN;:VFGNGBC7R-Y.XC"X Z#Y@
M<=:Z8Z[I"VZW!U6Q$+,460W";2P&2 <XSCGZ4DNM6\5G?7/ERNMG)Y;JH&6.
M%/RY./XAU(I+:W]?UL)[_P!?UW.(A\0-:6LOV766D<74CK(YB5+E3-M&!L)=
ML _<VC!SQD5T"7VHP>&;K57O9)WAN))63RDP(8Y2&10%R?D4\G)S6M%KMD89
M9+J06)BF,#K=.B$/@,!D,0<@@\&G7LNEWMB\-U=0M;.'W_O]H8(?G!((X'1A
MT[&C9#W9RUKK^JM>6RW-R899?*E2WD\E%DCD8EASARRJ=HV]UYSFH;37[_4=
M9M;*UUB3R)WB9F_<R2QADF8HV$VJ?D3CDCUYKL/[:TA%ASJ=BHE'[K_2$&_G
M'R\\\\<59^UVV5'VB++.8P-XY< DK]0 3CV--:,$<QJVKW-MX@NK>+5/+DBB
MMVM['8G[]F=@PY&X\ #@C'6J%MKNJWT$8343#++) LZ_N&>V9I0I55&2!C<,
MN,Y7ZUU4=[I*Q7>KPW4$D80">>*3>,("0."1D;CTYYI\&I[HI9KNSGL((UW&
M6Z>(*1D_W7..@/..H[Y 2!ZG)#6+JVAO$?4A9>3]H>W(AC'VJ43R+M(V_,?E
M3(7#$OUS4EIJDESKFE27^I!;E9[DS6#!%%LJHX!Z;A\N#EB0<Y'%=-<Z_I-I
M8_;)-1M?)(8H1.G[PKU"\X)[8J3[7IVHJU@\T$CS0[GM6<%S&P[KG.,&G<)6
M?]>AB^+=<.G62R6M^;>0V\D\;[XQ%)M P"65BQ)(P%P3ZUGG6-9BT\WR7CSR
M337D:0&%"J"/S-F H#$C8.I.<UU4VKZ9:-+#)?6J20(7>+S5#*H&?NYSTQ^=
M5Y/$%M'X>76C!<-;F/S D:J[XZ_PDJ./>D@Z6.<2\!3Q)-;:NU^JV\"FZ79E
M%(?<04 !P"3T_E586]@?$[VGDV( O71A&X^T&+[,HP5QQ'TR<GMQ76WNLV\$
M\EM):SRQ+L6>554QQ;^ &R03UYP#@'FJ?]N:;]EFM)[2ZBL$AF42R %72([7
M PQ?VY S0)(I?VI<)I6BFYU-K"":U=Y+Q@F6<*NP'>"!N!9L8S\M4=)UN_GT
M.2_OM6G&XVT2%$AC56>&)RS,R$#)9LYZ X SBNI$":Q:J+FTO[)%X5/M!B+
MC_ID_3V/3TJ6/4-*M7-@EY9Q/;1\P"508T4 \KG@ 8_"FWN4GH<AINMZM>6U
MQ>'52\=MY05(XXRDV9W0L6V G*J/N[?7%,DUB[T^2:V&JO&?/NW,DK0 *X?Y
M$8O@!2I+8'S$#@@"NT;5]-2S6\;4;06K-L68S*$+=,!LXSP?RJ.77=(@<)+J
MMC&Q4. ]P@)4C(/7ICG-+J)',#4)KKQ#HZ7>H@70U*=6TX!,1HL4H5N!NY&#
MDG!W_2I!?R6E[=6\NM/;1-J$@FG?RLPC8"B_,N%#>I'.,#DUU']J:?BW/V^U
MQ<_ZC]\O[W_=Y^;KVI(]7TR9YDBU&T=X03*JSJ3&!U+<\8[YH!ZG-:AKUS#X
M>LII+Y[2ZECE=9CY<:2!,@%MZ-RP*L%49/T!J.*_UJ[A>XCU1D>:Y6WCB$,>
MR/= &SRN2=QSR<=L5T$7B/2)O.9=0MA%%(L9F,R>6S$9PK9Y/M3[S5].CNH]
M.DND-S<,(O)CF D7(SG (8#'<>HH P[?7M0O/#<VK,[6D<MS'$I:,9MHPRI(
MQR.S>8<G( P>E11:CJ5[J9M;?6)?LB+<M'=1QQ,9P@AQSM*X5I'&5 SMK?N;
MVP\/V]E:[=HED$$$0=<D]>K$9]2<Y^I-3_VOIF9Q_:-I_H_^N_?K^[YQ\W/'
M/'-#ZC6FYS6A>(+_ %+5+99KA5:3'F6K-$H$?E!@Z#/F$EL?[."?3-5VU'4D
MM]3EM[XVZ6<5W<"*."/;(RSR ;LKTPO.,$YSG-==+J^FP0PS3:A:1Q3C,+O,
MH60?[))Y_"D.LZ6L\D!U*S$T>=\9G7<N.N1GBG?44=%KY'"ZQJDLZ^9-J2R7
M:+?%K!XHRL(6*0*2I7.",?>R&W9'%7VU;4I;HVKN'-A=11RAH5Q*TDP,>,C@
MB/'3'+>HKL)K^RMXII9KN"..%@LKO( (R<8#$G@G(Z^H]:C.KZ:((ISJ-H(9
M7V1R><NUV] <\GCI1TL*VAP\6M2KJMC>-K(GD^RQF[5DC MMTT8D4X VCJ/F
MY&.M3ZEXKD%C<7%KJ@5HWG>%MT2Q2JK@*HRA+GMA<<'KR#73WGB72K.YCM3>
M02W3RB'[/',F]6.>H+#'0]?YU8;6M*3SMVIV8\C FS.H\O)Q\W/'/'/>B_4+
M;G.ARGAS3Y3=O:QKJ;>8ZE0,&=QR6!XJI!?7.DZ>DCZC<?9[B2[&U$B'DGSL
M*5)7C&>2V1U/:NJ;Q!HJ.4;5[!6 !(-R@(!P0>O?(_.IO[5T[SXH/M]KYTRA
MHH_.7<X.<%1G)!P>GI2_K^ON!(Y;2-2GO=8L);C5/,C$EU C(\924@H5&0H#
M'!/0#I]276.JS1:I!%)?1K#+>3Q"U@\I9"WGR ,R;<LI"\E2#D$G/)'21:UI
M4\,LT6IV4D42AI'2=2J ]R<\#BGQZII\TT4,5_:R2RKNC19E+..>0,\C@_D:
M:'T:.7EO-1:]O$MKYK6.%+R;;%#'\[(ZA=V5/J<]SZU7GU>YL[^XW:C-$MS<
MQ&0@P@PH8 05\P!0"XVY.?3J<UV$^J:?:W*VUQ?VL4[8VQ23*K'/3 )SS@_E
M1-JFGV[A)KZVC<OY85YE!+<?+@GKR./<5*T0=SE++5M8DCDO9-0$NR[MH%@B
M6,Q.KQQDD, 2<E\C#8^HK-;7+A+^TN1J[3S/9*+HJD(-F6D3>.0 O/&'SCOF
MNYLM:L+Z*T*7$:2W4*S102.HE*D9^[GZ]/2I[J]@LS&9W6-&W9=W50H52Q)R
M1Q@'IG\N:IZ,&KG!ZKJ]U<:+=QWNL) OV8&W">4WVS,CKR0""=H0$(1@DGIB
MMGQ#>7&GZT)8KUXM]H%"':5 \U0[@$9)526_#GBNCM;^SOHVDM+N"X13AFAD
M#@'&<$CVJ ZYI*VPN3JED+<OL$IN$V[L9QG.,XYQ2_K\+!;6_P#7<Q?[6NAI
M.IR6^H?:H8;B...^VH=L;;/,;*@(VP%CG&.,'.#6?9^)G@U2]%QKB7&G1O/'
M%<2"-07$<#*NY0 2-TO3K@]<5T]_KVF:;#(\]Y"72+SO)65?,9<$Y )YX!/X
M&I+&;3)$N;VQN()4E??-+','7<%49)S@?*%HZ,::."U'Q%<W>EM$;\O]HL94
MGMY#$#G[*7+*BH& R!R6[G QC&B(;N[UII+:<)<10WIMU\J/:KAXP#]W.3GD
MYS^M=4NNZ0YB"ZK8L9CB/%PAWG(''//)'YBDN-5TA[:=9=4M5B4^7*PN@A0G
M(P6!!4\'N#P:;?;S$MDF8MOKTUWX9;5I9I[6.[N0+;B-#$F0HW%U( )4DD@G
MYL#G%5O#VOW-[?VB76J)<B8R1I';O$?N%QND&P-@A00RX&<<#//07&HZ=H<>
MG60VHLS""WC1U& %)S\Q'  ^O3K4HUS2&CBD75+$I*VV-A<)ASG& <\G)'YT
M=1=#-UVUCTJQUG7;1VAOVM6/FGY@N%&#M/'\(K(N->N8F\N/6'FL#-M&I)]G
M!SY>=FY@(^O?&>W6NCO]4T&6.XL;[4[$ @I-$]RJD#H0>01U%3ZCJD&FV(NW
M26:(D >0N[@]\] /<G]<4N@WN<E(VHZMI$LFH:@Q!O[2$V\*1-$ 3"6P2I+
MEB>21C%%QKFHB!1;:KF[D9TGMQ%&?L0#@*<;<CL/FSG.176/JBC4C90VMQ<.
M@4S/'M"1!NFXLPSQDX7)P/<9-.U1=37S8;6X6V89BN'VA)1ZJ V[!]P*>XNA
MS\DNK?VE-"NM7*QQW\5H!Y,).TP*['[GWB23Z>U4)O$UY']G U)A<).D#QR>
M4HF!E9-RKLW$[1DD%5!''<5U)UZW NY3!<?8[7>);O"^6"F=P SN)!&.%QFI
M5U.;[(;A]+O(P.2KM$"%QG=]_ 'XY]JE[%=3FHM5U2VL[3[3JKNMQ:V\T]T\
M48^S[R=[#"@ =!\P..IIZZ[=#6_LT%^;I4D188S); 7497+,/NDMG<!MPOR<
M]S711:U9-IEK?W$RV45R@>,73K&W(R ><9QVS3;/7],O#.B7<*2P/*LD3R*'
M41L59B,\+QG)[$53W?\ 7]6)2T_K^M3F=4U.:#Q!>SI<RZ?>?V= 8;*01,UP
MXEE 4XW9SP,*<_-4<GB*ZDU">*VUF**)HWDQ=2PJT1695V\)A"06 W[CP,X.
M:ZV/6])E\GR]4LG\YBD6VX0[V&.%YY/(Z>HI3K6E"!ISJ=D(4?RVD\]=H;&=
MI.<9QVI#>IQA\4:G(DSV=S(950>3;W(@S+'Y.[S-JX=GW9/RC:0I '>MOPW/
M'<:YJ[1:I_:2".W G^3T?C*  ]?3O6S-JUC!J$=C+<QI/)"TRJS ?(N,G]?T
M/I4UK>VM]#YMG<PW$6<;X9 XSZ9%,3U)Z***0PHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *\M^"G_'CXC_[";?RKU*O+?@I_P >/B/_ +";?RH ]2HH
MHH **** "BBB@ KR;QW_ ,EG\%_A_P"AFO6:\F\=_P#)9_!?X?\ H9H ]9HH
MHH **** "BBB@#)EL;Q-9FNX%@DBN88X9-\A1XMI;E<*=W#GCCD=>>,=/#.H
M2'2EG^Q(FFI'$OELQ\U5DC8L05&TXC&!SRQYXYU]8$JZEH\B7,R*;LH\2-A7
M!C<_-Z].G3VJ#6<SZM!:R74]O +2>?,,S1DNI0 DJ1D ,3@\<\CBB]E?^M-0
M:OIW_P"&,O5_#MVNA72Q)#+)B^<(@+%_.<LHQCGC&?ZU8N-"U:>]_M)3:PW)
MDY@CF^3;Y>S.]HS\W_ .G&:H6FH7L]FNJ27%Q]N6ZMH1;B1@A5XXRP,?W23O
M=LXSQUXK1\/32_:=//VN>X%YIWVF?S96<"3*8(!.%!W-P,#CIQ3<>G];?Y"<
MKZC8O"\L.GS6R);L&N;>54>0G*1QQJ59MO\ L,,XZ'MTJ&[T+Q!/I,UBL]OY
M#QRQQP->2?NPRJ%S($W.!\YP<=0"3BJE]J%W::>VHP7EQ]JFEO8Y%,C,D:QB
M3:0A^5=NQ.0!G/.<U9*L/$B:*+Z].GLJR%OM<F\OL<[/,W;L84-C/;T-%[Z_
MUW'>SN2WWA>^O#<Q>;;I#+([A]S%OFM_*P5QC&1GKR#VJR-#OKG7+;5+I;2(
MQR1EH8I&<;4CE7()4?-F4<8X"]>U26U]J1\*6EU;#[3/A=SNF\M&#@N%!7<2
M!G&1U[]#FVNN7L<UY?\ VVVFTTW=NG,3@[7ABRRY;Y5RV[;@]^><T7!*R_KT
M.DTFSDL-/6WE*%A)(WR'C#.S#]"*R]<T?4;N>]:Q^RLMY:);.9Y&4Q[68Y "
MG=D.?3&!UJC%XAUB;4(+!#:!YI8ML\ELR#RWCE;/E^82#^ZXR1UZ=ZE@U[6K
MR-Y;2S25'#,O^CN/*"R!2"68"1BI)^4KRI'-&JU_KI_D'2W<=-X8N);"&!7M
MU:,W+'KAC))O4'CD>O\ 6HI=!UF749M2'V*&9Y]XABF)!7R@F2[1'YN/[O0X
MS72Z?<B\TZWN!*LOF1AMZQE W_ 221]">*LTK 8VA:.^CQ7:A8\2-&8UWEB
ML*)AFVC/*'G'3\JRV\/:IYR7-O\ 9;/R[A9DM(9RT8)1U=@S1G:3OZ!,?+V+
M''6T4V[NX'.:;HEYIL,]M$EN;>ZC4.6G8M"1&$VK\@#KP"/N]3Q4%KH6J6UQ
M;WH2R>>$*ODM,VP@1!"=VS(/']WH2*ZJBEYAN<M;>&+F"TNHR]N9)T@ (R I
M25G(Z?=&[ ^G:MN^LY+F]TV9&4+;3M(X)Y(,;KQ^+"KU% K'*VN@ZIICR-8+
M9*Z"<QN\S_OR[;E$@V\!<]B>G&,FDET2\AL+=!$C2[I4F<2&0NTJ$&4G:.=V
M,X'"Y],5U=%*VEA];G.3>'ISYA0P#(L0.O2"3<W;TZ?TI8M+O);"VN%2-;E+
MY[T6\Q*KAMX"D@'! ?/0_,*Z*BJ;;!:*Q@Z7HUU::A%=S- #MN3)'$20K2R*
MX"Y R!M.3QD\XYHCT:Z&KI<.+<P1WLERAW$L0T13&-N 03Z]/RK>HI ]3D=-
M\,7]C=1B66*6V,T<S!9MI1D7  'EDD<#^)?O'\=&/1)U\0RZ@[0F)IGD49.X
M PQQ^G7*-^!K=HHZ6'??S..7PQJD-M:)%+;;X+:T0GS",O"6R.488.[()'!
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M;AV+3 NA)8;?EX3)&6R3VQSUU%'4.EC!\2Z;J>J6KV]C)#Y4D$D3QR3-$-S
M!6)522 -WR\9S52Y\.DV"QW(C:);N:XG$:LS,CQ.F  ,EOF''M74T4#3.-73
M-2C\#0)-']IU2>Z@N)U=2,N9D;Y@,X 4 'K@+3[GPUJ<US->!K;?<B99[83;
M4"NL8P',39SY?/RC[WMSU]%.XNB,&#0IH! %:+$>H/=,<G)4HRCMRW(_*LUO
M"^H30:;;2_8Q%I^Q4<.Q:91+&Q+#;\O$><9.6/48KL**2T#R,'^PICJ27),&
MT:D;P]<[?(,8[?>SC\.]9Y\/:OY=E;&6W:W@E@<#SW4)L?<V%"X<G QD\>@Z
MGKJ* Z6.37PQ>PV^C>4UJ9=.M4C*,Q"2.K(<9V\#Y2<XR#@X-6%T749-:>[G
M\K[/-/'<.B7',;(H4 9BRP^4'[R_>/X])13OK<'K?S.>O=.GCBUA)(TELK[,
MC21ES.A\L+A453NP5!!R.O3CFMH.CZKIT=O>2"">[N;<"]$LA0I(79V*X5L\
MN1CC[J\UU5%(#C],\,ZAIQMUFDCG@002.$FVE7BC"X4&,EAE1_$OWCQZW]9T
MR^\0:/;9BBM;AH)?,BDD+!&DA9-N0.<%AGCL:Z&BG<=];F+/HLLW]K(LJQ)>
MV:6Z,G5"%<$X_P"!#'TK.71=:6)F#0>;)A94%X5$BJA"_,D*E<$] ,D <\8K
MJZ*3U$M#D+;PWJ5MH%UI&+*5+J!%>5I6!5A$J$8V'<N4&#D<'IQSJW>C2W,>
MK(KQJ+S88\@D950,,/0XQ]*VJ*;=W<21S.K:;KVJQ^6PLXXF108ENY J,&R6
MR(QOR,  X QWSQ7?0-8%VLUN]O#!"Y,-K]I+A=P8,0[1';U&%VD#G!&<5UU%
M(9BR:-)]CTBWA**MB"&#.6X\EHP <<\L.<#C\JH-X>OH;%;>W6R?S-,CT^42
MLP6/:"-R@*=P.X\';G:.?3J:*;=P6AS]KH$L$]J[-"XANYIRQSN(9&4=NO(S
M4J:/<+X/@TC?%]HCMHX2V3LRH&><9QQZ5MT4K]!6Z?UV.;O?#]S+K$]U;^0H
MN)89&N&E821!,!E50,$,!CJ.ISG&*ATK2-0\/PP^5;0RI! EL(X9V)N#O4>:
M^Y<+M4$_Q=2,\"NJHH6@WJ<;<>$+J:.ZM8W@AAEDN)#.LK^9*)"6",N   S9
MR&/W1@#)Q>.B7\NF7MH1;6T=W)&K012LZ1Q<"3:2H^9AGL!DY]:Z2B@'O<R=
M:T^ZNH(?[.6*.YASY4S3-'Y7&.@4AQZJ< X_$4&T'4([6,6L]O%=1W5W.LG.
M/WOF;>W4;US].]=+10'2QR5CX9OQJUU>W3P()HYD79.\SJ72)0VYE'/[MCQC
M&0!3$\.:HEJ&VV_V^-(XX;@7A01A%<*P"P@?Q$;3D$'D\"NPHH!ZF!K>BWFI
M20M&\!_T62&0R$@9+(P. #D$I@C(X-7--L[J.\O+V\6".6YV#RH'+JH4$9W%
M5R3GTZ 5IT4!8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRWX
M*?\ 'CXC_P"PFW\J]2KRWX*?\>/B/_L)M_*@#U*BBB@ HHHH **** "O)O'?
M_)9_!?X?^AFO6:\F\=_\EG\%_A_Z&: /6:*** "BBB@ HHHH 8\4<A0O&K%&
MW(6&=IQC(]#@G\ZIC1=.,+12VD4Z-,TY$Z"3YV))//UQ].*OT4 5S8V;7BWA
MM8#=*NU9C&-X'H&ZXY/YU!)HFFR0RQ+9PQ+-(LDOE($,A5MPW$=>>N>N3ZU?
MHH KI86<=U)<I:0+<2C$DHC =QZ$XR>@_*HO[&TL69LQIMG]E+;C#Y"["?7;
MC&:NT4 5[BQM+NW%O<VL$T QB.2,,HQTX/% L+,(4%I $+*Q41C!90 #]0
M/3 JQ10!2M](TRS</;:=:0,&#9B@53D @'@=<$CZ$TCZ)I,CRN^F63-,<R,U
MNA+G.>>.>0#5ZB@"&"TMK;_CWMXHLJJ?NT"_*OW1QV';TJ:BB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7'>QVTC&6*-TA9) ^7?:,X0X&>_/TZ9O1:[:E464GSF=T$=O')*1L;:20$R
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ML0D+,\,BJ=AVOM)7#8/'&:AB\56#R70<3HL$JQ &WD\QV*;S^[V[A@<].G-
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M]F16L;0VD,38W)&JG'J!4M%%-N[N2E96"O+?@I_QX^(_^PFW\J]2KRWX*?\
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M ^BBF2RQPH'ED2-2P7+, ,DX ^I) _&@!]%%% !1110 4444 %%%% !1110
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MT /HHHH **BEN8(9(XY9HXWE.V-68 N?0#N:EH **** "BBB@ HHHH ****
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MI4)GY\9R5!(.<<UHSVMS>>!=1@?[3+(\4PB0^:),9.U<L%=O3)'(QUSST]%
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>6_!3_CQ\1_\
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M2@NI2R11B&2)U92%6158<$'B5CZ<#\7I_7S_ . $?[W]?UJ5U\4>8]K(NGW
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M)Z#;YN2GRXQVQ7>44+0=SA!_:!GNTTJ75'OHKFX0&:25X/+$;!1EB4)W[/\
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M4?\ H;-9_P"_5G_\8H W**P_["U'_H;-9_[]6?\ \8H_L+4?^ALUG_OU9_\
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M_5G_ /&*/["U'_H;-9_[]6?_ ,8H W**P_["U'_H;-9_[]6?_P 8H_L+4?\
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M;-9_[]6?_P 8H W**P_["U'_ *&S6?\ OU9__&*/["U'_H;-9_[]6?\ \8H
MW**P_P"PM1_Z&S6?^_5G_P#&*9I!OK;Q)J6G7.J7-_#%9VT\;7"1*R,[SJP_
M=HH(Q&O4&@#?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O+?@I
M_P >/B/_ +";?RKU*O+?@I_QX^(_^PFW\J /4J*** "BBB@ HHHH *\F\=_\
MEG\%_A_Z&:]9KR;QW_R6?P7^'_H9H ]9HHHH P_&G_(B^(?^P9<_^BFK<K#\
M:?\ (B^(?^P9<_\ HIJW* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@##\:?\B+XA_[!ES_Z*:MRL/QI_P B
M+XA_[!ES_P"BFK<H **** "BBB@ K#\6?\@>W_["=A_Z5PUN5A^+/^0/;_\
M83L/_2N&@#<HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@##
MNO\ D>M)_P"P9>_^C;6MRL.Z_P"1ZTG_ +!E[_Z-M:W* "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@##NO\
MD>M)_P"P9>_^C;6MRL.Z_P"1ZTG_ +!E[_Z-M:W* "BBB@ HHHH *P[7_D>M
M6_[!EE_Z-NJW*P[7_D>M6_[!EE_Z-NJ -RBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *\M^"G_'CXC_ .PFW\J]2KRWX*?\>/B/_L)M_*@#U*BB
MB@ HHHH **** "O)O'?_ "6?P7^'_H9KUFO)O'?_ "6?P7^'_H9H ]9HHHH
MP_&G_(B^(?\ L&7/_HIJW*H:Y8+JGA_4M/:80+=6LL!E*Y$89"N[&1G&<]17
M$VFF>,;U$>#XB7!1R K-X;5 >"<Y('&!UZ=.>10!Z+17#_\ ",>._P#HHO\
MY1(/\:/^$8\=_P#11?\ RB0?XT =Q17!P^'_ !M<*S1?$@.%=D)&B0<,#@CK
MV-2?\(QX[_Z*+_Y1(/\ &@#N**X"ZT/QI9(CS_$=@'D6-=N@Q,2Q. , DU2$
M7B8R^7_PLUU;?Y8W>'D4,PD$9"D\-AR <9QGTHW ],HKSV32?&45\+)OB-*9
MRH?:GAZ-@%)(!)&0.0>I[4S^S_%?VV[M#\3E$]I&)9U.AP@(I!().<=!^'&>
MHH'8]%HKS46OBPQ12?\ "Q;H"9_+C#>& &=MI;A2,D8!.<8XJQ=:3XRLHHI)
M_B/(!,P2-5\/QN[$C. HRW0$GCC!S0(]"HKSA['Q9'$\C_$J0;-H*?\ "/1[
M\L,A0GWBV.P&:3[%XL$MK$_Q*DBDNI&BA2;PZD9=E&2,-CMW[]LT >D45YXV
ME^+TM)+IOB7B&.4Q.W]@Q<,&VD=?7OT[]*BDL_%,4M_$_P 3P)+"-9;E1H41
M,:D$@]>> >!DT!8](HKS06_BII(47XD3L9F98]OAI2&*DAAD#'&#4_\ 9OB[
MR8)?^%F?)<.T<1_L*+YF4,2.O'"-U]* 6IZ)17F<47B6>.[DC^*(9;.))9_^
M)#%E$9=ZG'4Y7GC^=37^G^+M-=$N?B1*&=&D41^'8Y#M7&XG;G &X=?6C8%J
M>C45YK<6WBFU?;)\3'(""1WC\/1ND:GH79<A1WY(XYZ5(VG^+$:13\3?FCE2
M%E_L&+.]L;0!G)!SU''7T- 'HU%<!9Z)XTO[?S[;XD,T>]D.[08E(96*L,$@
M\$$5/_PC'CO_ **+_P"42#_&@#N**X?_ (1CQW_T47_RB0?XT?\ ",>._P#H
MHO\ Y1(/\: .XHKA_P#A&/'?_11?_*)!_C1_PC'CO_HHO_E$@_QH W/&G_(B
M^(?^P9<_^BFK<K@+WP9XSU"PN;*[^(7F6UQ$T4J?V+"-R,"",ALC@GI56QM/
M%>I/&EM\2I"98Q+'YGAU(Q(OJI;&[J.F<9% 'I-%<'+X?\;0M&LGQ("F5]B
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MXHKA_P#A&/'?_11?_*)!_C1_PC'CO_HHO_E$@_QH [BBN'_X1CQW_P!%%_\
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MO6>U$D;;',L20Q*R?> (W*>"P!V^E9G_  F/Q._Z$:'_ +^__94?\)C\3O\
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M?B=_T(T/_?W_ .RH ]2HKRW_ (3'XG?]"-#_ -_?_LJ/^$Q^)W_0C0_]_?\
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M?B=_T(T/_?W_ .RH_P"$Q^)W_0C0_P#?W_[*@#U*BO+?^$Q^)W_0C0_]_?\
M[*C_ (3'XG?]"-#_ -_?_LJ /4J*\M_X3'XG?]"-#_W]_P#LJ/\ A,?B=_T(
MT/\ W]_^RH ]2KRSX)D&P\1$'(.IM@CZ57O=<^*^M0'3[7PU;Z89@5:Z,@R@
M/<$MQ^1/I79^ O!\7@OPVFG"437$CF:XE'1G( X]@ !^O>@#J**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P;+3[F
M#6IO,@8V2,YMG5QQYOS.2,Y&&! Q_>^M;U% '.OI$K>$+C1_LTFXPRB,>:,$
M[B44G=GTZ\>M=". *6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Y Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6H;?585T+6FEL5>TO?$LJR27B2+';H54AY%7#8Z<' YYJFK77];I?J):J_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M23[=J9IVBV.E/));),99  \L]Q).Y Z#=(S' R>,XYK0HH KK96ZZ@]^(_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJBN'_P"$G\=_]$Z_\K<'^%=5H]U?WNE0W&IZ=_9UX^[S+7SUF\O#$#YUX.0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***#TH8!17&Z%%9W?
M@V6#RK(9M09/LTWSO@$_O  "/H2<\BH=:%Y/HFGH;.=["""WFWQN@$DNY< @
ML#A<9Z8)(]*/^ #T_'\#N**YN^M%?7+PQS-:S7.EN&F9R?*.0 >N!CKQQU-<
MNX)OPD,>DP:*TEO'<M!*9+5G"39WG"@G=Y8([_*">U"U&>F45R-Y??:? ]ZD
M.EF*W:RFVR1;!!@;@,#.[#8R/EQAA67K6G06$L:7,6E1+<>?,L5V^RTB_=HN
M%R,&3C=G X+T,2U/0J*XBTDTK4=8TLV2PP7=M&DUQ+,56Y=C%A(6/5C@@M]!
MZ\9,%Q_Q)8(2EBUU,L,FI7*D[X_WJB1;ANO/.0<<*PX S3MK8.ESTVBN$N)=
M-%K;WX_L6);1;F."U:-1'=_,GS1#/&2H' ;EN_?N8F+Q(Q4H64':>H]J0#J*
M** "BBB@ HHHH ***\^^)OBS5='&EZ'H"_\ $VU:4QQRX!\L9 XSW)8<]@#0
M!Z#17DJ?!O4;N)9=4\::E+=MRY4L5!/H6;)I?^%(_P#4W:I^7_V5 'K-%>3?
M\*1_ZF[5/R_^RH_X4C_U-VJ?E_\ 94 >LT5Y-_PI'_J;M4_+_P"RH_X4C_U-
MVJ?E_P#94 >LT5Y-_P *1_ZF[5/R_P#LJ/\ A2/_ %-VJ?E_]E0!ZS17DW_"
MD?\ J;M4_+_[*C_A2/\ U-VJ?E_]E0!ZS17DW_"D?^INU3\O_LJ/^%(_]3=J
MGY?_ &5 'K-%>3?\*1_ZF[5/R_\ LJ/^%(_]3=JGY?\ V5 'K-%>3?\ "D?^
MINU3\O\ [*C_ (4C_P!3=JGY?_94 >LT5Y-_PI'_ *F[5/R_^RH_X4C_ -3=
MJGY?_94 >LT5Y-_PI'_J;M4_+_[*C_A2/_4W:I^7_P!E0!ZS17DW_"D?^INU
M3\O_ +*C_A2/_4W:I^7_ -E0!ZS17DW_  I'_J;M4_+_ .RH_P"%(_\ 4W:I
M^7_V5 'K-%>3?\*1_P"INU3\O_LJ/^%(_P#4W:I^7_V5 'K-%>3?\*1_ZF[5
M/R_^RH_X4C_U-VJ?E_\ 94 >LT5Y-_PI'_J;M4_+_P"RH_X4C_U-VJ?E_P#9
M4 >LT5Y-_P *1_ZF[5/R_P#LJ/\ A2/_ %-VJ?E_]E0!ZS17DW_"D?\ J;M4
M_+_[*C_A2/\ U-VJ?E_]E0!ZS17DW_"D?^INU3\O_LJ/^%(_]3=JGY?_ &5
M'K-%>3?\*1_ZF[5/R_\ LJ/^%(_]3=JGY?\ V5 'K-%>3?\ "D?^INU3\O\
M[*C_ (4C_P!3=JGY?_94 >LT5Y-_PI'_ *F[5/R_^RH_X4C_ -3=JGY?_94
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M*** "BBB@ HHHH *\F\>$_\ "YO!8SQQ_P"AFO6:\F\=_P#)9_!?X?\ H9H
M]9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRWX*?\>/B
M/_L)M_*O4J\M^"G_ !X^(_\ L)M_*@#U*BBB@ HHHH **** "O)O'?\ R6?P
M7^'_ *&:]9KR;QW_ ,EG\%_A_P"AF@#UFBBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "O+?@I_QX^(_^PFW\J]2KRWX*?\ 'CXC_P"PFW\J
M /4J*** "BBB@ HHHH *\F\=_P#)9_!?X?\ H9KUFO)O'?\ R6?P7^'_ *&:
M /6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\M^"G_'C
MXC_[";?RKU*O+?@I_P >/B/_ +";?RH ]2HHHH **** "BBB@ KR;QW_ ,EG
M\%_A_P"AFO6:\F\=_P#)9_!?X?\ H9H ]9HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KRWX*?\>/B/_L)M_*O4J\M^"G_ !X^(_\ L)M_
M*@#U*BBB@ HHHH **** "O)O'?\ R6?P7^'_ *&:]9KR;QW_ ,EG\%_A_P"A
MF@#UFBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O+?@I_Q
MX^(_^PFW\J]2KRWX*?\ 'CXC_P"PFW\J /4J*** "BBB@ HHHH *\F\=_P#)
M9_!?X?\ H9KUFO)O'?\ R6?P7^'_ *&: /6:*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3=T+#TS1*WV=K/\ +^OF3KUWT_,YSP7KVN^(8;*ZO/B18V\\EP5.EO9VWFN
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MY)91]X*I(  _SUXYRU\-ZQHWQ:T>SBL;B30;2:XN+6X2)C'"LJ$F,L!@88'
M]_>MJR&L> -?UO\ XD=]JNBZC<M>12Z>HDEB=OO*R$@G_P"M^1HTGZ_FO^"#
M35UZ?K_P#NM'M]1M=.2'5;]+Z[4G=<)"(@XSQ\H) .*OUST'B>XG.E_\4]JT
M0OY'1O-AP;8+T:7&0H/;FNAH8@HHHI %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7EOP4_X\?$?_83;^5>I5Y;\%/\ CQ\1_P#83;^5 'J5%%%
M!1110 4444 %>3>._P#DL_@O\/\ T,UZS7DWCO\ Y+/X+_#_ -#- 'K-%%%
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M *&:]9KR;QW_ ,EG\%_A_P"AF@#UFBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "N0TOX?:7!>ZI?:S#9ZS>7]R9_-N;-3Y2] BAMW ]>]=?11Y@<*?AO#
M?$D.GWZ6>GZW (_LD=J-ENX&-RX8 CKQ@=>M7=2\$?VAX>\/Z3_:'E_V1-;R
M^;Y.?-\I<8QN^7/U./>MGQ)K/_"/^'+_ %;R/M'V2(R>5OV;L=LX./RKGK#X
MB6^H_#V\\4Q6)$EHK>=9&;E6';=M[@@YQWHYK+TM_P  =M?6_P#P34TCPO\
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M8)?+,OERS*K;!U;!/0>M1'7M&6VAN3JU@()SMAE-RFV0^BG."?I0NENG^?\
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M:S;-@)Q@\=Z[FJDF]_/\=Q1LM%Y?@<=\+=*N]'^'^GVU]"T,[%Y3$XPRAF)
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MZ3-:PMXKN+G2[7 CM7M(PY4# 5I.I'X \5GZM\25TGQ[%X;ETIF@9X4>^$^
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MR%E(VY[86Z>6QSG)7&"<@4DO=M_6_P#EH4G:5_/_ "_5#])_Y UC_P!>\?\
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M>/\ NRJ.#CMD9ZTF]7;;_@_Y ME?^M'^IZ;HVK?VS9M<'3[^P*OL,-]#Y;]
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M\5Q6.F7&C:9>B%].TVYQ&=Z$,WR9Q&&QT]3[5*^'[_S7Z;6*:3:^7ZG<:?\
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M2&]M=57;$C8^40@DG.>I!(]Z4=TGV_0J6E[=SU6BBBD 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>6_!3_
M (\?$?\ V$V_E7J5>6_!3_CQ\1_]A-OY4 >I4444 %%%% !1110 5Y-X[_Y+
M/X+_  _]#->LUY-X[_Y+/X+_  _]#- 'K-%%% !1110 4444 %%%% !1110
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MEQN8L0X(4]%7!]:%_7X_Y ]';^NAV%%<9IOB'7KS2-+GD&G)=ZLP6W58G*0
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M\P>E_P"N_P#D=M1112 *\M^"G_'CXC_[";?RKU*O+?@I_P >/B/_ +";?RH
M]2HHHH **** "BBB@ KR;QW_ ,EG\%_A_P"AFO6:\F\=_P#)9_!?X?\ H9H
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M\GS/(D\GS,XV>;MV;L\8W9SQ52T\765QJ.K6TT=Q;1Z<PW336\J(1M!)W,@
M.3@#.2.1D&E?^ON_X V:NG:=#ID4T<+.PEGDG;>0<,[%B!@=,GBJ^HZ(M]=I
M>07UW87:IY1FM=F73.=I#JRD9Y'&1S@\FI=.UBRU7S!:O*'CP7CG@DA< ]#M
M=0<'!P<8.#5^@5S)B\.V4"Z:L9E7[!,\\9W9,CNK*Q<D<D[V/;FKFHV$.J:;
M<V%SN\FYB:)]IP<$8.#ZU5A\0Z;-=26PEFBD16?,]M)$K*OWBK.H# ?[)-3:
M;J]IJT;R6GVC8N/FFM9(0P/0KO4;A[C(HW#9D=GHRVMY%>27ES=7,=N;?S)M
M@+*6W9(15&>W ''YU3_X16VC@MEM;V\M;BV:4QW,10R 2/O=2&4J5)QP5[#O
M5W4==T_2YD@N99?-=2X2*"24JO3<VQ3M7_:.!65H_BBW'AO3+O4;B2:XNXV=
M1;V[RNX!^\$C4G &.<8Y%%PM;^O(U(-&CBOK6]ENKFXN;>WDMQ)*5^<.RL2P
M50,Y0=,#VJ*+P[:0VNGVZR3E+"X-S$2PR6._AN.GSGICM3IO$>EQ"VQ-+-]I
M3S(Q;6\DY*=-Q"*=H]S@4W^V[2U749KJ_5XK:Y$)58&#1L50B, 9,C'<"-H_
MB QD4_Z_'_-@6=*M[ZWMI?[0N%FG>>20;?NHA8[%' Z+C\<UFWWA*VOY+P-J
M%_%;7CB6>VB9 C2 * V2A8?=7C=@XZ5*GB_0VM[N=KMXDLS&+@3V\D31%SA=
MRLH(R?;WZ58L]?TZ^%QY,DP:W0/+'-;21.%.<,%=0Q!P<$ @XI>8;_U_7<8=
M"$FKQ7]SJ-Y<""1I8+:3RQ'$Q4KD;4#'AB/F8]:J^)-'N=6O=$,#S1);7;2R
M3PNJO$/*=0PW9!^8@8P>O(Q1>>+]/@T?4+Z%+N1[*+S'MWLYHY.0=I*LFX*2
M#\V,#!YX-3#Q1IRV%I<R_:T:Y4LD(LIFE('WCY83?M&>N,<CUH_0 B\-6J1*
M);FZGF^UI>27$C+OED7 &["A0, #  Z4^^T%;N^>\M]0O;">5!',UJ4_>J,X
M!#JV",GD8//6G7'B32K>.VD-P\HN4\R(6\$DS,G=L(I(49&2< 5%X5U*75_#
MT-]+.)S)+-MD  #*)&"]./N@46O_ %\@V^8U_">ER0B%TE,*6GV2*/?Q"N<E
ME/4,2%)8DGY12S>&+2X6X,UQ=/-/Y),V]0ZO%]UU(& V>3Q@^F.*EN/$NDVM
MZUI+<2!T8)(ZP2-%&QZ!Y NQ3R."1U%,O/%6CV-U<6T]S)YML1Y^RVE<0@@,
M"[*I"K@_>) Z\\&C<+#UT>[%DT!\0:F9F<.+DK!O48QM \K9C_@.?>H['19]
M-N[..UNF_L^%)GF5SF2>9V#;FP ,<N>,<D<8K7:54A:7ED"[OD4L2/8#D_A7
M&'QPEW::=>QK<6<+:HUK.LMK(-Z 2@!=R DDHO"\@_+UXH6X;K^O4Z?5-*AU
M6*)7EF@F@D$L$\) >)\$9&01T)&""#GI52;P\UQ;6ZRZQJ+7=O,9HKW]SYJD
MJ5(QY>S&"1C;^M2Q^(]+DT^:^^T.D,#^7*LL$D<B.<84QLH?)R,#&3D8ZU9T
M[5+35(G>U>3]VVUTEA>)T.,X9' 8<<\B@#,7PE:1VQ2.\ODN!=-=I=B13*DC
M##$97:01GY2".>G3%RVT58;ZVOI[ZZN[J""2 23>6-RNRL<A%49&P 8 X]:6
MYU[3K358]+EF?[;(BNL*0NYVDE0QV@@#(Y)X'?&:BA\3Z3<2O''<2G:K,'-O
M($D"\MY;%=LF/]DFB]@L6]-TV'2[:2"!I&5YY9R7()W.Y<] .,L<54?PY8R:
MQ>:D_FM)=VWV:2,L-FWH2!CJ0%!/HHJ>36]-ABMY9+M%BN(6GC<@X,:@,6)[
M#!'7UJNGBC2'L[NZ:>6**TB\Z;S[:6)ECY^<*RABO!Y (H:[_P!=!IO=?UU&
M6?A>QLM'T_3(Y;EHK&9)D=W!=V4Y&XXY_2DE\+V\K7JM>78@NYTN6@!38DBL
MK;E.W=R4&021UQBGMXJTD10N'NI/.W>6L=C.[L!C+!50G9R/FQM.1S4MUXBT
MNSO/LL\\@D&W>RP2,D6>F]PI5,_[1%/6]_ZZ?\ E6_K^O-ED:?"-7;4MS^<T
M @VY&W:&+9Z9SD^M1:EI*:C/9SBZN+6>TD+QR0;,G(P5(96&"/;/H15NZNH+
M*UENKF18X(E+N[=% ZFLP:Y;70LG@GFMEENA#MN;&6-I3L9MH#A2.F=V,<8[
MTD,/^$;L_P"R1IOF3^2+O[7NW#=O\[SL=,8W<=.G?O0GA\0:@]S::G?6L,LW
MGRVD1C,3OW/S(6&<<A6'ZUFZ_P"+;:")8+"ZD%U]N@MR_P!G<QDF95=!(5V%
ML%@0#D<^E:TGB+2XM1-BT[^:'$;,()#$KGHADV[ QR."<\BFN_\ 73_@#?F:
ME%%%(05Y;\%/^/'Q'_V$V_E7J5>6_!3_ (\?$?\ V$V_E0!ZE1110 4444 %
M%%% !7DWCO\ Y+/X+_#_ -#->LUY-X[_ .2S^"_P_P#0S0!ZS1110 C?=/TK
MS_PU%J.I^&/#MD=,>""W>*Y:\\V/RV5"6 4!M^X\ Y4#D\GOZ#4<$$-M D$$
M211(,)'&H55'H .E"W!ZJQQXTW5O[$'AO^S'V>?G^T?-C\KR_-W[L;M_F8[;
M<;N])J'A>]U&_P!8L7C TJXBDGMY-XRMQ(H4@#J,%6;/J_M71:=J<VH:A?QK
M;1I:6LI@$IE)=Y  3\FW 7GKNR<=*MR7MO%?063OBXG5WC3!Y"XW'/3^(?G1
MT_KM_P "X7U_KN<;)X?U6^T"SO+^VD_M47:7=U:V]V8G(6,Q[$E5A@X^;[P&
M<C/-6(-"9I-.N+;2;ZU*ZFMQ<"_O1<2%5B=0Y8R/W(  .?:NBT;4_P"U[!KK
MR?*Q/-#MW;O]7(R9S@==N?QJW!))(9?,@:+:Y5=S [U_O#!X!]#SQ3OJ'2WR
M_,EKBK33-5MM/TTG3)6FTF]ED\HRQ8N4?S!NC.[ (#@_/M[CWKM:S]&U/^U[
M!KKR?*Q/-#MW;O\ 5R,F<X'7;G\:2WN@94T:VO)-6U'5KNT>R^U+%%';2.K.
M%3=\S;"5R2QZ$\ 5F>)['5[^[N8$MKZXLY;79;BTO1;HDOS9,I#JY'W<8W#K
MD5UU8$'B;SKBTB^R8^T:C<6.?,^[Y0D.[ISGR^G;/4XH:YM!K37^OZT,'39-
M1TKQ'/#'I$M[(FCV44B0RQJT;CS1R78 KUR02?8T64%_X?UW2K=-/;4)8='*
M2I;NBLI,BGY?,905SQU'&*[E8(5N'G6*,3.H5Y HW,!G )ZD#)Q]34%K-97E
MS// J//;N;:239A@1@E<D9QR/:FW=W_KK_F3:RMZ?I_D<O9:1J>C2V.I"Q:\
MD"W0FM()$#Q^=*)1L+LJG&,'D>HIT&BZDVHV.H2VWEF35);R:'S%/D(;=HU!
MP<$D[2=N>6/4<UV-,E?RH7DQG:I;'KBDW97':YRMEHM_#X;\,VCV^V>RN(GN
M$WK\@"L"<YP>O;-:.AP7=GJ&KP3V<B12W;7$5SO0HZL%X #;@1@]5 ]Z-'\1
M?VK)IZ?9?*^UZ<M]GS-VS) V=!GKU_2MRFTTW?S_ *_ 5^;7^NK_ %,@V,Y\
M7I?^4/LXL&A\S(X8R XQUZ"L/3]#U"WDTUKBQ\R."/4%ECWH<^9*&1>N/F _
M#OBNBUK4SI.G?:$A$TKRQPQ1E]@9W<(N6P<#+#)P?H:O0F5H$,Z(DI4;U1RR
M@]P"0,CWP/I2MI_7F_U'L[_UT7Z&#X9M]0MY;I);6[M-- 06MM>3)++&>=V&
M1F^3[N 6)'/08J+6;6^;6X9]+T^[CN\QJ]\DT8@:,-EED0ON; W8PA(SP1S5
M^?Q!;K;6MQ:K]HCGO19YR4VMO*,>1S@J?KZUKT[]0[HX>\T[6DTW4='M]*>8
M3WYNDN_.C$7EM,)",%M^X<C&W''6GSV6LQR^)K./16FBU68^1<B:((H,*(3(
M"P; (/0$\'CIGM:*2VM_73_(=W>YRAT^^MM=MO[.L;R$JT:W5VTT?V>YC50#
MN3>6WXX!V@\#)QQ59M)U1K*YL/[/D^76DO4F\R/9)$;@2$CYMP*KG(('MFNE
MTS4O[1:]'E>7]ENGM_O9W;0#GIQUZ5?IIZW_ *[BZ6_KJCC]2TC4KB7Q+:Q6
M;,NH".:WN#(@CW*B+L;YMP)*]=I&#UJS!%JFI>)1?SZ5+8VRZ?);CSY8V?S&
M=3T1F&,#@Y['..,]/14VTM_6S7Y,'J[_ -=/\CS^/0M1;2O#[W&EZCYFEV[6
M<UM;7X@DD!5!YD;I*H(RG1F7@].!6_I4UOI)L-+ATZ[MI;YIIVBN+GSI(P.6
M=W+MG)*]&/+5T-%4W=W8&3XA347TT#3A,S^:AE6!U25H\_,$9B%#?4COR#7+
MP>'=2-M?8L;B-;C5K.ZCCNKL3R"-#%O+,7;D;6XR?09KJKW59H-:L=,MK:.:
M6X1YI&DE,8CB0J&(PIW-EQ@<#KR*U*%IK_7]: ^W]=3D]:T*^O\ 4]6EAC4)
M-9VHA9G $DD4KN4/< Y49QWJ:Q35+[Q@FIW.CRV%JE@\ ,TL3.7+JV"$9AC
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MVU5XK&T@NI[J&U@CN)\>=*D8#R8&!N(Y./>A/5,.A!K2W[Z-=+IAQ>%/W1R
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M#D\9ZUVM%5?6_P#7<A*RM_6UCC=9\/7]]<ZI,D,C*;RVN8DCN3"TRH@# .K
MJ>N#D<@=JU?#EA%:_:KA=,U&REF*A_[0O3<R.%!P<^;)@#)[_A6[5)M2C?[=
M':1M<W-GA7@7"DL5#!06P.01WQS26F@WJ46TR>3Q5>W;1[;>;3H[=901G<'D
M)&.O1E-8?AOPZ;&73K>^TC5//L$PMW)JC2VVX(5W)&9B1D$\%!C)KJ+K5;>W
M:ZA!W7-O;?:6BY'R_-CG&.2I%3V%U]NTZUN]FSSX4EV9SMW '&>_6A?U^/\
MP0;O_7I_P#B5\)ZG<:=JME.JHL$)M-,/FXW1;_,!)4Y7.$3U^3-/GT"2\T/6
M4@T35;>_FL'MHSJ&I_:/,W?PINF< 9 Y.VNZ=MJ,V,X&:I:+J7]L:)8ZEY7D
M_:H%E\O=NV[AG&<#/Y4UW'YF1XDM+ITMVT[3;U]0CB9;>[M9HHQ"3CB0.XW(
M2 2-K=.F<5D7/AN8ZEJ(O]+U/48=0D61FLM4:"(91499(_.0$94G(5L@X[5V
MEM?6]W-=102;GM9?*F&"-K;0V.>O##IZU8HVU%Y%3488Y-*N('LVO(VB*FV!
M ,@Q]T%B!GZD?6N7M=-UF9]/,MO=):VVIK-%'>3QR310B%U.YE8AOF/'S,<'
MGV[.BEUN'2QPESIFM+I,&AQ:.\JPZE'.;PS1"-HA<"0D MNWXZ@J!P<$\9=%
MX:,.I7%O>:5JMY#-?-<)<0ZHR6X5GWC?$9EY4]@AS@&NQN+ZWM;BU@FDVR74
MACA&"=S!2Q'MPI/-6*:T_KT_R0/M_77_ #84444@"O+?@I_QX^(_^PFW\J]2
MKRWX*?\ 'CXC_P"PFW\J /4J*** "BBB@ HHHH *\F\=_P#)9_!?X?\ H9KU
MFO)O'?\ R6?P7^'_ *&: /6:*** &3>9Y$GE8\S:=F?7'%>=:<-),.C"P$/_
M  E/GP_;\8^T]?W_ )^.=N-WWN,[<=J](HH6CN#VL<OX.TO3["76VL[&UMF.
MHR1DPPJAV@+@<#H,GCWJ#Q!9Z,GCC0;[4K:P4M'-&L]PB<R@QF-0S?Q?>VCK
MUQ77@@]#1D>M"Z>0=_,\UM]-L[;PZFL1V\8U(:ZP6Z*YD56O2A4-U"E21MZ<
MFIKZ+3I;/4&U&^TZWCCUJ5UBU/:;>X.P#8X)&>N1UP0#@XQ7>V=[;ZA:I<VL
MGF0N2%;!&<$@\'GJ#4]']?E_E^(;Z_UU_P S/T*=+G0;&:.S%FCPJ5MP,",8
MZ#@<>G XKSK3_P"Q38R"U\C_ (2;^V)?)Z?:,?:FSM_B\K;G./E^]GFO5:A2
M[MI+J6VCN(GN(0#)$K@N@/0D=1G!Q3OK?^M[ATM_78\WU>^MKCQ%'=0+I5KJ
M,6K0P/&(=U^T?FJA9G# I&P[%2"".<FKEOYGVG3/*QYG]OZALSZ[)\5Z%126
MBL-L\WTX:28=&%@(?^$I\^'[?C'VGK^_\_'.W&[[W&=N.U:GAD>']"NO$(5-
M.L9X;QVE5$2-TA(7:2!SMR3CMS7:57O;&WU"W^SW4?F1;U<KN(R58,.GN!Q3
MOK_7E_D3;^OO_P R9WV1,X4MA2<#J:\QTF[M;CQ%87=C_9$+7<%Q]JM["$^:
MA\O<%GDW?,X/8J""#[UZ3]MM_MXL?,_TDQ>=LP?N9QG/3K2W-Y;6:HUU<0P*
M[B-#*X4,QZ*,]2?2I:O_ %ZK^O0=_P"ON.-\(?\ 'SH'_8NQ?^A)6AXJ^Q?V
MEI?]M^3_ &'B7S_M&/)\W"^7YF>,8WXSQG'?%='<W,%G;R7%U/'!!&-SR2N%
M51ZDG@5(K*ZAE(*D9!!X(JI.[O\ UJV_U%%6_KT/-+S3]-OM&DV6EM<:.NMV
MJZ=OC5T$;/$)!'D?<+;QQP1GM7I'V>'[/]G\J/R-FSRMHV[<8QCIC':I*9)*
MD,;R2,%1%+,3V ZFDVK6_K8?6YYC8Z?HW]A1:=;P6D4X\0;+N&W"I(%^T2;
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M)J6F:%I5\-2D>"6_-N;/RD\O8\S+G.W?N&0<[L>U2V.L>)-0OOMEM9Z@]O\
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M'R1M< @'CKU-$K-Z=_U;%&Z_KRL<#XAOI->\)2:;.!YT%G<3:BH' :$%0/\
M@4@##U"U:N=4UV>^DLM+AU';9VL)3[&MJ5=V7/[SSF#;> /DQT//IU)T#2R^
MI/\ 9%#:FH2\8,090%VXZ\<'MBF7GAS3+V5)9(YXY4C$0>WNI8&9!T5C&P+
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M^VC4)Y Q'S>:MP1'^.%0#VQ741>'M,AU#[<D#B7>9 IF<QJYSEUC+; QR?F
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M>U_L^WLU2ZF>-@8M_P ^51L_>''?U&.4AD:^)6?Q3OLK>_U&VN-*AN(H+?:
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ML_V1;7-VT<]UF(841.P&9591EE7M4>C^),:--=3SR:E#]L-M8SQ(OF7HP,8
MVKG=N&>%PN>!5_7[#4;JYTJ[TV.UEEL;EI6CN9FB5@8W3AE1N?FST[5G#PWJ
M.V2_WVD>I&_%\D",Q@4B/RRA; )RN<MMZG..*:V_KNA/^OQ_X!H+XHM$M[I[
MNVNK.XMMF^UF53*=YPFW8S*VX\#!Z]<4Q_%=O;6M]+?V%]8R6=N;IX)EC+O$
M.K*4=E/IC.1QGJ*IW'A[4M3DN=0O'M;;4#Y'V>*%VEBC\ERXW,54MN)(/RC
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M>8//*80_REN/OKT(ST^[C&3Q26/A_6XO^$?M)SIZV>C2#$D<KM).HB>,':4
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M:.1<D;E(P1D<]*DC18HUC0850% ] *=10 4444 %%%% !1110 4444 %%%%
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M<:7JRVMM>SFXGMY+-)B'.-Q1B1MSCG(:M*+Q=H,VJ2Z:FI1_;(6D62(JP*;
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M!K44>IR0+!=R-8J\4X4DJP0ME6&<9W'Z5ICQ;H3:+%JXU&,V4K^7&X5MS/\
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M_P#)9_!?X?\ H9H ]9HHHH 1ONGZ5XSX>TO6_$'PXT[1;;3(DM);XS-J'GJ
MB+.6/R_>WY! QD8[U[/4-K:6UC;K;V=O#;P+G;'"@11DY. ..I)H6COZ?@[C
M>L;?UM8Y*Q\,7;7?C03Q_9AJ[[+>X#*6*>4%SP<C!SP<5E6_A[Q#?6/AG1KO
M2X;&'1;B*:6]2X5A*(P0!&H^8;N^X#\:](HH6EOE^&WYB_X/XGG=GH&N6WCU
M?%)TJ,+=RR6T]J'CWP0\!)LYP6.WY@"3@@=JI3:1)<_%672[:6*32)I(]8NT
M1L[)8P4"G'3<P5N?[M>HU6M=/LK)YGM+.WMWG;?*T400R-ZM@<GW-"TMY?U^
M>H/6_G_7Y:%/Q+I"Z]X;U#2VQFXA9$)[-U4_@<&O/6\->+?["37%L$_X2G[4
M6:#ST_U1A\G&[.WL'QFO5Z*5M_Z_KL.^QP]EX5N],USPW]G@W6>GZ5-;2R[U
M'[QMO;.3D@G(%9^A>%M9L[3P.EQ9[&TR6Y:\'FH?+#JP7H><Y'3->D455W>_
M];M_J3;2W];6.1\9:9JM[JGAR\TNQCO/L%XTTR22J@"[".I[^F ><5SE[X+U
MS7!K^J36ZV%U>W5K/;V7VG!(@_O.F0K-V(/'%>HT4EI_7I_DBK_U]_\ F<GX
M3T9[34+O4+C2K^RN)(DBWWNIF[>0 DX^\V .W/<\"LKQOX7UG4-5WZ)&I@U:
M%++5&\Q5,<:N"' )Y.TNO&3R*]!HHZKR$M+G%WFC:GHWC"/6])TU=1M6T];$
MVRS+&\.UL@J6P-OJ,YX[UD'P=K=KX3LPD$4^H0ZV-6>SBE 4#>28T9L#@'O@
M9S7I=%%W_7K?\P_K\+?D>;:GX8U27Q'?:J=,U"ZM]5@B$EM:ZL;9X'5=I1\.
M%=?<$]^#FK%MX?U?PYX@:[TO1TO+.YTV&T$378!M6C!P"S<LG/49/M7H-%'2
MW]=?\QW_ *^[_(YCX>Z3?:'X)L-/U* 07<1DWQA@P&9&(Y!(Z$5S=MX3UA;3
M1XY;$?Z/XCEOI09$.V$ERK]>>HX'/M7I=%._O<Q+5U;U_$YG1=)O;3QQXEU&
M:#9:7HMO(DW*=Y1"&X!R,'U K#\5:)XEU74-7@2*XN+&XM0ECY.H&WCA;:0W
MF*I!<DGC.5['%>A45+5U;Y%<VM_Z_K0\]TS1M?\ #NL6^J0Z3_:"W&EVUI-$
MMQ&DEO)&,'ECM*GV/6KN@Z=K7A[7=6@_LLW=CJ=\UV+V.X0&$.!E75B"<8XV
MY_"NUHJF[N[\_P 7<E*RMZ?@>6GPGXB_X0]_!8T^$P-<EQJQN%V^7YOF;MGW
M_,[=,>]=#IWAN[3Q'XNN)XO*BU*.&*VN=REF BVL>#D8/KBNQHI/5-/K_DE^
M2*N[W_K>_P"9Y6GA_P 4-H_A71I-"A1-&U&&2:Z6ZC(>-"?G1<YZ')S@^@-/
MUCPYXKU,W*7-O<W,JZDD\,PU+9 8!*"%6$$#< .=P]P2:]1HIW=[_/\ +_(7
M2W]=?\S@9?#6IMI/CN(68,^JR2&T&],R@Q!5YSQSGKBDL](UWP_X@CU6WTH:
MBESIEO:S1)<(DEN\8YY8@%3['K7?T4EI_7E8'K_7FG^AY?/X*OH]2U>WN-,O
MM1L=2NVN5:#5V@B4/@E98]PS@CJ V1BN^UO1X=9\/7FDR?ZN> Q GG:<<'Z@
MX-:5%'V>4=WS<QY+_P (SXP_LAM<^P)_PDXO,B'STP8?(\G[V<?[>,UT=OX5
MN].UGP:+:'?9Z5:SQ7$NY1M9D4 XSDY8'H#7;T4[_P!?UZW]2;:6_K^M+'E]
M[X9U]O"'BC0$TOS6NKU[JUG6>/;,KRJVW!(*D '.>/>NIET>\/Q TS4X[<"R
M@TV6W>0,HVN64JN,YZ ]L5T]%):6_KI;\AO7^N[N<MXNT[4KB^T+4]-L_MKZ
M==M+);B58V=60K\I8@9&>YK)?PWJDFC>.H_L(%QJTCM:*9$S(#$ .<X'S9ZX
MKOZ*5M&O7\;?Y#OJG_6E_P#,\SN?".JV^J17XLKZ\BGTZWMIH;+5#:O$\:X.
M<,JNISZG!S@<UW.C:<FF^';2PBMS;K% $$'FF3RSC[NX]<=,UIT4WJFN_P#P
M?\R4K6\O^!_D>.^&_!WB"UM-$M!X<ATF]L[OSKK5Q<1;Y8MY)CQ&2S9! PW'
M%:\_AOQ#:Z/XA\.VVF074.K7,TT>H-<*JQK(1GS%/S%E[8!S@=*]+HH>N_\
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M444EI_7R&]7<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "O+?@I_QX^(_P#L)M_*O4J\
MM^"G_'CXC_[";?RH ]2HHHH **** "BBB@ KR;QW_P EG\%_A_Z&:]9KR;QW
M_P EG\%_A_Z&: /6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *\M^"G_'CXC_ .PFW\J]2KRWX*?\>/B/_L)M_*@#U*BBB@ HHHH ****
M "O)O'?_ "6?P7^'_H9KUFO)O'?_ "6?P7^'_H9H ]9HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KRWX*?\>/B/\ [";?RKU*O+?@I_QX
M^(_^PFW\J /4J*** "BBB@ HHHH *\F\=_\ )9_!?X?^AFO6:\F\=_\ )9_!
M?X?^AF@#UFBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O+
M?@I_QX^(_P#L)M_*O4J\M^"G_'CXC_[";?RH ]2HHHH **** "BBB@ KR;QW
M_P EG\%_A_Z&:]9KR;QW_P EG\%_A_Z&: /6:*** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *\M^"G_'CXC_ .PFW\J]2KRWX*?\>/B/_L)M
M_*@#U*BBB@ HHHH **** "O)O'?_ "6?P7^'_H9KUFO)O'?_ "6?P7^'_H9H
M ]9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRWX*?\>/
MB/\ [";?RKU*O+?@I_QX^(_^PFW\J /4J*** "BBB@ HHHH *\F\=_\ )9_!
M?X?^AFO6:\F\=_\ )9_!?X?^AF@#UFBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "O+?@I_QX^(_P#L)M_*O4J\M^"G_'CXC_[";?RH ]2H
MHHH **** "BBB@ KR;QW_P EG\%_A_Z&:]9KR;QW_P EG\%_A_Z&: /6:***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\%_A_P"AF@#UFBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #R*X/1++Q+X-BGTFT
MT:/5M-\]Y+2:*Z2%XU<EML@?T)/(S]*[RBA;W#I8\_FT?Q!IEYXDCL](AU&+
M6V\Q)FN$3R6*;2L@;DJ.VW-2^'O"=_HWBG2I94$UK9:"+(W.X?ZT2 X SNQC
M/..E=W10M/Z]5^H?U^7^1YH/"NMQ>#K"%+$->V.N'4!:^<@,D8E9@ V=H)#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KRWX*?\ 'CXC_P"PFW\J]2KRWX*?\>/B
M/_L)M_*@#U*BBB@ HHHH **** "O)O'?_)9_!?X?^AFO6:\F\=_\EG\%_A_Z
M&: /6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\M^"G_
M !X^(_\ L)M_*O4J\M^"G_'CXC_[";?RH ]2HHHH **** "BBB@ KR;QW_R6
M?P7^'_H9KUFO)O'?_)9_!?X?^AF@#UFBBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5@V6GW,&M3>9 QLD9S;.KCCS?
MF<D9R,,"!C^]]:WJ* .=?2)6\(7&C_9I-QAE$8\T8)W$HI.[/IUX]:Z$< 4M
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
7 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
